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 ABSTRACT 
 
 
This descriptive correlation study had four purposes: describe depressive and 
anxiety symptom levels in pregnant and non-pregnant African American (AA) HIV-
positive women, examine the association between underlying vulnerabilities and 
depressive symptoms in HIV-positive AA women, determine the association between 
underlying vulnerabilities and anxiety symptoms in AA HIV-positive women, and 
determine the predictors of depressive and anxiety symptoms among African American 
HIV-positive women.  A convenience sample of 80 African American HIV-positive 
women was recruited from university-based obstetrics/-gynecology and infectious 
disease practices in a large metropolitan city in the Mid-South. Depressive symptoms 
were measured with the Center for Epidemiologic Studies Depression Scale (CES-D) 
and Edinburgh Postnatal depression Scale (EPDS). Anxiety symptoms were measured 
with the Beck Anxiety Inventory (BAI). Sleep quality was measured with the Pittsburg 
Sleep Quality Index (PSQI). An investigator-developed demographic data form was 
used to obtain patient characteristics including data about inherited and acquired 
vulnerabilities. Inherited vulnerabilities included family history of mood disorders and 
family history of alcohol and/or drug use. Acquired vulnerabilities included educational 
level, income level, alcohol and/or use, HIV disclosure status, sleep quality, and history 
of sexual assault. The stress diathesis theory provided the conceptual basis for the 
study. The sample consisted of both pregnant (n = 20) and non-pregnant (n = 60) 
women. Participants were typically single (57.5%), middle-aged (33.21 ± 10.7 years), 
and had completed high school (30%) or some college (35%). Poverty was prevalent in 
the sample, with 70.5% reporting annual household incomes below $10,000. Most 
women (92.5%) had disclosed their HIV status.  Almost half of the sample (42%) 
reported a history of sexual assault. Substance abuse was higher in the non-pregnant 
group of women (40%) than the non-pregnant group (5%) of women. Median 
depressive symptom scores for the total sample were mildly elevated. Median anxiety 
symptom scores for the total sample illustrated little or no anxiety symptoms. Poor 
sleep quality was prevalent in both groups and was associated with elevated CES-D, 
EPDS, and BAI scores in both groups of women. Family history of mood disorders was 
associated with elevated CES-D scores in the group of pregnant women, and elevated 
BAI scores in both groups. HIV disclosure was associated with elevated CES-D scores 
in the pregnant group, and substance use with elevated CES-D scores, in the non-
pregnant group. Non-pregnant HIV-positive women had higher depressive symptom 
scores on both the CES-D and EPDS when compared to pregnant HIV-positive women. 
Regression analyses were performed to determine which independent variables 
predicted elevated depressive and anxiety symptom scores. Substance use and poor 
sleep quality were statistically significant predictors, accounting for 55 % of the 
variance in CES-D scores, 43% of the variance in EPDS scores, and 53% of the 
variance in BAI scores. Future studies should include testing interventions that improve 
sleep quality. Untreated mood disorders are problematic in HIV-positive patients, as 
depression is associated with decreased adherence to highly active antiretroviral 
medications. Ongoing assessments of depressive and anxiety symptoms are necessary, 
as clinically significant levels resulting in referrals were warranted. 
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 CHAPTER 1. INTRODUCTION 
OVERVIEW 
 The human immunodeficiency virus (HIV), the virus that causes the fatal disease 
acquired immune deficiency syndrome (AIDS), is a significant health problem in the 
United States.  The Centers for Disease Control and Prevention (CDC) reported an 
estimated one million HIV cases in the United States through 2003 (Branson et al., 2006; 
CDC, 2006). Each year, there are 40,000 new cases of HIV in the United States. HIV is 
the leading cause of death among Black women between the ages of 25-34 and the third 
leading cause of death among Black women between the ages of 35-44 (Centers for 
Disease Control and Prevention, 2007a). 
 
 The most common mode for HIV transmission in the United States is sexual 
contact, followed by parenteral exposure to contaminated blood or blood products as 
occurs with intravenous drug abuse or blood transfusion recipients, and lastly, between 
mother and fetus (Roper, 1991).  In 2006, 80% of women diagnosed with HIV in  the 
United States were infected through heterosexual exposure (Centers for Control and 
Prevention, 2008; Centers for Disease Control and Prevention, 2004).  Injection drug use 
among women accounted for 19% of cases. In addition to the direct risks associated with 
sharing of needles during intravenous drug use, drug use is also linked to decreased 
inhibitions and increased sexual risk taking, which further propagates the heterosexual 
spread of the epidemic (Centers for Disease Control and Prevention, 2004). Women using 
non-injectable drugs (i.e., cocaine, “crack”, methamphetamine) are at greater risk for 
heterosexual HIV transmission as they trade sexual encounters for drugs or money 
(Centers for Disease Control and Prevention, 2004). Although the routes of transmission 
of the virus are known, the incidence of infection continues to increase. 
 
The AIDS epidemic has had a major effect on morbidity and mortality in women.  
Studies of international AIDS research found that more women between the ages of 13 
and 25 years are being infected than women in other age groups that women are infected 
at a much younger age than men, and that in developing countries, as many or more 
women are infected than men.  Since 1985, the proportion of all AIDS cases reported in 
the United States among adult and adolescent women has more than tripled, from 7% in 
1985 to 25% in 1999 (Centers for Disease Control and Prevention, 2004). A dramatic 
increase in the numbers of HIV cases has been documented in women of color (Centers 
for Disease Control and Prevention, 2004).   
 
The prevalence of HIV transmission among women is disproportionate, affecting 
racial and ethnic minorities, especially African-American and Hispanic women, at a 
much higher rate (Centers for Disease Control and Prevention, 2004).  Of the 9708 
women diagnosed with HIV in the United States in 2005, 66% were African American 
(Centers for Control and Prevention, 2008).  African  Americans make up only 13% of 
the total U. S. population, yet African Americans account for approximately 49% of the 
new cases of HIV (Centers for Control and Prevention, 2008). African Americans are 
disproportionately affected by HIV/AIDS across all stages of the disease. Sixty-three 
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 percent of the AIDS cases among women in the United States were among African-
American women (Centers for Disease Control and Prevention, 2004). HIV was the 
leading cause of death among African American women between the ages of 25 and 44 
years in 2002 (Centers for Disease Control and Prevention, 2004).  
 
Transmission patterns indicate that the rate of heterosexual transmission of HIV is 
increasing, directly affecting women of childbearing age. The importance of this growing 
epidemic among women is significant, encompassing women’s physical, emotional, 
spiritual, and social needs.  These needs are often compounded by the additional 
responsibility of children, some of whom may also be infected with the virus.  Although 
the use of antiretroviral drugs in pregnancy has drastically reduced perinatal transmission 
of HIV, perinatal transmission accounted for 9300 cases of pediatric HIV in the United 
States (CDC, 2006). The burden of these needs coupled with many complex social 
factors increases the risk of depression and anxiety in this population. HIV-positive 
women with children are more likely than men to suffer from chronic sorrow related to 
their illness, fear of death, poverty, and social isolation (Morrison et al., 2002). 
 
The causes of depression and anxiety have been connected to both biological and 
biobehavioral factors. Biological and genetic factors, including family history of mood 
disorders, increase the risk of depression (Gutman & Nemeroff, 2003). Stressful life 
events have been linked to depression (Mazure & Maciejewski, 2003). History of sexual 
abuse in depressed adolescents has been shown to increase the likelihood of psychiatric 
hospitalization or depressive relapse (Barbe, Bridge, Birmaher, Kolko, & Brent, 2004).  
As the medical community continues to learn more about the course of HIV infection and 
the consequences of HIV transmission among women, the identification of depression 
and anxiety in this population becomes imperative. HIV has become a chronic illness, 
with increasing numbers of available treatment regimens, and increasing life expectancy. 
The denial of appropriate assessment and treatment of depressive and anxiety symptoms 
in this population would be neglectful and unethical.  
 
According to the Surgeon General’s Report on Mental Health (USDHHS, 1999), 
the current annual prevalence estimate for mental disorders is about 20% of the U. S. 
population. Mood disturbances are the most frequently diagnosed mental health 
disturbances in the U. S. and more common in persons with chronic disorders such as 
HIV/AIDS (USDHHS, 1999). Depression and anxiety commonly occur simultaneously. 
There are many studies describing either depression or anxiety, with fewer studies 
examining the co-morbidity of these common diagnoses.  
 
Hirschfeld (Hirschfeld, 2001) examined the co-morbidity of major depression and 
anxiety in primary care settings, concluding that 10 to 20% of office visits were related to 
a depressive or anxiety-related episode, and over 50% of these patients experienced both 
depression and anxiety. Murphy and colleagues (2004) investigated the prevalence and 
comorbidity of anxiety and depression in the general population, reporting anxiety as 
twice as common as depression, and more prevalent in the female population. In a meta-
analysis of studies that explored depression, Ciesla and Roberts (Ciesla & Roberts, 2001) 
reported that HIV-positive persons were twice as likely to experience depression as their 
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 HIV-negative counterparts. African Americans may be less likely to suffer from major 
depression than non-Hispanic whites (USDHHS, 1999).  
 
The prevalence of major depression in persons with HIV infection ranges from 
22% to 36% (Bing et al., 2001; Ferrando et al., 1998; Rabkin, Wagner, & Rabkin, 1999). 
Untreated depression along with other co-morbid conditions may increase clinic visits, 
hospitalizations, substance abuse, and risky behaviors, as well as reduce adherence to 
treatment and quality of life (Valente, 2003). Stressful life events, such as learning of the 
diagnosis of HIV, the death of a partner or friend with HIV, the onset of HIV-related 
symptoms, HIV treatment failure, and progressive disease exacerbations leading to an 
AIDS diagnosis may increase depressive symptoms (Valente, 2003). Like untreated 
depression, these stressful events may also increase alcohol and substance use (Valente, 
2003) and increase levels of anxiety. Studies (Croughan, Miller, Wagelin, & Whitman, 
1982; Kosten, Anton, & Rounsaville, 1992) have demonstrated that increased life 
stressors are often associated with increased injected drug and crack cocaine use, as well 
as increased levels of psychological distress. As stress increases, high-risk sexual 
behavior may escalate (Low-Beer et al., 2000).  
 
In newly diagnosed HIV-positive patients, high rates of anxiety are experienced 
after learning of their diagnosis (Croughan, Miller, Wagelin, & Whitman, 1982; Jones, 
Garsia, Wu, Job, & Dunn, 1995; Krikorian, Kay, & Liang, 1995; Rabkin, Johnson et al., 
1997). Depressive symptoms among women with HIV are associated with HIV disease 
progression (Ickovics et al., 2001; Mayne, Vittinghoff, Chesney, Barrett, & Coates, 
1996). HIV-positive women with chronic depressive symptoms were twice as likely to 
die as HIV-positive women with limited or no depressive symptoms (Ickovics et al., 
2001). The complex challenges of the disease and its treatments along with disease-
related physiological changes increase the predisposition to depression and anxiety in this 
population (Moore et al., 1999; Valente, 2003).Depression and anxiety produce or create 
a more significant problem for people with a concomitant diagnosis of HIV because the 
feelings of loneliness, helplessness, hopelessness, and despair may lead to suicide 
(Valente & Saunders, 1997).   
 
There are many different factors that may play roles in the development of 
depression and anxiety in HIV-positive persons.  Inherited and acquired risk factors 
associated with depression and anxiety, combined with side effects of antiretroviral 
medications, distressing events related to stigma and shame of the diagnosis of HIV and 
the loss of a partner through abandonment following disclosure or death all may 
contribute to an environment that increases the risk for depression and anxiety. Patients 
with HIV infection are also subject to overwhelmingly complex treatment regimens.  
Drug resistance and intolerance, metabolic complications and toxicities, noncompliance, 
and virulent strains of the disease often lead to treatment failures and regimen changes.  
Tsao and colleagues (Tsao, Dobalian, Moreau, & Dobalian, 2004) reported that HIV-
positive patients with HIV-related symptoms were more likely to suffer from persisting 
depression and anxiety or develop new cases of anxiety and depression. In addition, 
depression and anxiety have been related to an increase in other physical illnesses such as 
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 cardiac disorders, hypertension, gastrointestinal disorders, genitourinary disorders, and 
migraines (M. C. Harter, Conway, & Merikangas, 2003).  
 
 
PURPOSE OF THE STUDY 
 The incidence of HIV transmission continues to increase.  The CDC reported a 
cumulative estimated number of 525,442 deaths of persons with AIDS through 2005 in 
the 50 states and the District of Columbia (Centers for Control and Prevention, 2007; 
Centers for Disease Control and Prevention, 2004).  The prevalence of HIV infections in 
the heterosexual community has led to an epidemic that directly affects women of 
childbearing age. Women are at increased risk for major depression (Blazer, Kessler, 
McGonagle, & Swartz, 1994; Blehar & Oren, 1995; M. C. Harter, Conway, & 
Merikangas, 2003; R. C. Kessler, McGonagle, Swartz, Blazer, & Nelson, 1993) 
irrespective of their HIV status and at even greater risk for depression in the presence of 
HIV infection (Rabkin, Johnson et al., 1997). Identifying the predictors of depression and 
anxiety in HIV-positive women can lead to early detection and treatment of depression 
and anxiety in this vulnerable population. This study collected information on both 
pregnant and non-pregnant African American HIV-positive women. The inclusion of 
pregnant women is an important aspect of the study, as African American women of 
childbearing age represent a significant portion of new HIV cases in the United States. 
Pregnant women often have different needs and concerns than non-pregnant women. 
These differences have the potential to influence anxiety and depressive symptoms, and, 
thus need to be examined. Therefore, the purposes of this study of HIV-positive women 
are fourfold: (1) to determine the levels of depressive and anxiety symptoms in African 
American women who are HIV-positive; (2) to describe the underlying vulnerabilities, 
both inherited and acquired, for depressive and anxiety symptoms in African American 
women who are HIV-positive; (3) to identify which vulnerabilities may serve as 
predictors of depressive and anxiety symptoms among African American HIV-positive 
women; and (4) to describe the differences in predictors of depressive and anxiety 
symptoms among African American HIV-positive women.   
 
 
AIMS AND RESEARCH QUESTIONS 
 This study was guided by the existing literature including gaps in knowledge 
regarding symptoms of depression and anxiety in women who are HIV-positive. Study 
aims were examined within one clinical population of African American women seeking 
treatment in two large university-based clinics that provide healthcare for women with 
HIV/AIDS. The specific aims and research questions that guided this study were:  
 
Specific Aim One 
 Specific Aim One was to examine the levels of depressive and anxiety symptoms 
in African American women (pregnant and non-pregnant) who were HIV-positive in a 
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 southeastern urban university obstetrics and gynecology and infectious disease practice 
using the following questions. 
 
a. What were the levels of depressive symptoms in pregnant African-American 
women who were HIV-positive? 
b. What were the levels of anxiety symptoms in pregnant African-American women 
who were HIV-positive? 
c. What were the levels of depressive symptoms in non-pregnant African-American 
women who were HIV-positive? 
d. What were the levels of anxiety symptoms in non-pregnant African-American 
women who were HIV-positive? 
 
Specific Aim Two 
Specific Aim Two was to examine the associations among inherited (family 
history of mood disorders, family history of alcohol and/or drug use) and acquired 
(educational level, income level, alcohol and/or drug use,  HIV disclosure status, sleep 
quality, history of sexual abuse or assault) vulnerabilities and depressive symptoms in 
African American women who were HIV-positive using the following questions. 
 
a. What was the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to depressive symptoms in 
pregnant African American women who were HIV-positive? 
b. What was the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to depressive symptoms in pregnant African American 
women who were HIV-positive? 
c. What was the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to depressive symptoms in 
non-pregnant African American women who were HIV-positive? 
d. What was the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to depressive symptoms in non-pregnant African 
American women who were HIV-positive? 
 
Specific Aim Three  
Specific Aim Three was to examine the associations among inherited (family 
history of mood disorders, family history of alcohol and/or drug use) and acquired 
(educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep 
quality, history of sexual abuse or assault) vulnerabilities and anxiety symptoms in 
African American women who were HIV-positive using the following questions. 
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 a. What was the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to anxiety symptoms in 
pregnant African American women who were HIV-positive? 
b. What was the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to anxiety symptoms in pregnant African American 
women who were HIV-positive? 
c. What was the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to anxiety symptoms in non-
pregnant African American women who were HIV-positive? 
d. What was the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to anxiety symptoms in non-pregnant African American 
women who were HIV-positive? 
 
Specific Aim Four  
Specific Aim Four was to examine the influence of inherited vulnerabilities 
(family history of mood disorders, family history of alcohol and/or  drug use) and 
acquired vulnerabilities (educational level, income level, alcohol and/or drug use, HIV 
disclosure status, sleep quality, history of sexual abuse or assault) on depressive 
symptoms in non-pregnant African American women who were HIV-positive. 
 
a. What was the influence of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) on the level of depressive 
symptoms reported by non-pregnant African-American women who were HIV-
positive?  
b. What was the influence of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) on the level of depressive symptoms reported by non-
pregnant African-American women who were HIV-positive? 
 
Specific Aim Five 
Specific Aim Five was to examine the influence of inherited vulnerabilities 
(family history of mood disorders, family history of alcohol and/or drug use) and 
acquired vulnerabilities (educational level, income level, alcohol and/or drug use, HIV 
disclosure status, sleep quality, history of sexual abuse or assault) on anxiety symptoms 
in non-pregnant African American women who were HIV-positive. 
 
a. What was the influence of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) on the level of anxiety 
symptoms reported by non-pregnant African-American women who were HIV 
positive?  
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 b. What was the influence of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) on the level of anxiety symptoms reported by non-
pregnant African-American women who were HIV positive? 
 
 
CONCEPTUAL FRAMEWORK 
 A conceptual framework is defined as interrelated concepts or abstractions that 
are assembled together in some rational scheme by virtue of their relevance to this 
common theme (Polit & Hungler, 1995). The conceptual framework that guided this 
study served to organize the empirical data, formulate the research questions, select the 
study instruments and interpret study findings. Furthermore, the conceptual framework 
aided in the exploration of existing knowledge gaps, which may facilitate development of 
future theories that might improve understanding of the factors that predict depressive 
and anxiety symptoms in the study population, and strategies to improve patient 
outcomes. The proposed study investigated inherited and acquired vulnerabilities as 
predictors of depressive and anxiety symptoms among African American HIV-positive 
women.  
 
The stress diathesis model proposes that vulnerability factors contribute to the 
onset of depression when there is an interaction between these factors and negative life 
events (A. T.  Beck, 1967; Monroe & Simons, 1991). According to this model, 
individuals form a psychological vulnerability to depression through stressful life events 
that influence the development of negative cognitive schemas (Sacco & Beck, 1995). 
Predispositions to mood disorders are developed as negative schemas become latent 
during cycles of recovery but have the potential to be reactivated. The cascade of events 
begins when a traumatic event, or event that is reminiscent of a previous trauma, occurs 
and thereby reactivates the negative cognitive process, leading to negative experiences 
and symptoms (Sacco & Beck, 1995). 
 
Some persons, even under conditions of extreme stress, do not experience a 
diathesis that leads to mental health compromise (B. P. Dohrenwend & Dohrenwend, 
1979). All individuals experience daily and chronic stress, all with different backgrounds 
and predispositions, resulting in different responses to stressors. The concept of allostatic 
load plays an integral part in the stress diathesis model. Sterling and Eyer (Sterling & 
Eyer, 1998) identified allostasis as the ability to achieve stability through change. There 
is a broad range of behavioral responses to stressful life events. Positive outcomes, such 
as coping, are the result of successful adaptation to stressors. It is when the body is 
unable to adapt to stressful life events that injury occurs. McEwen (Bruce S. McEwen, 
2002) explored the relationship of allostasis and allostatic load on mood disorders. 
Allostasis (Bruce S. McEwen, 2002) refers to the adaptation that occurs as a response to 
stress. The process is complicated when adaptation is altered, either for biological or 
situational reasons, resulting in an allostatic state. An allostatic state results when there is 
the failure to turn off mediators after stress (Bruce S. McEwen, 2002). When adaptation 
fails, the result is injury. Cumulative effects of stress may be the result of repeated 
failures in adaptation. Allostatic load is the long-term effect of repeated injury to the 
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 body. McEwen (Bruce S. McEwen, 2002) describes four situations associated with high 
allostatic load: (1) frequent stress, (2) repeated stressors, (3) inability to turn off allostatic 
responses after the stress is over, and (4) the trigger of compensatory responses due to 
inadequate allostatic responses. Increased allostatic load has an effect on virtually every 
body system, resulting in impaired immunity, obesity, atherosclerosis, and bone 
demineralization (Bruce S. McEwen, 2002). Prolonged allostatic load increased the risk 
for permanent damage to the brain in rats (Lowy, Wittenberg, & Yamamoto, 1995). 
Allostatic load can be caused by genetic or developmental disturbances that prevent 
adequate coping. Individual responses to daily stressors are influenced by neurobiological 
factors, which effect the interpretation and response to stress (Bruce S. McEwen, 2002). 
 
Hans Selye was one of the first scientists to explore the physiologic stress 
response. Selye (1976) noted that the secretion of excess adrenocorticotrophic hormone 
by the pituitary gland results in an increased release of glucocorticoids from the adrenal 
cortex. This classic neuroendocrine response is present during both positive and negative 
periods of stress (Selye, 1974). Excessive hypothalamic-pituitary-adrenal and 
nonadrenergic system activity and dysfunction of the serotonergic system play a role in 
the pathophysiology of suicidal behavior (van Heeringen, 2003). The effect of stressful 
life events on neurobiological systems and the dysfunction of neurobiological systems 
have been linked to suicidal behavior, impulsivity, aggression, and increased levels of 
anxiety (van Heeringen, 2003).  
 
Stressful life events, whether acute or chronic, lead to increased cortisol secretion 
in both healthy and depressed persons (B. S. McEwen, 2006; Sher, 2004). The amount or 
level of stress cannot predict outcomes, as there are individual variations in responses, 
and the theory that some people have underlying vulnerabilities to depression and other 
mood disorders. The prevention of stress is not feasible; therefore successful coping 
strategies are suggested in order to maintain homeostasis in stressful situations.  
 
The physiological stress response has been correlated with lifestyle. Early adverse 
experiences (Gutman & Nemeroff, 2003) and sleep deprivation (McEwen, 2006; 
McEwen & Wingfield, 2003) affect the physiologic stress response. Early adverse 
experiences may sensitize corticotropin-releasing factor processes (Gutman & Nemeroff, 
2003). Depression in adults may also be linked to the disruption of neurological pathways 
caused by early adverse life experiences. Poor quality of sleep or disruptions of sleep 
patterns may result in hypothalamic-pituitary-adrenal axis dysregulation, while short 
periods of sleep deprivation have been shown to cause increased levels of cortisol, 
glucose, insulin, and insulin resistance (B. S. McEwen, 2006; Plat et al., 1999). 
Hypercortisolism has been linked depressive disorders (Sher, 2004).  
 
Increased allostatic load can result in adverse outcomes. The physiologic changes 
that occur as a result of increased allostatic load may affect the immune system, resulting 
in the expression of inflammatory, infectious, and autoimmune diseases (United States 
Department of Health and Human Services [USDHHS], (USDHHS, 1999). Long term 
effects of chronic depression may be associated with increased allostatic load, resulting in 
pathophysiologic changes (B. S. McEwen, 1998). There is a potential for adverse cardiac 
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 outcomes and increased platelet reactivity with concomitant long-term increased 
allostatic load and major depression (Heuser, 2002; Lederbogen et al., 2001; Thayer, 
Smith, Rossy, Sollers, & Friedman, 1998). 
 
Although the precise etiology of mood disorders is unknown, there is evidence 
that the interplay of biological, psychological, social, and cultural factors results in mood 
disorders for some individuals (USDHHS, 1999). There is increased evidence that there 
are biologic and physiologic causes of mood disorders.  Responses to stressful life events 
may vary. However, the body’s successful adaptation to stress results in allostasis, 
appropriate responses, and successful coping. It is when the body is unable to adapt to 
stressful life events that mood disorders are often expressed (Bruce S. McEwen, 2002).  
Prolongations of stressors that result in a physiologic stress response have the potential to 
cause adverse outcomes.  
 
Although it is impossible to predict who will develop a mood disorder, the 
assessment of lifestyle, individual and family history, and presence and type of current 
stressors is an important aspect of evaluation of mood disorders. Thus, in the current 
study, these underlying vulnerabilities were examined as potential predictors of 
depressive and anxiety symptoms. Underlying inherited vulnerabilities that were 
examined in this study included family history of mood disorders and family history of 
alcohol and/or drug use. Underlying acquired vulnerabilities assessed in the current study 
included educational level, income level (annual household income), alcohol and/or drug 
use, HIV disclosure status, sleep quality, and history of sexual abuse or assault.  
 
The evaluation of potential predictors of psychopathology is essential in the 
comprehensive care of women with HIV infection. Healthcare providers often overlook 
the importance and prevalence of depression and anxiety in this population. However, all 
persons have underlying vulnerabilities, both inherited and acquired, which have the 
potential to trigger a cascade of events resulting in disrupted mental processes.  
 
The stress diathesis model appropriately describes and explains this process, 
therefore serving as an appropriate conceptual framework for this study.  The stress 
diathesis model has been used to understand depressive and anxiety in this population 
(Ickovics et al., 2001), and has been shown to be useful for understanding depression and 
anxiety in general (Monroe & Simons, 1991). Therefore, this study tested the utility of 
the stress diathesis model in this population. Figure 1.1 depicts the stress diathesis model 
as it applied to the conceptual framework of the current study.   
 
 
Definition of Major Concepts 
A variety of theoretical and operational definitions have been published for the 
concepts of interest within the current study. For the purpose of the current study, the 
following definitions were used in order to provide conceptual consistency and clarity. 
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Inherited Vulnerabilities
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Depressive Symptoms
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Figure 1.1 Conceptual Framework Depicting the Stress Diathesis Model with Inherited 
and Acquired Vulnerabilities. 
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 HIV-positive women 
In this study, the theoretical definition of HIV-positive women is women that have 
been diagnosed with the human immunodeficiency virus by their health care professional 
with positive HIV antibody testing, including the HIV-1 ELISA and HIV-1 Western Blot. 
The diagnosis of HIV was confirmed by medical chart abstraction. This concept was 
quantified as English-speaking African American females who were over the age of 18 
years, who had been diagnosed with HIV, and were receiving care at a university 
outpatient obstetrics and gynecology clinic or outpatient infectious disease clinic.  
African American 
 The theoretical definition for African American is pertaining to or characteristic of 
Americans of African ancestry (Mish, 1997).  The definition of African American will be 
operationalized through self-report. Participants must have lifelong residence in the 
United States in order to eliminate the influence that cultural differences might play in the 
interpretation of study instruments.  
Depression 
Depression refers to a reduction of the level of functioning; a sinking of spirits so 
as to constitute a clinically discernible condition (Hensyl, 1990). The NIMH (National 
Institute of Mental Health, n/d) describes three main types of depression: dysthymia, 
major depression, and bipolar disorder. The operational definition of depression that was 
used for this study was Center for Epidemiologic Studies Depression Scale (Radloff, 
1977) or Edinburgh Postnatal Depression Scale (Cox, Holden, & Sagovsky, 1987) scores 
at or above the recommended cut-off for additional evaluation. No attempt was made to 
assign a diagnosis to participants’ symptoms. The study described the level of depressive 
symptoms that were present in study participants and compared their symptoms with 
other populations.  
Anxiety 
The theoretical definition of anxiety is an apprehension of danger and dread 
accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly 
identifiable stimulus (Hensyl, 1990). The NIMH (National Institute of Mental Health, 
n/d) defines generalized anxiety disorder as a chronic disorder, which results in feelings 
of impending disaster, often related to money, health, family, or work. Sources of anxiety 
are not always identifiable. The operational definition of anxiety that was used for this 
study was a positive score on the Beck Anxiety Inventory (A. T. Beck, Epstein, Brown, 
& Steer, 1988). The proposed study instrument did not serve as a tool for diagnosing 
anxiety, but rather as a means to assess the level of anxiety symptoms reported by study 
participants and therefore determine the need for further assessment of anxiety symptoms 
in this population. The proposed study findings will provide additional insights that may 
guide recommendations for future assessments in this population. 
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 General Definitions 
Health  
Health is defined as a state of complete physical, mental and social well being and 
not merely the absence of disease or infirmity (World Health Organization, 1992). Health 
can be defined as a state (at one time) or a continuum (over a longer period of time). This 
study used a comprehensive definition of health that included both mental and physical 
health, and was measured through self-reporting of subjective symptoms, and 
documentation of disease markers (CD4 count), which were obtained through medical 
record chart abstraction.  
Mental Health 
Mental health is defined as emotional, behavioral, and social maturity or 
normality; the absence of a mental or behavioral disorder; a state of psychological well-
being in which the individual has achieved a satisfactory integration of his instinctual 
drives acceptable to both himself and his social milieu (Hensyl, 1990). For the purposes 
of the proposed study, mental health was theoretically defined as the scores on the CES-
D (Radloff, 1977), EPDS (Cox et al., 1987), and Beck Anxiety Inventory (A. T. Beck et 
al., 1988).   
Inherited Vulnerabilities 
 The term inherit can be defined as to receive from one’s ancestors (Mish, 1997). 
Vulnerability can be defined as susceptibility to wounds, or capability of being wounded 
(Mish, 1997).  In the current study, the term vulnerabilities referred to susceptibility to 
mood disorders. In the current study, inherited vulnerabilities were defined as family 
history of mood disorders and family history of alcohol and/or drug use. The underlying 
predispositions to biologic and familial manifestations of mood disorders are key 
concepts in the stress diathesis model. This definition is consistent with components of 
the stress diathesis theory that serves as the conceptual framework for this study. The 
inherited vulnerabilities of the sample were individual characteristics that were 
determined through self-report. 
Acquired Vulnerabilities 
 The term acquired can be defined as gained by or as a result of effort or 
experience (Mish, 1997). Vulnerability can be defined as susceptibility to wounds, or 
capability of being wounded (Mish, 1997).  In the current study, acquired vulnerabilities 
were defined as educational level, income level, alcohol and/or drug use, HIV disclosure 
status, sleep quality, and history of sexual abuse or assault. This definition is consistent 
with the stress diathesis theory that serves as the conceptual framework for this study. 
These acquired vulnerabilities of the sample were individual characteristics that were 
determined through self-report. 
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 Concept Relationships 
The identification of inherited and acquired vulnerability cannot solely predict 
depressive or anxiety symptoms in a person.  There are many different variables that 
influence mental health, all of which may never be identified. Variables included in 
inherited vulnerability are the following: family history of mood disorders, and family 
history of alcohol and/or drug use. Researchers (Moore et al., 1999; Perkins et al., 1994; 
Rabkin, Ferrando, Jacobsberg, & Fishman, 1997) have documented an increased 
prevalence of depression among HIV-positive women (30-60%), when compared to HIV-
positive men (20% or less). Researchers have demonstrated that minority status is often 
associated with poverty and lower socioeconomic status (Wilhelm & Parker, 1994), and 
that lower socioeconomic status is associated with greater risk for mood disorders 
(USDHHS, 1999). Minority women are at greater risk for feelings of isolation and 
alienation, which may lead to unhealthy behaviors and coping mechanisms, therefore 
increasing their risk for depressive symptoms (Boyd-Franklin, 1987). Family history of 
mood disorders has also been correlated with adult depression and anxiety (Gutman & 
Nemeroff, 2003).  
  
Variables included in acquired vulnerability are the following: educational level, 
income level, alcohol and/or drug use, HIV disclosure status, sleep quality, and history of 
sexual abuse or assault. Moore and colleagues (Moore et al., 1999) reported that 
disadvantaged socioeconomic and environmental backgrounds were more related to 
depressive symptoms than HIV infection. Adverse life events are also predictors of 
depressive symptoms in women with HIV (Moore et al., 1999). Insomnia has been 
associated with psychiatric disorders, including depression (Lustberg & Reynolds, 2000). 
The assessment of sleep patterns, sleep preparation practices (also known as sleep 
hygiene), sleep quality and duration of sleep are important aspects of comprehensive 
sleep assessments. The relationship of sleep disturbances to depression and anxiety has 
been documented. Socioeconomically disadvantaged women, regardless of HIV status, 
have many barriers and adversities that make health maintenance and promotion difficult 
(Moore et al., 1999). The identification of reported histories of sexual abuse or assault is 
pertinent to the assessment of mental health. The relationship between a history of child 
sexual abuse and adult depression and anxiety has been well documented (Barbe et al., 
2004; Barker-Collo, Read, Barker-Collo, & Read, 2003; Walrath et al., 2003). Adult 
sexual abuse or assault has been associated with increased feelings of sadness and 
dysphoria (M. Conway, Mendelson, Giannopoulos, Csank, & Holm, 2004). 
 
Depression has been explained through several cognitive stress diathesis models 
in the literature (Hilsman & Garber, 1995; Monroe & Simons, 1991). The intersection of 
underlying predispositions with a major life stressor has the potential to activate a 
cascade of events that result in psychopathology (Monroe & Simons, 1991). The 
identification of persons with vulnerabilities to mental illness is essential in evaluating 
risks of a major mental health disorder. Although the presence of predispositions to 
psychopathology will not always activate the diathesis that results in a significant event, 
it is important to identify the underlying predispositions in persons at greater risk for 
depression and anxiety. Gender and the presence of a HIV diagnosis have been 
documented (Ciesla & Roberts, 2001; J. M. Murphy et al., 2004; National Institute of 
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 Mental Health, n/d) to have a direct impact on increased levels of depressive symptoms. 
Therefore, the evaluation of underlying predispositions, or vulnerabilities, is critical to 
monitoring the potential onset of depressive symptoms, as well as symptoms of anxiety in 
the study population.  
 
SIGNIFICANCE OF STUDY 
Although the routes of HIV transmission are well documented and prevention 
inexpensive (i.e. abstinence, condom use), the rates of HIV cases and heterosexual 
transmission of HIV continue to increase. Women of childbearing age are at a greater risk 
for depression and anxiety than the general population.  The cost of mental illness in the 
United States is staggering, ranking second to cardiovascular conditions in the burden of 
disease in established market economies (USDHHS, 1999).  Depression can lead to poor 
self-esteem, feelings of hopelessness, and suicide. “Mental problems affect and are 
affected by chronic conditions such as cancer, heart disease, diabetes and HIV/AIDS. 
Untreated, they bring about poor health behaviour, non-compliance with prescribed 
medical regimens, diminished immune functioning, and negative disease outcomes” 
(World Health Organization, 2004).  
The identification of depressive and anxiety symptoms among HIV-positive 
women is imperative and relevant to nursing practice for the following reasons: (1) to 
identify the levels of depressive and anxiety in one clinical population; (2) to provide the 
preliminary evidence as to whether there is a need for implementing early screening and 
subsequent evaluation, diagnosis, and treatment of depressive and anxiety symptoms in 
this vulnerable population; and (3) to provide an environment for the developing and 
implementing of therapeutic interventions. The findings of this study may give 
practitioners cause to be aware of potential inherited and acquired vulnerabilities that 
increase the risk for mood disorders such as depression and anxiety among their female 
African American patients who are HIV-positive. It is through the identification of 
predictors of depressive and anxiety symptoms, that the proper screening, diagnosis, and 
treatment of depression and anxiety can be instigated. The findings from this study 
identified the relationship between the research variables and depressive and anxiety 
symptoms in one sample, which addressed gaps in existing literature related to this area 
of inquiry.  
 
 Nurse clinicians have the unique opportunity to influence their environment 
through research, education, and practice.  The knowledge gained from this research 
study added to the existing information regarding HIV-infected women.  This research 
study is significant, in that there are few studies describing the predictors of depression 
and anxiety among HIV positive women in general and African American HIV-positive 
women in particular.  This research study may provide the baseline information, which 
can lead to early identification and treatment of anxiety and depression in HIV-positive 
women.  
 
 Nurse clinicians must provide education to not only their patients, but also to their 
co-workers and communities regarding HIV transmission, depression, and anxiety.  
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 Although HIV, depression, and anxiety are subjects that are avoided in many social 
situations, nurses have the opportunity to bridge the gap between science and practice. 
The identification of depressive and anxiety symptoms in HIV-positive women is critical 
to long-term success of antiretroviral treatment and adherence to medical appointments. 
The long-term ramifications of the identification, assessment, and treatment of depressive 
and anxiety symptoms in HIV-positive women include decreased health care costs related 
to decreased numbers of inpatient hospitalizations and increased longevity of successful 
highly active antiretroviral treatment (HAART) regimens. Successful long-term HAART 
treatment leads to better patient outcomes as patients experience complete virologic 
control and immune reconstitution, as well as decreased transmission of drug resistant 
viruses (Havlir & Richman, 1996).  Depression has been associated with poor adherence 
to medication regimens among HIV-positive persons (Gordillo, del Amo, Soriano, & 
Gonzalez-Lahoz, 1999; Starace et al., 2002; Wagner et al., 2006). 
 
 It is imperative that nurses explore the predictors of depression and anxiety 
among their HIV-positive clients.  This information is vital to the development of 
counseling strategies and treatment interventions that can be implemented in order to 
maintain stable mental and physical health in these patients with complicated health care 
needs. 
 
Assumptions 
 The following assumptions for this study were used in the development of study 
framework, design, and interpretation of the results. The assumptions surrounding this 
study are the following: 
 
1. Women who agree to participate in the study are aware of their family history of 
depression and anxiety. Several researchers have described the influence of 
genetic factors and family history on depression (Gutman & Nemeroff, 2003; 
Reinherz et al., 2003).  
2. Women who agree to participate in the research study will be able to read and 
understand the study’s instrumentation.  
3. Women who participate in the study will answer the instruments honestly.  
4. Positive HIV status is a stressor for the subjects in this sample. 
5. The concepts in the study framework are relevant for the study sample and 
population. 
 
Limitations 
The investigator for this research study identified several potential limitations.  
These limitations were methodological in nature. The techniques used to minimize them 
are discussed.   
 
1. Non-probability sampling (convenience sampling) was used and consisted of 
HIV-positive women receiving care at university clinics. This sampling method 
15 
 contributed to a weaker design than if random sampling had been utilized.  A 
random sampling procedure increases the likelihood of generalizability by 
guaranteeing that each unit of the population has a non-zero chance of selection 
(Hulley, 2001). A convenience sampling method was appropriate due to the 
limited existing body of knowledge regarding the subject matter and economic 
considerations that alternative sampling methods required. The use of non-
probability sampling limits external validity by limiting the generalizability of the 
findings to target populations (Penhazur & Schmelkin, 1991).  The sample was 
entirely composed of HIV-positive women engaged in medical care, thus 
decreasing the generalizability to African American female HIV-positive 
populations who are not receiving medical care.   
 
2. The potential inability of the subjects to honestly report symptoms of depression 
and anxiety was another limitation of the study. The stigma that is often 
associated with mental health issues may encourage subjects to underreport 
symptoms. The questionnaires did not contain subject identifiers, which should 
have encouraged truthful reporting. LoBiondo-Wood and Haber (Lo-Biondo-
Wood & Haber, 1994) suggest that anonymity may be important when the study 
deals with sensitive issues.   
 
3. Women who are severely depressed may not be represented in the study as their 
levels of depression may have prevented them from accessing care or 
participating in the study.  
 
4. Subjects were at different stages of their disease, and had different durations of 
diagnosis. Data were collected during only a single time point, therefore 
decreasing the external validity of the findings. The identification of different 
levels of severity of depressive symptoms during different stages of disease and 
length of diagnosis will, however, add to the body of existing literature regarding 
HIV-positive women. 
 
5. The women accessed their care in a metropolitan area, thus the results may not be 
generalized to similar populations living in rural settings. 
 
6. Socioeconomic and demographic characteristics of the sample may differ from 
the HIV-positive women that seek care in private practice facilities. 
 
 
SUMMARY 
 The prevalence of HIV infection among women has become a significant health 
problem in the United States. The numbers of heterosexually transmitted infections have 
increased significantly in the last decade (Centers for Control and Prevention, 2007). 
Despite education regarding HIV prevention, the numbers of new infections continue to 
rise.  Women of childbearing age represent a substantial number of new HIV infections 
each year, and the rates continue to climb among minority women (Centers for Control 
and Prevention, 2007; Centers for Disease Control and Prevention, 2005, 2007b). 
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 Women who have been diagnosed with HIV have compounding issues that often 
complicate the course of the disease. Women often experience additional stressors such 
as the following: stigma, isolation, and shame that is often associated with HIV; loss of 
family or partner support following disclosure of HIV status; responsibilities of being the 
primary caregiver to children; guilt associated with potential mother to child HIV 
transmission; and anxiety regarding permanency planning for their children. When these 
stressors are combined with the diagnosis of HIV, there may be an increase in 
experiencing significant depression and anxiety. Women are often burdened with 
additional stressors such as single parenthood, caring for children and/or aging parents, 
work and home responsibilities (Barroso, Pence, Salahuddin, Harmon, & Leserman, 
2008).  
 
Women experience hormonal factors that occur during menstrual cycle changes, 
pregnancy, miscarriage, postpartum period, pre-menopause, and menopause, all of which 
may contribute to the increased rate of depression in women (Barroso et al., 2008). 
Physiological and or genetic factors have also been associated with depressive disorders, 
and may have impacted the development of depression and anxiety (Barroso et al., 2008).  
Therefore, it is important that both pregnant and non-pregnant women be included in 
studies. The inclusion of pregnant and non-pregnant women will add to the body of 
knowledge regarding women with HIV.  
 
In this chapter, the problem, purpose of the study, aims and research questions, 
definition of terms, conceptual framework, concept relationships assumptions, 
limitations, significance of study, and significance to nursing were discussed.  The next 
chapter presents the review of literature. 
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 CHAPTER 2. REVIEW OF LITERATURE 
OVERVIEW 
 Much of the earlier published literature regarding depression and HIV has focused 
on HIV-positive men (Atkinson et al., 1988; Perkins et al., 1994; Rabkin, Goetz et al., 
1997), homosexual men (Atkinson et al., 1988; Rabkin, Goetz et al., 1997), and 
populations of substance abusers (Lipsitz et al., 1994; Rabkin, Johnson et al., 1997), 
reflecting the original transmission patterns of the virus observed in the United States. 
Current epidemiologic trends illustrate that African American women of childbearing age 
are the fastest growing group of newly diagnosed HIV infected persons in the United 
States (Centers for Disease Control and Prevention, 2005   2007c). More recently 
published literature about persons who are HIV positive focuses on the impact of 
depression on morbidity and mortality in this population. A substantial proportion of this 
literature documents the negative consequences of depressive symptoms on adherence to 
HAART and medical appointments. Few studies examine the multiple inherited and 
acquired vulnerabilities thought to influence the development of both depressive and 
anxiety symptoms in this population. Although the current study focuses on African 
American women who are HIV-positive, women in general may share similar 
backgrounds and experiences that contribute to their vulnerability for mood disorders. 
Therefore, within this chapter, specific attention will be given to describing inherited and 
acquired vulnerabilities that increase the risk for depression and anxiety symptoms in a 
sample of African American women who are HIV-positive.  However before exploring 
these vulnerabilities, the prevalence and epidemiology of HIV in the United States within 
the general population and in specific populations will first be discussed followed by a 
review of mood disorders in the general population and in specific populations.  
 
HIV IN THE U.S. POPULATION: PREVALENCE AND EPIDEMIOLOGY 
 Research indicates that despite prevention education, prevalence rates for HIV 
infection continue to increase in the United States. Surveillance data, although 
comprehensive, can only provide an estimate of overall cases. The CDC began collecting 
statistics on AIDS cases at the beginning of the epidemic, but currently collects 
surveillance data for HIV. This process provides a more comprehensive illustration of the 
epidemic, as earlier data did not account for healthy persons with HIV, who had not yet 
developed AIDS. Reporting requirements vary by state; therefore, CDC surveillance data 
only includes information from 33 states with confidential name-based HIV infection 
reporting (Branson et al., 2006). 
 
Approximately one million people are living with HIV in the United States 
(Branson et al., 2006), including 250,000 persons that have not yet been diagnosed. 
Surveillance data for HIV in the United States includes descriptions of cases by age, 
race/ethnicity, sex, and transmission category. The prevalence and epidemiology of HIV 
on African Americans and African American women, as well as HIV within the context 
of pregnancy will be discussed in the next sections. 
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 HIV IN AFRICAN AMERICANS 
More than half of new HIV infections (51%) in the United States occur in African 
Americans (Centers for Disease Control and Prevention, 2007c). In general, minority 
populations in the United States are disproportionately affected by HIV. African 
Americans make up 12% of the total U.S. population, yet account for over 50% of the 
new infections each year (Centers for Disease Control and Prevention, 2007c). The rapid 
spread of HIV infection in African American communities has been accentuated by many 
factors including poverty, racism, lack of education, barriers to health care, illicit drug 
use, and high rates of sexually transmitted infections (Coleman, 2003; Mayberry, Mili, & 
Ofili, 2000; Plowden & Young, 2003; Treadwell & Ro, 2003). 
 
The stigma that is associated with HIV combined with the mistrust of 
governmental research and educational programs in African American communities have 
catapulted HIV to one of the leading causes of death among African Americans (CDC, 
2006; Centers for Disease Control and Prevention, 2007b; Coleman, 2003; Plowden, & 
Young, 2003; Treadwell, & Ro, 2003). The myth that HIV is a homosexual disease has 
hindered HIV prevention efforts in African American communities and created a culture 
of silence (Beatty, Wheeler, & Gaiter, 2004). This cycle has been counterproductive, 
resulting in the perpetuation of myths and increases in compensatory sexual behavior 
(marrying or having sex with the opposite sex) to prove one’s heterosexuality (Joint 
United Nations Programme on HIV/AIDS [UNAIDS], (UNAIDS, 2000). This sequence 
of events has resulted in discrimination and rejection of HIV-positive persons in African 
American communities. Moreover, HIV-related shame and stigma has created another 
minority within a minority population.  
 
 
HIV AND AFRICAN AMERICAN WOMEN 
HIV is now the leading cause of death among African American women 25 to 34 
years of age in the United States (CDC, 2006; Centers for Disease Control and 
Prevention, 2007a); however risk factors for HIV transmission vary by region. Among 
women and adolescent females with AIDS, the most prevalent risk factor in the Northeast 
was intravenous drug use, while heterosexual contact was the most prevalent risk factor 
in the South (Centers for Control and Prevention, 2007). Although the primary focus of 
the current study centered on African American women, minorities are grossly 
underrepresented in much of the research literature. Minorities, both men and women, are 
also under represented in HIV- related research studies nationwide.  
 
Significant psychosocial issues facing African American HIV-positive women are 
cited in the literature and include: poverty, low levels of education, stressors related to 
caretaking roles, barriers to healthcare, depression, and poor access to quality healthcare 
(Bunting, Bevier, & Baker, 1999; Centers for Disease & Prevention, 2007; Centers for 
Disease Control and Prevention, 2005, 2007b; Heslin et al., 2005; Hu, Byers, Fleming, & 
Ward, 1995; Washington, 2001). Women respond to the needs of their families, which 
may result in a lack of self-care, often leading to negative health consequences. 
Researchers reported that African American women who were HIV-positive were more 
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 likely to have a family member with HIV than White American women who were HIV-
positive (Fiore et al., 2001). The result of family caretaking burden experienced by 
African American HIV-positive women may impact their level of HIV care. Literature 
reveals that caretaker burden affects the overall quality of life of HIV-positive women, as 
the care of a HIV-infected child or partner often takes precedence over the care of the 
woman who is HIV-positive (Fiore et al., 2001).  As the rates of HIV continue to increase 
among women of childbearing age, the impact of HIV on pregnancy becomes critical. 
HIV in pregnant women will be discussed in the next section. 
 
 
HIV IN PREGNANT WOMEN 
 Transmission patterns in the United States indicate increased heterosexual 
transmission of HIV, with rising rates of infection documented in women. The prevalence 
of HIV among women in the United States has directly affected women of childbearing 
potential, with the majority of new infections documented in women between the ages of 
25 to 44. The proportion of HIV/AIDS cases among women and adolescent girls (age 13 
and older) increased by 14% between the years 1986 to 2001 (Centers for Disease 
Control and Prevention, 2003). The concentration of infections among females aged 15 to 
44 years directly impacts women during their highest years of fertility, thereby having an 
impact on pregnancy. 
 
 Transmission of HIV from mother to child has greatly decreased since the advent 
of antiretroviral therapy, with initial decreases noted with Zidovudine monotherapy 
(22.6% to 7.6%) and even further reductions with HAART (Centers for Control and 
Prevention, 2002). As women live longer, healthier lives with successful HIV treatment, 
an increasing proportion of HIV-positive women are becoming pregnant (Cohan, 2003). 
Although pregnancy has been associated with decreases in absolute CD4 cells, no studies 
have indicated that pregnancy causes an increased rate of disease progression, HIV viral 
load, or death (Centers for Disease Control and Prevention, 2002). Despite these hopeful 
findings, HIV-positive women often view themselves as “bad mothers” or “bad women 
for wanting to become mothers” (Sandelowski & Barroso, 2003).   
 
 Much of the literature regarding HIV and pregnancy is related to HIV treatment. 
Antiretroviral distribution and metabolism is different in women when compared to men, 
as women have higher percentages of body fat and lower percentages of lean muscle 
mass than men (Anderson, 2002; Hader, Smith, Moore, & Holmberg, 2001). Limited 
pharmacokinetic studies have addressed sex-related differences in regard to metabolism 
of some antiretroviral agents in non-pregnant women (Anderson, 2002). Physiologic 
changes that occur during pregnancy may change the pharmacokinetic profiles of some 
antiretroviral agents (Anderson, 2002; Mirochnick, 2000), thereby prompting the need for 
additional pharmacokinetic studies in pregnant women with HIV. No studies were found 
in the literature describing the impact of pregnancy on depressive and anxiety symptoms 
in HIV-positive women.  Mood disorders, including depression and anxiety will be 
discussed in the next sections.  
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 MOOD DISORDERS 
According to the Surgeon General’s Report on Mental Health (USDHHS, 1999), 
the current annual prevalence estimate for mental disorders is about 20% of the U. S. 
population. Mood disturbances are the most frequently diagnosed mental health 
disturbances in the U. S. and more common in persons with chronic disorders such as 
HIV/AIDS (Barroso et al., 2008; National Institute of Mental Health, n/d). In primary 
care settings, an estimated 10 to 20% of office visits are related to depressive symptoms 
or an anxiety-related episode (Hirschfeld, 2001). Literature related to depression and 
anxiety in the general population, as well as women, persons with HIV, African 
Americans, and pregnant women will be discussed in the following sections. 
 
Depression in the General Population 
Depressive disorders include a wide range of specific illnesses including major 
depressive disorder (MDD), dysthymia, and bipolar disorder (Barroso et al., 2008). 
Depression is considered a major health problem and is one of the leading causes of 
disability in the United States (R. C. Kessler et al., 2003; R. C. Kessler & Kessler, 2003). 
Patients with depressive symptoms describe poor physical and social functioning, which 
limits their activity (K. B. Wells, Stewart et al., 1989). Impaired functioning has a direct 
impact on not only the patient, but also their families and communities.  
 
An estimated 14.8 million adults or 6.7% of the U. S. population suffers from 
depression in any given year (R. C. Kessler et al., 2005; Wang et al., 2005). Healthy 
women in the general population are twice as likely to be diagnosed with depression as 
their male counterparts (Blazer, Kessler, McGonagle, & Swartz, 1994; R. C. Kessler et 
al., 2003; Wang et al., 2005); depression is the leading cause of disability in women (R. 
C. Kessler, 2003).  Despite these facts, research has shown that general practitioners 
often fail to diagnose depression in primary care practices (Goldberg & Huxley, 1992; R. 
C. Kessler et al., 2003). 
 
A wide range of literature focuses on depression and its prevalence in the general 
population (R. C. Kessler et al., 2005; R. C. Kessler, McGonagle, Zhao et al., 1994) with 
prevalence rates ranging from 10 to 21.3% (R. C. Kessler, McGonagle, Zhao et al., 1994; 
J. K. Myers et al., 1984; Olfson & Pincus, 1996; Olfson et al., 2000). Significant 
depressive symptoms have been documented in primary care populations (K. B. Wells, 
Golding, & Burnam, 1989), and depression is the most frequently studied outcome in 
populations with chronic diseases such as diabetes (Gore, Krupski, Kwan, Fink, & 
Litwin, 2005; M. Gore et al., 2005; Ludman et al., 2004; McKellar, Humphreys, & Piette, 
2004), coronary artery disease (Rudisch & Nemeroff, 2003; Ruo et al., 2003), cancer (C. 
H. Kroenke et al., 2005; Williams & Dale, 2006) and HIV (Ciesla & Roberts, 2001; Low-
Beer et al., 2000; Mock, Phillips, & Sowell, 2002).  
 
Literature illustrating racial differences in diagnoses of depression has been 
documented for decades (Neighbors, Jackson, Campbell, & Williams, 1989), however 
disparity continues (Neighbors, Trierweiler, Ford, & Muroff, 2003). Depression is 
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 diagnosed more frequently in White Americans than African Americans (Neighbors et 
al., 2003); schizophrenia is diagnosed more frequently in African Americans (Neighbors 
et al., 2003). The subjective nature of the clinical diagnosis of depression suggests that 
clinicians’ bias may lead to inaccurate diagnoses despite the use of structured diagnostic 
criteria (Neighbors et al., 2003). 
 
In one of the largest national epidemiologic studies conducted, Kessler and 
colleagues (R. C. Kessler, McGonagle, Zhao et al., 1994) examined prevalence rates of 
depression in a sample of 8098 persons from communities in 48 states. Participants’ age 
ranged from 15 to 54 years. Data were collected by trained interviewers using the 
Composite International Diagnostic Interview (World Health Organization, 1990). 
Lifetime prevalence of major depression was estimated at 17.1%. When the sample was 
assessed for current depression (within the last 30 days), the prevalence rate averaged 
4.9%. Distributions across age ranges were constant, but were twice as high in females as 
in males. The highest lifetime prevalence rates (21.1%) were noted in African American 
women between the ages of 35 to 44 years. These findings emphasize the need to screen 
African American women for depression and justify the need for the current study as 
many of the participants in the current study were women within these age ranges.  
Additional results pertinent to the current study were: 1) persons in lower socioeconomic 
ranges were at higher risk for depression than their more affluent counterparts and 2) 
persons in urban areas were at greater risk rural participants. The current study was 
implemented in an urban area and most participants were poor. 
 
Anxiety in the General Population 
The American Psychiatric Association (APA) classifies anxiety disorders as many 
different, distinct disorders including: panic disorder, agoraphobia without panic disorder, 
specific phobia, social anxiety disorder, generalized anxiety disorder, posttraumatic stress 
disorder, obsessive-compulsive disorder, and separation anxiety disorder. The four most 
common anxiety disorders are panic disorder, social anxiety disorder, generalized anxiety 
disorder, and posttraumatic stress disorder (Gillock, Zayfert, Hegel, & Ferguson, 2005; 
Issakidis, Sanderson, Corry, Andrews, & Lapsley, 2004; Wittchen, 2002; Wittchen et al., 
2002). Approximately 130 million people in the United States have a lifetime history of 
anxiety (Regier et al., 1988). In studies of clinical samples, 50% or more of patients with 
a primary anxiety disorder have at least one additional anxiety or mood disorder (Fiore et 
al., 2001). An estimated 25% of all primary care patients have an anxiety disorder 
(Sartorius, Ustun, Lecrubier, & Wittchen, 1996). Despite its high prevalence, only 15% to 
36% of patients with anxiety are diagnosed in primary care settings (D. Kessler, Lloyd, 
Lewis, & Gray, 1999). 
 
In one of the largest replicated epidemiologic studies conducted (N = 9282), 
Kessler and colleagues (R. C. Kessler et al., 2005) examined lifetime prevalence and age 
of onset of DSM-IV diagnoses. Face-to-face assessments were conducted by trained 
professional interviewers from the Institute for Social Research at the University of 
Michigan, Ann Arbor, between February 2001 and April 2003. The response rate was 
70.9%. The estimated lifetime prevalence of anxiety disorders in the general population 
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 was 28.8%. Median age of onset for anxiety disorders was quite young (11 years) 
compared to depressive disorders (30 years).  
 
In another epidemiologic study, patients from 15 primary care clinics in the U. S. 
completed self-report questionnaires and a follow-up telephone interview (K. Kroenke, 
Spitzer, Williams, Monahan, & Lowe, 2007). Demographic characteristics of the sample 
included an average age of 47.1 years, majority female (69% of the sample was women), 
and majority (81%) non-Hispanic White Americans. The sample was educated, like the 
current study sample. Many of the participants (29%) had a high school degree or 
equivalent and 39% had some college. Of the 965 participants, 19.5% had at least one 
anxiety disorder (95% CI, 17% to 22.1%). Almost half (41%) of the participants 
diagnosed with an anxiety disorder were not receiving treatment.   
 
Prevalence of anxiety symptoms among women is twice as high as those for men 
(Breslau, Schultz, & Peterson, 1995; J. M. Murphy et al., 2004; Olfson et al., 2000) 
which informs the present study, as anxiety symptoms are not routinely and 
systematically assessed in populations of women. Recent literature related to anxiety 
includes investigation of genetic correlates for anxiety (Landgraf & Wigger, 2003). 
Unlike depression, evidence does not support a significant association between family 
history of anxiety disorders and a personal risk for anxiety disorders (USDHHS, 1999). 
However, epidemiologic studies consistently document high rates of co-morbid 
depression and anxiety within the general population (Brown, Campbell, Lehman, 
Grisham, & Mancill, 2001; R. C. Kessler et al., 2005; R. C. Kessler, McGonagle, Nelson 
et al., 1994; J. M. Murphy et al., 2004; Olfson et al., 2000). The next section will discuss 
co-morbid depression and anxiety. 
 
Co-morbid Depression and Anxiety in the General Population 
Overlapping symptoms of anxiety and depression often occur in persons 
diagnosed with mood disorders (Brown et al., 2001; R. C. Kessler et al., 2003; R. C. 
Kessler, McGonagle, Nelson et al., 1994; J. M. Murphy et al., 2004). The significant rates 
of co-morbidity have prompted investigation into overlapping symptoms, diagnostic 
trends, and effective treatment regimens (R. C. Kessler et al., 2005; R. C. Kessler, 
McGonagle, Nelson et al., 1994; Wang et al., 2005; Zimmerman & Chelminski, 2003). 
Hirschfeld (Hirschfeld, 2001) recognized a lack of information regarding the co-existence 
of these disorders in primary care settings, and subsequent epidemiologic studies (R. C. 
Kessler et al., 2005) illustrate high levels of co-morbid conditions within both the general 
population and in primary care populations (Rodriguez et al., 2004). Because previous 
research indicates that the prevalence of depression and anxiety is higher in women than 
men (Blehar & Oren, 1995; Breslau et al., 1995; J. M. Murphy et al., 2004; Olfson et al., 
2000) and these conditions often co-exist, it reasonable to expect women to experience 
co-morbid depression and anxiety more often than men. 
 
 The need for routine screening is evident due to high prevalence rates and the fact 
that depression and anxiety are common in the context of physical illnesses such as 
cardiac disorders, hypertension, gastrointestinal disorders, genitourinary disorders, and 
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 migraines (M. C. Harter, Conway, & Merikangas, 2003). High prevalence rates of co-
morbid depression and anxiety have been noted in several national studies (Brown et al., 
2001; R. C. Kessler et al., 2005). Brown and colleagues (2001) reported high co-
morbidity rates in a sample (N = 1,127) of patients with diagnosed anxiety and mood 
disorders who were seeking treatment at a university-based specialty clinic. Co-morbidity 
for specific anxiety and mood disorders were noted in patients with generalized anxiety 
disorder, with 65% having a current co-morbid mood disorder and 88% with a lifetime 
co-morbid anxiety or mood disorder. Ninety-two percent of patients with post-traumatic 
stress disorder had a current mood disorder and all had a lifetime history of a mood 
disorder. Kessler and colleagues (R. C. Kessler et al., 2005) reported co-morbidity rates 
for anxiety disorders, mood disorders, impulse control disorders, and substance use 
disorders in a national epidemiologic study. In this sample of 5692 participants, 55% had 
a single diagnosis, 22% had two diagnoses, and 23% had three or more diagnoses.  The 
numbers and types of diagnoses have illustrated racial differences.  
 
Mood Disorders in the African American Population 
 Researchers examining mental health diagnoses by race and ethnicity have cited 
racial differences in DSM diagnoses (Loring & Powell, 1988; Neighbors et al., 2003). 
Schizophrenia is diagnosed more frequently in African Americans than White 
Americans, while White Americans are more likely to receive a diagnosis of bipolar 
disorder than African Americans (Neighbors et al., 2003). These differences in mental 
health diagnoses were studied by Neighbors and colleagues (Neighbors et al., 2003), 
through semi-structured diagnostic instruments administered to a group (N = 665) of 
African American and White American psychiatric inpatients. Results indicated that race 
was related to diagnosis and dependent upon accuracy of clinical judgment. Pre-existing 
cultural beliefs may impact clinical decision making. The authors recommended that 
cultural information be integrated into clinical training programs to decrease this bias.   
Racial differences in access to mental health care have illustrated disparities that 
affect African Americans. African Americans have less access to health care across 
health care disciplines, including mental health and psychiatric services. Some reports 
indicate that African Americans are more likely to have depression than their White 
counterparts (Gazmararian, James, & Lepkowski, 1995; Hough, Brumitt, & Templin, 
1999; Husaini et al., 1990; McBarnette, 1996); while other studies reveal that rates of 
major depression are either higher than (Blazer, Kessler, McGonagle, & Swartz, 1994) or 
equivalent to (Berkman et al., 1986; Murrell, Himmelfarb, & Wright, 1983) the rates 
among non-Hispanic whites than African Americans.  Plant and Sachs-Ericsson (Plant & 
Sachs-Ericsson, 2004) reported that ethnic minority women report more depressive 
symptoms than Caucasian women, while George and Lynch (George & Lynch, 2003) 
reported that African Americans experience greater stress than White Americans and 
therefore greater depressive symptoms than White Americans. Lower income levels have 
been associated with greater stress levels due to the inability to meet basic needs, which 
could increase depressive symptoms (B. P.  Dohrenwend & Dohrenwend, 1969; Turner 
& Lloyd, 1999). A plausible explanation for the difference in results of these studies was 
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 the large amount of missing income data in the Blazer and colleagues’ (Blazer et al., 
1994) study. 
 Teresi and colleagues (Teresi et al., 2002) explored racial differences in the 
recognition of depressive symptomatology. In a population of nursing home residents,   
(N = 270) African Americans had fewer depressive symptoms than other ethnic groups. 
The referral of patients to psychiatry may have had an influence on these results, as the 
authors noted that the persons with the most involvement with the patients (nursing 
assistants) gave the most accurate report of depressive symptomatology compared to 
other health care professionals (nurses, social workers) engaged in the care of the 
patients. One possible reason for this difference in perceptions could be related to race. 
Nursing assistants were more often African American, whereas nurses and social workers 
in the study were predominately Caucasian.  
 
 Economic differences have been investigated as possible barriers to mental health 
care among African Americans with conflicting results. Economic barriers such as 
unemployment, low income, or lack of health insurance are often used to explain racial 
disparities in health care among African Americans. However, research has shown that 
African Americans who had health insurance were actually less likely to use mental 
health services than White Americans (Snowden & Thomas, 2000). Furthermore, African 
Americans have low overall rates of outpatient mental health service use (Alegria, 
Canino, Rios, & et al., 2004; K. Wells, Klap, Koike, & Sherbourne, 2001). Moreover, 
discrepancies in use of mental health services may be related to stigma related to mental 
illness within African American communities. Stigmatization of mental illness is one of 
the main reasons treatment is delayed until the disorder becomes debilitating or a crisis 
develops (United States Department of Health and Human Services, 1999; Zhang & 
Snowden, 1999). Literature illustrates low rates of mental health care by African 
Americans. Although several reasons have been hypothesized, stigmatization remains a 
strong force that must be addressed. The current study examined anxiety and depressive 
symptoms among African American HIV-positive women, a population drenched in 
shame, stigma, and isolation.  
 
Depression and Anxiety in HIV-positive Patients 
Mood disorders are common among persons living with HIV in the United States 
(Bing et al., 2001; Ickovics et al., 2001; Moore et al., 1999; Morrison et al., 2002). 
Depressive symptoms are the most commonly examined psychiatric symptom in HIV 
populations. Early in the epidemic, homosexual men represented a large proportion of 
samples in HIV literature, which appropriately reflected the HIV population at that time 
(Atkinson et al., 1988; Bing et al., 2001; Ickovics et al., 2001; Leserman et al., 1999; 
Lyketsos et al., 1996; Perkins et al., 1994; Rabkin, Goetz et al., 1997). Recent literature 
describes the effects of mood disorders in HIV-positive women (Cruess et al., 2005; 
Evans et al., 2002; Ickovics et al., 2001; Morrison et al., 2002; Perkins et al., 1994; 
Rabkin, Goetz et al., 1997), as the HIV epidemic grew to impact demographically 
different populations across the country. 
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 Many of the published research studies regarding mood disorders in the HIV 
literature are cross-sectional, capturing information during one specific time point. HIV, 
like many chronic diseases, has stages and progresses differently based on multitude of 
factors. Cross-sectional studies may not accurately reflect the varying levels of depressive 
and anxiety symptoms that occur throughout the course of the illness. Dissimilar findings 
across studies may indicate differences within the sample, such as varying stages of 
disease and varying lengths of HIV diagnosis which likely influences the intensity of 
depressive symptoms.  
 
HIV literature reveals varying rates of co-morbid depression and anxiety, 
however similar trends are noted. Rates of mood disorders in a sample of HIV-positive 
women (n = 93) were 19.4% for MDD, 4.3% for dysthymic disorder, 2.2% for 
generalized anxiety disorder, and 10.8% for any anxiety disorder (Morrison et al., 2002). 
Higher rates of depression and anxiety have been reported in populations of HIV-positive 
men (n = 56), with rates as high as 30.3% for MDD and 39.3% for generalized anxiety 
disorder (Atkinson et al., 1988). In general, higher rates of depressive disorders (MDD) 
have been illustrated in HIV-positive groups, when compared to their HIV-negative 
counterparts. Maj and colleagues (Maj et al., 1994) reported MDD rates of 7.14% in a 
group of 602 HIV-positive men and women, compared to a lower rate of MDD (1.98%) 
in the group of HIV-negative men and women (n = 353). Contrasting results were seen in 
Rabkin and colleagues’(Rabkin, Goetz et al., 1997) study, with lower rates of MDD seen 
in HIV-positive men (n = 183) than HIV-negative (n = 65) men (7.65% vs. 8.33%, 
respectively). However, in this group of men, higher rates of dysthymic disorder 
(13.11%) were seen in the group of HIV-positive men than the group of HIV-negative 
men (4.76%), indicating the need for comprehensive assessment of a wider range of 
mood disorders.  
 
The prevalence of a wider range of psychiatric disorders among HIV-positive 
men and women was assessed in a large (N = 2864) epidemiologic study (Bing et al., 
2001). Trained interviewers assessed major depression, dysthymia, generalized anxiety 
disorders, and panic attacks. Results illustrated that almost half of the participants had 
scores indicating presence of a psychiatric disorder. The most common disorders 
included MDD (36%) and dysthymia (26.5%) with lower rates noted for generalized 
anxiety disorder (15.8%) and panic attacks (10.5%). The high numbers of HIV-related 
side effects in the sample may explain the higher rates of depressive disorders and 
dysthymia in the study. Anxiety disorders were lower in this sample than seen in the 
general population. A plausible explanation for this finding may be the high frequency of 
marijuana use that was reported by the participants.  
 
Previous studies provide consistent evidence that HIV-positive persons 
experience significant levels of depression, yet the concept of depression has been used 
broadly, with some studies focusing on diagnoses of specific mood disorders such as 
MDD (Bing et al., 2001), while others focused on the presence of depressive symptoms 
(Atkinson et al., 1988; Bing et al., 2001; Lipsitz et al., 1994; Perkins et al., 1994; Stern et 
al., 1992). In some cases, the effects of mood disorders on HIV treatment are specified, 
such as adherence to HAART or medical appointments (Starace et al., 2002), while other 
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 research has focused on the detrimental effects that depression has on HIV disease 
progression (Cruess et al., 2003; Leserman, 2003), morbidity, and mortality (Ickovics et 
al., 2001).  
 
Thus, evidence suggests that when compared to their HIV-negative counterparts, 
HIV-positive persons may experience greater levels of depressive and anxiety symptoms. 
Studies must be viewed with caution, as prevalence rates vary greatly among studies. 
Rates of depressive symptoms alone have ranged from 5% to 50% among HIV-positive 
persons (Atkinson et al., 1988; Bing et al., 2001; Leserman, 2003; Lipsitz et al., 1994; 
Perkins et al., 1994; Stern et al., 1992). The wide range of assessment techniques, varied 
instrumentation, varied outcome measurements (depressive symptoms, anxiety 
symptoms, MDD, dysthymia, generalized anxiety disorder), combined with differences 
among samples (concomitant substance use and differences in HIV disease progression) 
across studies makes comparison of findings difficult; however, similar trends are noted. 
Because most studies in the HIV literature do not include an assessment of multiple risk 
factors or vulnerabilities for mood disorders, this lack of consensus in findings is not 
unexpected.   
 
Depression and Anxiety in African American HIV-positive Women 
Women of color are now one of the fastest growing groups of newly infected 
persons with HIV (Centers for Disease Control and Prevention, 2002, 2005, 2007a; 
Ickovics et al., 2001; Morrison et al., 2002). Consistent with the general HIV literature, 
varying prevalence rates of mood disorders are documented in women who are HIV-
positive. Prevalence rates of mood disorders vary from 30% to 60% among populations 
of women who are HIV-positive (Ickovics et al., 2001; Morrison et al., 2002; D. K. Smith 
et al., 1996; Taylor, Amodei, & Mangos, 1996). African American women, although 
underrepresented in many other areas of research, were well represented in several HIV 
studies. In Ickovics’ (Ickovics et al., 2001) study, 62% of the women in the sample were 
African American, while Morrison’s study contained approximately 55% African 
American women. Depressive symptoms are the most common mental health outcome 
assessed in studies of HIV-positive women. 
 
Consistent with earlier HIV literature that compared HIV-positive men with HIV-
negative men higher rates of depressive symptoms have been documented in similar 
populations of women. Ickovics and colleagues (Ickovics et al., 2001) examined the 
prevalence of depressive symptoms among HIV-positive women (N = 765) in a 
prospective longitudinal cohort study. The majority of the sample (62%) was African 
American, unemployed (84%), and denied substance use during the study duration 
(54%). Participants were evaluated every six months and required at least three study 
visits for analysis. Depressive symptoms were measured using the CES-D (Radloff, 
1977), which captured self-reported symptoms experienced within the past seven days. 
Chronic depressive symptoms were defined as elevated CES-D scores (using the cut-off 
score of 16 or higher) for 75% of their study visits, intermittent depressive symptoms 
were defined as elevated CES-D scores for 26-74% of their study visits, and limited or no 
depressive symptoms were classified as no more than 25% of their study visits revealing 
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 CES-D scores at or above 16. Almost half of the sample (42%) reported chronic 
depressive symptoms, while 35% reported intermittent depressive symptoms. 
 
Morrison and colleagues (Morrison et al., 2002) examined differences in mood 
disorders, including depressive and anxiety symptoms, among HIV-positive and HIV-
negative women in a large, longitudinal cohort study (N = 155). Although the authors did 
not specifically document a case-control design, one is implied. The authors do not 
indicate if participating women were matched according to race, age, or any other 
demographic characteristic. There was a larger group of HIV-positive women (n = 93) 
than HIV-negative women (n = 62). Racial distributions were similar in both groups, with 
the majority of the sample being African American (55.9% in HIV-positive group; 53.2% 
in the HIV-negative group). 
 
Comprehensive measurements included physical and psychological exams, 
interviews, and the completion of questionnaires [Hamilton Depression Rating Scale [(M.  
Hamilton, 1967)] and Hamilton Anxiety Rating Scale [(M. Hamilton, 1959)]. The cohort 
design allowed the researchers to follow populations over time and gather information 
about the natural history of disease, examine sequences and patterns over time as well as 
inferring causality, which may illustrate risk factors. Two groups of women were 
followed from 1997-2000. Differences in the rates of depression and anxiety disorders in 
the group of HIV-positive women were compared to a group of HIV-negative women.   
 
Results indicated that HIV-positive women had higher prevalence rates of major 
depressive disorder (19.4%) than HIV-negative women (4.8%) and these differences 
were statistically significant (t = - 4.9, df = 152, p < 0.0001). Similar results were noted 
for diagnoses of anxiety disorders, with 10.8% of the HIV-positive women being 
diagnosed with any anxiety disorder and 2.2% of the HIV-positive women being 
diagnosed with generalized anxiety disorder. Lower rates of any anxiety disorder were 
noted in the HIV-negative group of women (6.5%), but the HIV-negative women had 
higher rates of generalized anxiety disorder (3.2%) than their HIV-positive counterparts 
(2.2%). Anxiety symptom scores were higher in the group of HIV-positive women when 
compared to the HIV-negative group, and these differences were statistically significant 
(t = - 4.5, df = 152, p < 0.0001). HIV-positive women (n = 47; 50.5%) also had higher 
rates of active substance use than their HIV-negative counterparts (n = 19; 30.6%), a 
difference that was statistically significant (odds ratio = 2.3, 95% CI = 1.2-4.6; p = 0.02, 
Fisher’s exact test) 
 
Demographic characteristics of women who are HIV-positive include multiple 
complex factors which may influence the risk for mood disorders. Caregiving roles as 
mothers and partners may add to stress and distress that is experienced by this population 
(Fiore et al., 2001). Literature reveals that HIV-positive women report high levels of 
fatigue and anxiety (Barroso, 2002; Barroso, Carlson, & Meynell, 2003; Barroso et al., 
2008; Meynell & Barroso, 2005) are frequent victims of violence (Leibschultz, Feinman, 
Sullivan, Stein, & Samet, 2000), and live in poverty (Ickovics et al., 2001; Wohl et al., 
1998).  
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 African American women with HIV are a unique population with additional 
stressors that may contribute to depressive and anxiety symptoms. Understanding the 
psychological burden the diagnosis of HIV brings to patients is imperative to 
appropriately counsel and guide them through the course of this chronic disease. 
Additional research regarding possible vulnerabilities to depressive and anxiety 
symptoms is necessary. 
 
Depression and Anxiety in Pregnancy 
In studies focused on mood disorders and pregnancy, the most frequently studied 
mood disorder is postpartum depression. However, results from investigations designed 
to examine predictors of postpartum depression consistently include antenatal depression 
as one of the main risk factors for postpartum depression. Therefore, the assessment of 
mood disorders in pregnancy remains a critical aspect of comprehensive prenatal care. In 
the next section the correlates of mood disorders and pregnancy will be discussed.  
 
Depression is the leading cause of disability in women (R. C. Kessler, 2003) and 
often first appears following pregnancy. Fifty to seventy percent of women experience 
psychological changes following childbirth (Mosack & Shore, 2003). The overall 
psychological reactions commonly known as the “baby blues” include transient, mild 
states of tearfulness, anxiety, restlessness, and irritability. Due to the high frequency of 
occurrence, these symptoms are often considered a normal part of the postpartum period, 
appearing as early as the first postpartum day. The duration of these symptoms is short, 
lasting approximately ten days in most affected women. Symptoms may reappear after 
exposure to decreased sleep quality and duration that are often associated with neonatal 
care. Increase in dysmorphic syndrome disorders is often attributed to somatic changes, 
not hormone level changes that occur immediately after childbirth (Dixit & Crum, 2000; 
Holahan, Moos, Holahan, Cronkite, & Randall, 2003; Nott, Franklin, Armitage, & 
Gelder, 1976; Schutte, Moos, & Brennan, 1995; Swain, O'Hara, Starr, & Gorman, 1997) 
 
Over the past few decades, an increasing number of studies have led to the 
identification of multiple variables that are correlated with post-partum depression. In 
contrast to earlier theories that included dramatic hormone changes that occur during 
pregnancy and immediately after delivery, the current etiology of mood disorders in 
pregnancy suggests a multifactorial process (Casswell, Pledger, & Hooper, 2003; 
Neighbors et al., 2003; L. E. Ross, Gilbert Evans, Sellers, & Romach, 2003). 
Investigators have examined specific risk factors of post partum depression and found 
that the most prevalent are: antenatal depression and anxiety, personal and family history 
of depression, life stress, and lack of social support (C. T. Beck, 2001; P. Cooper & 
Murray, 1997; P. J. Cooper & Murray, 1998; Howell, Mora, & Leventhal, 2006; O'Hara 
& Gorman, 2004).  
 
Early identification of vulnerable populations of women is essential. Prevalence 
rates of postpartum depression vary widely; however research suggests that 10 to 50 
percent of women experience postnatal depression. Varying rates are due to sampling 
techniques, populations studied, and the wide variety of screening assessments used 
29 
 across studies. Postpartum depression is the most common disorder that affects women 
following childbirth (C. T. Beck, 1998; Cox et al., 1987). Researchers have illustrated 
that levels of depressive symptoms in the immediate postpartum period are significant 
predictors of postpartum depression (Dennis, 2004; Hannah, Adams, Lee, Glover, & 
Sandler, 1992).   
 
In a longitudinal study, depressive symptoms of women (N = 217) that delivered 
infants at two British hospitals were assessed at five days postpartum, and again at six 
weeks postpartum using the EPDS (Hannah, Adams, Lee, Glover, & Sandler, 1992). 
Results indicated that women with EPDS scores greater than nine at five days postpartum 
were eight times more likely to have EPDS scores above nine, which is indicative of mild 
depressive symptoms, at six weeks postpartum. Similar results were found in Dennis’ 
2004 study of Canadian mothers (N = 594) where women were screened with the EPDS 
at one, four, and eight weeks postpartum. Elevated EPDS scores at one week postpartum 
were associated elevated EPDS scores at both four and eight weeks postpartum (Dennis, 
2004). Racial descriptions of the Canadian participants were not provided, limiting 
comparisons to the current study of African American women.  
 
Screening evaluations for post partum depression were evaluated in another study 
of postpartum women in North Carolina (N = 391). The majority of the sample (84%) 
was Caucasian and had at least a high school education (74%). Medical residents 
compared screening with the use of the Edinburg Postnatal Depression Scale with routine 
interviews of women that had delivered infants (Evins, Theofrastous, & Galvin, 2000). 
Chi square analysis compared 79 women evaluated with the EPDS with 96 women 
evaluated with clinical evaluations (structured interviews). Women were assigned to one 
of the two screening measurements by delivery date. Results revealed the incidence of 
postpartum depression detection with the Edinburgh Postnatal Depression Scale was 
significantly higher than the incidence of spontaneous detection during routine clinical 
evaluation (35.4% and 6.3%, respectively; p = .001). Investigators recommended that the 
EPDS is an effective method for screening postpartum women for depressive symptoms. 
The authors also recommend the EPDS as a useful instrument that should be introduced 
to medical residents during their training and used in their post resident practice. Thus, 
the evidence suggests that women with depressive symptoms immediately postpartum 
continue to experience depressive symptoms weeks after delivery, suggesting the need 
for early screening, identification and intervention. These results were important to the 
current study, and emphasize the need to not only screen women for depressive 
symptoms, but also train healthcare providers to implement early consistent screening in 
their practices. 
 
Mood disorders in pregnancy are a complex phenomenon which can have 
devastating consequences on both the mother and the infant. Complex psychological 
changes may occur in women during and after pregnancy, and may vary in duration, 
intensity, and severity. One third of women that experience postpartum depression, but 
are either untreated or undiagnosed, may continue to suffer from depression for one year. 
Therefore, it is important that women be screened for signs and symptoms of depression 
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 as early as possible. Many women do not report symptoms of postpartum depression (C. 
T. Beck & Gable, 2000), fearing social stigma (C. T. Beck, 2001).  
 
In studies focused on postpartum depression, investigators have examined the 
relationship between postpartum depression and major depression. The strongest 
predictor of postpartum depression is the presence of prenatal depression (C. T. Beck, 
1996; O'Hara & Gorman, 2004). Despite the grim realization of the effects of postpartum 
depression and the prevalence of the condition, many women are not routinely screened. 
Recognizing signs and symptoms of depression is imperative. Screening instruments 
have been shown to be useful in identifying depression by identifying depressive 
symptomatology. Use of such questionnaires may help identify women that experience 
signs and symptoms of depression. The most widely used instrument is the Edinburgh 
Postnatal Depression Screen (EPDS) (Cox et al., 1987), which was one of the instruments 
used to measure depressive symptoms in the current study. Assessment of underlying 
vulnerabilities for depression and anxiety may enhance screening procedures; inherited 
and acquired vulnerabilities for these disorders will be discussed in the next section.  
 
 
INHERITED VULNERABILITIES FOR MOOD DISORDERS  
Human genetic makeup is determined by building blocks that are provided by 
biologic family. The term inherit can be defined as to receive from one’s ancestors (Mish, 
1997). Vulnerability reflects susceptibility to wounds, or capability of being wounded 
(Mish, 1997). Inherited vulnerabilities are often the initial influences that affect not only 
the early life experiences, but also lay the groundwork for future coping strategies and 
lifestyle choices. In the current study, the term vulnerability referred to susceptibility to 
mood disorders; both inherited and acquired vulnerabilities were examined. The current 
study evaluated two inherited vulnerabilities that influence the risk for developing mood 
disorders: family history of mood disorders and family history of alcohol and/or drug use. 
 
Family History of Mood Disorders 
Family history of mood disorders has long been acknowledged as a strong 
predictor of mood disorders in many patients (Gershon et al., 1982; Klein, Lewinsohn, 
Seeley, & Rohde, 2001; Weissman et al., 1987). Depressive symptoms are the most 
frequently examined mood disorder in family history research. The method by which 
family history information is ascertained varies across studies and ranges from a report of 
a family member with a mental health history to structured interviews and psychological 
assessment of family members to clinicians determining the presence or absence of 
psychiatric diagnoses. The later is much more costly and labor intensive but may be more 
accurate. The family history method has been shown to have good sensitivity in family 
studies of depression (Kosten, Anton, & Rounsaville, 1992; Zimmerman & Chelminski, 
2003) but less specificity. Conclusions about the relationship between family history of 
mood disorders and individual presence of mood disorders may be equivocal because 
most studies included self-report measures of family history. Despite acknowledged 
limitations of subjective reports, in the current study, participants reported family history 
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 of mood disorders on the Demographic Data Instrument. Using this approach, however, 
facilitates comparisons between the findings of the current study and findings of 
published studies that determine family history using a similar approach. 
 
Numerous studies have consistently shown that the children born to parents with 
major depressive disorder have a three-fold risk of experiencing major depressive 
disorder in their lifetime (Downey & Coyne, 1990; Kosten et al., 1992; Lieb, Isensee, 
Hofler, Pfister, & Wittchen, 2002; Weissman et al., 1984; Williamson, Birmaher, 
Axelson, Ryan, & Dahl, 2004; Zimmerman & Chelminski, 2003).  Lieb and colleagues 
(Lieb et al., 2002) conducted an analysis of demographic, structured interview, and 
questionnaire data obtained as part of a prospective longitudinal study (N = 2427) 
designed to explore the incidence, prevalence, and risk factors associated with mental 
disorders. Subjects were recruited from a community sample in Munich Germany; racial 
descriptions of the sample were not provided.  Data were collected from adult 
participants and their children at entry and then four years later. Most participants were 
mothers (n = 1026) although some participants were fathers (n = 27) if the mother was 
not available. Diagnoses of depression, anxiety, and substance use disorders were made 
based on DSM-IV guidelines. Results indicated that major depression in a parent, either 
the mother or the father, increased the risk for mental disorders in their male and female 
children. Children’s diagnoses revealed that children born to two parents with depression 
were at no greater risk for developing mental disorders than children born to one parent 
with depression. However, onset of symptoms differed in children with one or both 
affected parents, with earlier onset of depression noted in children with two affected 
parents. Severity of depression among children (defined as the number of depressive 
episodes and level of treatment seeking) was greater if a parent had a history of 
depression. A limitation of the study was the assessment of only one parent. Interviews 
were used to gather additional information regarding the nonparticipating parent and 
most of the parents assessed were mothers. These aspects of methodology may have 
compromised the results, as comprehensive assessments of both parents might yield 
greater insights regarding the influence of this risk factor for mood disorders.   
 
Much of the published literature regarding family history for mood disorders 
focuses on parental histories or two specific generations of family members (Downey & 
Coyne, 1990; Kosten et al., 1992; Lieb et al., 2002; Weissman et al., 1984; Williamson et 
al., 2004; Zimmerman & Chelminski, 2003) however, multigenerational studies are now 
being conducted to further examine the strength of familial history as a risk factor. A 
three generation longitudinal study was conducted by Weissman and colleagues 
(Weissman et al., 2005). The twenty year study included a sample (N = 161) of 
grandchildren, their parents and grandparents. The third generation of the original cohort 
study was the focus of this study. The original cohort study reported a total sample of 73 
adolescents with MDD and 37 adolescents without MDD. The majority of the sample 
was Caucasian (58.9% in sample with MDD; 59.4% without MDD). African Americans 
represented 9.6% of the sample with MDD and 21.6% of the sample without MDD. 
Clinicians blinded to family history data collected information from participants, 
specifically lifetime history of diagnosis of a psychiatric disorder. This method of data 
collection allowed a less biased approach to data collection. . High rates of psychiatric 
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 disorders were noted in the grandchildren with a two generation history of major 
depression. Subjects with depressed grandparents also had increased risk of anxiety 
(relative risk, 5.17; 95% confidence interval, 1.4-18.7; p = .01). Subjects with depressed 
parents had an increased risk of any psychiatric disorder (relative risk, 5.52; 95% 
confidence interval, 2.0-15.4; p = .002). Severity of impairment was measured with 
multiple instruments, diagnostic interviews, and presence of divorce in the first and 
second generations. Results indicated that the more impaired the depressed parent, the 
higher the rate of mood disorders in the grandchildren (relative risk, 2.44; 95% 
confidence interval, 1.1-5.5; p = .03). Results also indicated an association between 
parental MDD and child diagnosis of MDD, which varied based upon the presence of 
grandparental MDD status. Grandchildren whose parents and grandparents illustrated 
moderately to severely impairing depression exhibited the highest rates of 
psychopathology, indicating the need for multi-generational historical information. 
 
Family psychiatric history has been shown to play an important part in adolescent 
psychiatric assessment, furthering the notion that markers or vulnerabilities may be 
present early in the developmental process. King and colleagues (King et al., 2006) 
investigated the family psychiatric histories of a group of adolescents (N = 71) that were 
being treated for MDD. Adolescents and their parents completed interviews and 
questionnaires to assess the presence or absence of severe behavioral disinhibition. The 
adolescents with increased behavioral disinhibition had a higher prevalence of drug use 
disorders in their biological fathers, higher proportion of paternal second degree relatives 
with alcohol use disorders, drug use disorders, and (King et al., 2006) psychiatric 
hospitalizations. The adolescents with increased behavioral disinhibition also had a 
higher prevalence of maternal second degree relatives with antisocial personality 
disorder. Results from this study, as well as other psychiatric studies in children and 
adolescents, encourage early screening and assessment of children with inherited 
vulnerabilities for mood disorders. The current study examines the impact of inherited 
vulnerabilities on depressive and anxiety symptoms. 
 
Prevalence of family history of depression was examined in an exclusively female 
community sample by Sullivan and colleagues (Sullivan et al., 1996). The authors 
hypothesized that a family history of depression increased the likelihood that a person 
would seek treatment for mental health evaluation; therefore they examined the 
prevalence of depression within a community sample.  
 
Family history of depression was assessed in three groups of women: (1) 54 
women randomly selected from the community with depression in the prior year, (2) 41 
women who entered a clinical trial for depression, and (3) 37 randomly selected women 
from the community who had no history of depression in the prior year. Presence or 
absence of depression in the parents and siblings of the women with depression was 
assessed by the family history method. Depressed women had higher family history 
scores of depression than other two groups (p < 0.00005 for both groups). As with many 
family history studies, direct interviews with relatives were not completed. Therefore the 
impact of differential reporting may have affected the study results.  
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 Although much of the family history literature focuses on genetic vulnerabilities, 
research suggests that the impact of familial mental disorders can be explained through 
both genetic and environmental factors (Beardslee, Versage, & Gladstone, 1998; Rutter, 
Silberg, O'Connor, & Simonoff, 1999a, 1999b).  The family history component of mental 
disorders suggests a familial transmission of depression, with a possible category of 
“familial subtype” of depression (Weissman, Warner, Wickamaratne, Moreau, & Olfson, 
1997).  However, both genetic and environmental factors influence depressive symptoms 
in both children and their parents, and investigators have recently incorporated this 
knowledge into their design (Sagrestano, Paikoff, Holmbeck, & Fendrich, 2003).  
 
Sagrestano and colleagues (Sagrestano et al., 2003) conducted a longitudinal 
study of child and parent depression in an inner city, urban, low-income population (N = 
302). All children were African American adolescents, aged 9-15. Two time points 
illustrated 7.3% of the parents and 3% of the children had depressive symptoms at the 
first collection, with 5.4% of the parents and 2.8% of the children were clinically 
depressed. Regression analysis revealed increases in conflict and decreases in parental 
monitoring were associated with higher depressive symptomatology in the children. 
Increases in conflict and decreases of positive parenting resulted in higher depressive 
symptomatology in the adults. The longitudinal design was a strength of this study. The 
current study was cross-sectional in nature, capturing data from participants at one time-
point, rather than multiple assessments over time. 
 
No direct cause of mood disorders can be identified, although published literature 
suggests that both genetic and environmental factors contribute to mood disorders. 
Researchers note the importance of obtaining accurate histories regarding mood 
disorders, especially parental diagnoses, as well as information related to family 
interaction patterns, an environmental aspect of family history (Shiner & Marmorstein, 
1998). The varying degrees of severity, co-morbidity occurrences, recurrence rates, 
environmental factors, and treatment modalities make causal inferences difficult. 
Therefore, additional research, particularly longitudinal multi-generational research 
studies are needed. Environmental factors, such as family history of alcohol and/or drug 
use, have also been examined in psychiatric literature, and will be discussed in the next 
section.  
 
Family History of Alcohol and/or Drug Use 
Much of the previous literature regarding family history of alcohol and/or drug 
use and has focused on the relationship between family history of alcohol and/or drug use 
and the presence of individual mood disorders (Beardslee et al., 1998; Dixit & Crum, 
2000; Maier, Lichtermann, & Minges, 1994; Todd, Geller, Neuman, Fox, & Hickok, 
1996). Alcohol abuse disorder is considered a mood disorder; familial transmission of 
alcohol dependence has been demonstrated (Reich, Cloninger, Van Eerdwegh, Rice, & 
Mullaney, 1988; Reinherz, Paradis, Giaconia, Stashwick, & Fitzmaurice, 2003). When 
compared to rates of alcoholism in the general population, increased rates of alcoholism 
are present in persons with a family history of alcoholism. The following epidemiologic 
study illustrates this finding.  
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 Rice and colleagues (Rice et al., 2003) examined the relative risk of alcohol 
dependence in parents and siblings of alcohol dependent subjects (N = 4099) in 
comparison with control subjects and their families (n = 1054). Survival analysis, using 
Kaplan-Meier and Cox proportional hazards model, were calculated based on the age at 
the onset of alcohol dependence. DSM-III-R criteria were used as the definition of 
alcohol dependence. Men had higher rates than women; relatives of alcoholics had higher 
rates than controls. Blacks (non-Hispanic) had lower relative risks than whites. Lower 
levels of education had higher relative risks (RR, 2.83; p < 0.0001) rates than higher 
levels of education. Interestingly, a father’s alcohol dependence was a significant 
predictor (p < 0.0001) of alcohol dependence, whereas, a mother’s alcohol dependence 
was not (p = 0.3). These results indicate that not only should family history of substance 
use be assessed, but what specific relatives and what ages the dependence began are also 
important aspects of a thorough history.  
 
Much of the published literature regarding the relationship between family history 
of alcohol and/or drug use and mood disorders has shown a positive relationship (Dixit & 
Crum, 2000; Winokur & Coryell, 1991). In a sample of 1383 women in Baltimore, 
women with family histories of alcohol and/or drug use were more likely to be depressed, 
and more likely to report a lifetime history of another psychiatric disorder (Dixit & Crum, 
2000).  Higher rates of family history of alcohol and/or drug use were seen in depressed 
women, but not in depressed men (Winokur & Coryell, 1991). Child or adolescent onset 
of depression (MDD) has led investigators to examine risk factors for depression, and 
familial history of both alcoholism and mood disorders remain strong correlates. Todd 
and colleagues examined prevalence rates of alcoholism in relatives of children with 
depression and bipolar disorder (Todd et al., 1996). The impact of family history of 
alcohol and/or drug use is evident early; 39 of the 48 children or adolescents (81.25%) 
with depression also had histories of alcoholism in either first or second degree relatives 
(Todd et al., 1996). Rates were higher among children with bipolar disorder (41 of 47 or 
87.23%) Although the prevalence rates of alcoholism have been high in samples of 
depressed persons across many ages, these statistics do not imply causation, as research 
objectives and methodology vary across studies.  
 
Inherited vulnerabilities have been associated with mood disorders for decades 
(Dixit & Crum, 2000; Downey & Coyne, 1990; Lieb et al., 2002; Maier et al., 1994; 
Todd et al., 1996; Weissman et al., 1984; Williamson et al., 2004). Family history of 
mood disorders and family history of alcohol and/or drug use have been the most 
common genetic vulnerabilities for mood disorders. Although much of the published 
literature focuses on the relationship between family history and depression, associations 
have also been illustrated with other mood disorders, including bipolar disorder and 
schizophrenia. The current study examined family history of both mood disorders and 
alcohol and/or drug use in this population of African American women who were HIV-
positive. Individuals are unique and have multi-faceted backgrounds, which provide 
justification for the comprehensive assessment of risk factors for mood disorders, 
including both inherited and acquired vulnerabilities. The acquired vulnerabilities for 
mood disorders will be discussed in the next section.  
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 ACQUIRED VULNERABILITIES FOR MOOD DISORDERS  
The etiology of mood disorders has been viewed as both inherited and acquired. 
The ways of conceptualizing vulnerabilities to mood disorders are many and vary across 
the literature. The relationship between some acquired vulnerabilities such as alcohol 
and/or drug use, and mood disorders have been investigated for decades (Hesselbrock, 
Meyer, & Keener, 1985; Holahan et al., 2003; Schutte et al., 1995)  while others, such as 
sleep quality are more recent explorations (Kripke et al., 2004; Lee, Portillo, & 
Miramontes, 2001). The current study focuses on five acquired vulnerabilities: alcohol 
and/or drug use, socioeconomic level, educational level, disclosure of HIV status, and 
history of sexual abuse or assault. These individual acquired vulnerabilities will be 
discussed in the next sections.  
 
Alcohol and/or Drug Use and Mood Disorders 
 Studies examining the relationship between alcohol and/or drug use and mood 
disorders were fairly consistent. Previous research indicates that alcohol and drug use has 
been positively correlated with mood disorders   Merikangas and colleagues (Merikangas 
et al., 1998) report that alcohol and drug use is often related to emotional trauma, 
psychological stress, and other mental health problems, with the substance being used as 
self medication in order to relieve emotional pain. Results of a large epidemiologic study 
(The Epidemiologic Catchment Area Study) indicated that approximately 30% of alcohol 
and/or drug users in the United States had a psychiatric disorder (Regier et al., 1990).  
 
Many studies have described the relationship between alcohol use and mood 
disorders (Dixit & Crum, 2000; Holahan et al., 2003; Schutte et al., 1995). Differentiation 
by gender is noted in patterns of alcohol use and rates of depression, with women 
reporting heavier alcohol usage than men (Dixit & Crum, 2000; Holahan et al., 2003; 
Schutte et al., 1995) and minorities, especially African Americans and Hispanics, 
reporting higher rates of alcohol use than White Americans. Literature reveals disparities 
in mental health care, particularly among African Americans and Hispanic Americans, 
when compared to White Americans (K. Wells et al., 2001). Lack of mental health and 
drug treatment services, decreased access to mental health care, and evaluation of quality 
of mental health care all issues that need to be addressed in order to alleviate racial and 
ethnic disparities (K. Wells et al., 2001).  
 
A review of the literature reveals equivocal results regarding the timing of 
depressive symptoms and the onset of heavy drinking. Helzer and Pryzbeck (Helzer & 
Pryzbeck, 1988) report depression preceding alcoholism in women; but alcoholism 
preceding depression in men.  Similar findings were reported in a group of alcoholic 
women by Hesselbrock and colleagues (Hesselbrock et al., 1985), with depression 
preceding alcoholism. Contrasting results were reported by Wilsnack and colleagues 
(Wilsnack, Klassen, & Wilsnack, 1986), with depression preceding heavy alcohol 
consumption in women. Plausible explanations for these different findings could be 
related to the cycle of self-medicating depressive symptoms, which may lead to 
depression related to heavy alcohol consumption (Dixit & Crum, 2000). Literature also 
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 reveals that alcohol abuse has also been identified as a risk factor for suicide (G. Murphy, 
2000). Higher rates of attempted and completed suicides have been noted in alcohol 
abusers than non-alcohol abusers (D. Lester, 2000).   
 
HIV literature reflects high prevalence rates of depressive symptoms in 
intravenous drug users with HIV (Turrina et al., 2001). The sample included two groups 
of intravenous drug users, one HIV-positive, and the other HIV-negative.  A group of 
HIV-positive persons were recruited from an outpatient infectious disease clinic in Italy. 
HIV negative persons were recruited from an outpatient methadone clinic. Major 
depressive disorder was diagnosed using DSM-IIIR criteria. Depressive symptom levels 
were higher in the group of HIV-positive persons (36.2%) when compared to their HIV-
negative counterparts (15.7%). Specifically, 36.2% of the HIV-positive sample had a 
diagnosis of major depressive disorder, compared to 15.7% in the HIV-negative group. 
Similar findings were found for dysthymic disorder (7.1% and 3.9%, respectively).   
 
Alcohol and/or drug use is one of many acquired vulnerabilities associated with 
mood disorders. Socioeconomic status is another acquired vulnerability linked to mood 
disorders, and will be discussed in the next section.  
 
Socioeconomic Status 
Most of the studies published over the past several decades that have investigated 
income level and mood disorders have used varied measures of symptoms and diagnostic 
criteria for mood disorders. Although many different symptoms and diagnoses have been 
explored, depressive symptoms have been the most frequently examined mood disorder. 
Socioeconomic status (SES) has been defined by several indicators, including income, 
occupation, and education (Daly, Duncan, McDonough, & Williams, 2002). The 
collection of information regarding SES provides information about an individual’s 
access to social and economic resources (Daly et al., 2002). Researchers have found 
ambiguous findings related to SES and depressive symptoms. For women, education is 
the strongest of the SES predictors of depression (R. C. Kessler, 1982). For men, family 
income is more important (R. C. Kessler, 1982). Of the three SES measures, education 
and income are more important than occupational status for predicting distress (R. C. 
Kessler, 1982).  The current study defined socioeconomic status as annual household 
income. Educational level and employment information were also captured on the 
Demographic Data Instrument. 
 
Populations of economically disadvantaged persons have higher rates of mood 
disorders than their more affluent counterparts (B. P. Dohrenwend et al., 1992; Olfson et 
al., 2000; Reiger, Farmer, & Rae, 1993).  Inverse relationships between depressive 
symptoms and income levels have been documented consistently in the literature, with 
lower levels of income being associated with higher levels of depression (B. P. 
Dohrenwend et al., 1992; Link, Lennon, & Dohrenwend, 1993) 
 
Anxiety symptoms display a similar pattern (Mirowsky & Ross, 1989) with 
inverse relationships illustrated in the literature. Individuals with higher income levels, 
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 tend to have lower levels of anxiety symptoms and distress (C. E. Ross & Mirowsky, 
1989).  Persons with lower incomes are less likely to seek mental health treatment and 
often lack resources to access specialized mental health care, instead seeking mental 
health treatment from their primary care provider  
 
Poverty among HIV-positive women has been demonstrated (Bunting, Bevier, & 
Baker, 1999; Hudson, Kirksey, & Holzemer, 2004). Literature suggests that poverty 
makes women at risk for a multitude of problems, including poor access to health care. 
Poverty in HIV-positive women has been associated with worrying about daily survival, 
fears of domestic violence, poor self-esteem, and lack of health insurance, which leads to 
difficulty accessing health care. Poverty and lack of insurance has been described as one 
of the strongest factors related to the health care disparities among African Americans 
(Mayberry, Mili, & Ofili, 2000). Previous studies have found that patients who are 
women, members of racial and ethnic minorities, poorer, less educated, or uninsured are 
less likely to receive needed care, due to lack of access to care (Ayanian, 1994; Kahn et 
al., 1994; Smedley, 2006). Educational level will be discussed in the next section as 
another acquired vulnerability for mood disorders.  
 
Educational Level and Mood Disorders 
Most of the literature published regarding educational level and mood disorders 
has been consistent over time (Morrison et al., 2002; Wang et al., 2005). The interwoven 
relationship between educational level and income is demonstrated in one’s access and 
use of mental health services. Higher levels of education have been associated with 
higher levels of income. Consequently, higher levels of income offer financial resources 
to pay for mental health services. Persons with high levels of income are more likely to 
have health insurance.  Educated consumers are more likely to access mental health 
services (Wang et al., 2005) and may be have greater knowledge regarding 
pharmaceutical treatment of mood disorders (K. B. Wells, Stewart et al., 1989).   
 
Morrison and colleagues (Morrison et al., 2002) illustrated the relationship 
between educational levels and depressive symptoms in a sample of women (N = 155). 
Depressive symptoms were measured in both HIV-positive (n = 93; 55.9% African 
American) and HIV-negative (n = 62; 53.2% African American) women with the 
Hamilton Depression Scale (M.  Hamilton, 1967). Higher depressive symptom scores 
were associated with less education in both groups of women, and these differences were 
statistically significant (t = 2.1, df 152, p = 0.04; beta = -0.6, 95% CI= - 1.2 to -0.02).  
Although educational level is an acquired vulnerability that has not been extensively 
studied in HIV-positive women, the process of disclosure of one’s HIV status is a 
concept that has been vastly explored in the HIV literature, and will be discussed in the 
next section.  
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 Disclosure of HIV Status 
Disclosure of one’s HIV status is a complex process, unique to that individual. 
Therefore, disclosure is not an isolated event, but rather a series of events or processes 
that are associated with both positive and negative outcomes (Kalichman, DiMarco, 
Austin, Luke, & DiFonzo, 2003; Vanable, Carey, Blair, & Littlewood, 2006; Zea, Reisen, 
Poppen, Bianchi, & Echeverry, 2005). Often, the very process of disclosure itself leads to 
negative consequences such as isolation, abandonment, and abuse (Lovejoy, 1990). For 
many women, disclosing one’s HIV status may lead to negative consequences that impact 
not only the patient, but also their children (Schmidt & Goggin, 2002).   
 
Negative consequences of HIV disclosure, including increased depressive and 
anxiety symptoms have been illustrated in the literature. Unsupportive social and family 
interactions have been associated with elevated depressive symptoms in populations of 
HIV-positive women (Schrimshaw, 2003). Moreover, the idea of voluntarily disclosing 
one’s HIV status, creating a situation that may lead to negative circumstances, is a 
daunting one.  Women often rely on their partners for environmental safety and security, 
and fear that disclosure may lead to abandonment and rejection (Holt et al., 1998; 
Metcalfe, Langstaff, Evans, Paterson, & Reid, 1998). Disclosure of HIV status for 
women has additional consequences that affect not only their intimate relationships, but 
also the safety and security of their children.  
 
HIV literature illustrates the impact of stigma on HIV disclosure. Shame and 
stigma associated with HIV often prevents patients from disclosing their serostatus to 
friends, family members, and sexual partners (Jenkins & Coons, 1996 ; Moneyham et al., 
1996a, 1996b). Disclosure of one’s HIV status is a complex process, with the stigma of 
the disease impacting both the reluctance to disclose and the aftermath of the disclosure 
(Vanable et al., 2006). Although stigmatization associated with HIV has decreased since 
the early years of the epidemic (Herek, Capitanio, & Widaman, 2002), HIV continues to 
be surrounded in fear and stigma. Herek and colleagues (Herek et al., 2002) conducted a 
nationwide survey exploring stigma related to HIV and reported that one in five 
participants reported “fearing” someone with AIDS, while one in six admitted to having 
feelings of “disgust” about persons with AIDS. Therefore, the stigma of HIV has 
blanketed the disclosure process in fear and discrimination. Disclosure removes the veil 
of secrecy. The idea of taking medication in secrecy often leads to decreased medication 
adherence, increased denial of the disease, and further perpetuates the stigma and shame 
that is associated with HIV. HIV-related stigma has been associated with an increase in 
HIV-related symptoms, depressive symptoms, and receipt of recent psychiatric care 
(Vanable et al., 2006). 
 
Although some published studies in the HIV literature reveal negative outcomes 
of HIV disclosure (Lovejoy, 1990; Vanable et al., 2006) most of the literature regarding 
the impact of disclosure on depressive and anxiety symptoms is positive (Schmidt & 
Goggin, 2002; Zea et al., 2005). Disclosure is essential to obtaining social support 
(Moneyham et al., 1996a). HIV-positive women that disclose their status to a partner or 
close friend demonstrated lower levels of emotional distress (D. K. Smith et al., 1996). 
 
39 
 Schmidt and Goggin (Schmidt & Goggin, 2002) found that through positive 
disclosure experiences, some HIV-positive women gain an increased perception of social 
support, resulting in fewer reported depressive symptoms. However, these researchers 
also noted that HIV-positive single mothers reported less satisfaction from the disclosure 
process, lower levels of perceived social support, and higher levels of depressive 
symptoms. The emotional support that is provided as a side effect of the disclosure is 
often the deciding factor in multiple daily activities which directly affect the lives of 
those infected with HIV, such as adherence with complex medication regimens and 
frequent medical appointments.  
 
In a study of HIV-positive Latino gay and bisexual men (N=301), participants 
were recruited from HIV clinics, hospitals, and community agencies in three metropolitan 
cities in the United States (Zea et al., 2005). Men that disclosed their HIV status had 
lower levels of depression and greater levels of self-esteem than those men that did not 
disclose their HIV status. Quality of social support was associated with disclosure 
patterns. Disclosure was highest among closest friends (85%), followed by primary male 
partner (78%), followed by parents (37% to mother, 23% to father). Results indicate that 
Latino men were selective with whom they disclosed their HIV status, but experienced 
positive benefits in psychological well-being in the process.  Despite the vast differences 
in sample demographics, this study informs the current study as both Latino men and 
African American women are minority populations and the groups shared the 
stigmatizing diagnosis of HIV.  
 
Stein and colleagues (Stein et al., 1998) examined the disclosure patterns of HIV-
positive persons (N=203) to their sexual partners. Participants were recruited from two 
outpatient urban hospital clinics, where persons HIV-positive persons sought healthcare. 
The sample consisted of Black Americans (46%), Latino (23%), and White Americans 
(27%). The majority of the sample was male (69%), which reflects the transmission 
patterns and epidemiological history of HIV in the United States. The sample reported 
varying risks for HIV transmission, with sexual transmission being the primary risk 
factor (59%). Twenty percent of the sample identified themselves as bisexual or 
homosexual males and 39% of the sample identified as heterosexual.  Injection drug use 
was reported in 41% of the sample. Of the 203 persons that were interviewed, 129 
reported sexual activity within the past 6 months. The majority (60%) of the sample had 
disclosed their HIV status to all of their sexual partners. In the persons that had not 
disclosed their HIV status to their sex partner, half of them reported only one sex partner 
in their lifetime. Failure to consistently use condoms during sexual activity was reported 
in the majority of the sample (57%) of nondisclosures. Multiple regression analysis 
revealed that persons with high levels of spousal support were 2.8 times more likely to 
disclose their HIV status to their partners than persons without high levels of support. 
Disclosure was 3.1 times more likely to occur in the white and Latino participants than 
the black participants.  
 
HIV literature reveals that disclosure of HIV status may also have an impact on 
immune status. A study of 373 HIV-positive patients that were being treated in an 
outpatient psychiatric setting participated in a study that investigated the relationship 
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 between disclosure of HIV stats and disclosure of sexual orientation and their immune 
function. Patients that had disclosed their HIV status showed increased CD4 counts over 
time. Patients that had always been open about their sexual orientation also showed 
immunologic benefit of disclosure (Boggs, 2007).  
 
Although disclosure of HIV status is a major aspect of living with HIV, research 
studies within the HIV literature regarding the disclosure process and ramifications of 
HIV disclosure vary widely. Dissimilar findings across studies were most likely due to 
differences in ways that disclosure was assessed (time from diagnosis, timing of 
disclosure, and hierarchy of order of persons disclosed to). Literature illustrates that 
stigma continues to retard the disclosure process. Moreover, failure to disclose HIV status 
can have devastating effects on public health. The most effective means of HIV 
prevention among sexually active persons is consistent condom use (Branson et al., 
2006).  Niccolai, Dorst, Myers, and Kissinger (Niccolai, Dorst, Myers, & Kissinger, 
1999) reported that lack of condom use among HIV-positive persons was prevalent in 
those that did not disclose their HIV status to their partner.  Disclosure patterns are vital 
pieces of information with potential psychological ramifications, and should therefore be 
tracked and studied in the future.  
 
Sleep Quality and Mood Disorders 
Evidence continues to accumulate supporting the association between sleep 
disturbances and poor sleep quality with mood disorders. Research studies have shown 
that 10% to 40% of adults have intermittent insomnia, while 15% of all adults report 
long-term sleep difficulties (Ringdahl, Pereira, & Delzell, 2004). Sleep quality has also 
been described as sleep efficiency, which is the ratio of total sleep time to time in bed or 
the proportion of sleep during the time period generally filled by sleep (Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1989).  
 
Consequences of poor sleep quality can be complex. Although traditionally given 
less attention in prior research studies, estimation of sleep quality has become an 
important aspect of comprehensive medical assessments. Research supports that fact that 
people tend to overestimate their duration of sleep with subjective sleep assessments, 
therefore studies with both subjective and objective sleep measurements are needed to 
garner more precise data (Kripke et al., 2004). Poor sleep quality is a common complaint 
among patients with alcohol use disorders (Dahl et al., 2003) and persons with mood 
disorders (Kripke et al., 2004; Lee et al., 2001).  
 
In a study of ethnicity and sleep, illumination, and mood disorders, Kripke and 
colleagues (Kripke et al., 2004) measured sleep with both objective and subjective 
means. The authors examined ethnic differences in sleep and depression in a sample (N = 
459) of European American (72.2%) and Hispanic (13.7%), African American (9.4%), 
Asian–pacific American (4.0%) and Native American (0.7%) postmenopausal women. In 
this population of women, Hispanic and African American slept less than less than 
European American women.  
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 Lee and Miramontes (Lee et al., 2001) examined the relationship between sleep, 
depression, and fatigue in a group of HIV-positive women (N=100). Subjective 
measurements of depressive symptoms and fatigue were captured by self report 
questionnaires. Objective measurements of total sleep time, numbers of awakenings from 
sleep, daytime activity, and sleep efficiency were captured using motion sensor bracelets 
(wrist actigraphy). Consecutive activity was recorded for a continuous 48 hour time 
period.  Lower depressive symptoms were noted in women with higher sleep efficiency.   
 
Sleep disturbances are of particular concern in the HIV population. Adverse 
effects of poor sleep quality on immunity has been reported in healthy individuals and 
individuals who are HIV-positive (Cruess et al., 2005). Researchers have found high 
levels of sleep disturbances among the HIV-positive population (Lee et al., 2001; Mock 
et al., 2002; Rubinstein & Selwyn, 1998).  Insomnia is often one of the first symptoms 
reported in persons newly diagnosed with HIV (Mock et al., 2002).  Prevalence rates of 
poor sleep quality vary across studies. Rubinstein and Selwyn (Rubinstein & Selwyn, 
1998) reported that 73% of their sample of HIV-positive persons reported sleep 
disturbances. Phillips and colleagues (Phillips et al., 2005) reported a 100% prevalence 
rate of sleep disturbances as measured by the PSQI in their sample (N = 107) of HIV-
positive men (n = 70) and HIV-positive women (n = 35). Mean PSQI score levels in this 
sample were 12.3 ± 3.8 were well above the cut-off score of 5 for poor sleep quality on 
the PSQI. African Americans were well represented in this study (n = 71, 82.6%), and 
other demographic variables such as income and educational level were similar to those 
in the current study.  
 
Similar results were noted in Mock and colleagues’ 2002 (Mock et al., 2002) 
study which included a sample of exclusively African American HIV-positive women (N 
= 174). Demographic characteristics of the sample were similar to the current study, 
especially marital status (52.3% of the sample was single) and income (54.9% o ft the 
sample had annual household income levels less than 10,000.  This sample of African 
American women was at varying disease stages, and results were differentiated based on 
stage and severity of illness. Depressive symptoms were measured with the CES-D I 
(which eliminates somatic complaints) and sleep dysfunction was measured with the 
PSQI. Results illustrated a high rate of fatigue (45.8%), depressive symptoms indicative 
of clinical depression (59%), and sleep dysfunction (59%). The authors noted that sleep 
disturbances often present before the diagnosis of HIV and become worse as severity of 
illness develops. 
 
Sexual Assault and Mood Disorders 
 History of sexual assault has been associated with depression and anxiety 
disorders (Barbe et al., 2004; Barker-Collo & Read, 2003; M. Conway et al., 2004; Lee et 
al., 2001; Mock et al., 2002; Peleikis, Mykletun, & Dahl, 2004; Rubinstein & Selwyn, 
1998; Walrath et al., 2003). The long term effect that sexual abuse or assault has on an 
individual varies. Dickinson and colleagues (Dickinson, deGruy, Dickinson, & Candib, 
1998) describe a spectrum of resulting mood disorders, ranging from mild to complex 
symptoms. Dickinson enrolled 99 women in a study to evaluate the existence of complex 
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 post traumatic stress syndrome in women that report a history of sexual abuse. Results 
illustrated that varying degrees of symptoms were found in this group of women. The 
most severely abused subjects were characterized by symptom patterns similar to those of 
a complex post-traumatic stress syndrome. The type and duration of abuse often has a lot 
to do with long term consequences.  
 
The prevalence of childhood sexual abuse has been documented to be between 
15-30% in adult women and between 25-77% in adult women with diagnoses of mental 
illness (Lundqvist, Hansson, & Svedin, 2004).  In studies focused on the impact of sexual 
abuse or assault, associations with mood disorders have been reported (Barbe et al., 2004; 
Barker-Collo & Read, 2003; M. Conway et al., 2004; Lee et al., 2001; Mock et al., 2002; 
Peleikis et al., 2004; Rubinstein & Selwyn, 1998; Walrath et al., 2003).  
 
Barbe and colleagues (Barbe et al., 2004) examined the relationship between 
history of sexual abuse and depression among 107 adolescent females. Subjects had a 
diagnosis of MDD by DSM-IIIR guidelines and were between the ages of 13 and 18. 
Subjects were randomly assigned to one of three treatments: (1) cognitive behavioral 
therapy, (2) systemic behavioral family therapy, or (3) nondirective supportive therapy 
and then followed for three and a half years.  Lifetime history of sexual abuse was 
captured as either present or absent. Results indicated that girls with a lifetime history of 
sexual abuse were more likely to have a psychiatric hospitalization or depressive relapse. 
Cognitive behavioral therapy was the most efficacious treatment in the absence of sexual 
abuse. Nondirective supportive therapy was most efficacious in the presence of sexual 
abuse. These results suggest the need to screen adolescent girls for history of sexual 
abuse as part of a psychosocial assessment. 
 
Whereas most studies have focused on the emotional impact of sexual abuse, 
Girdler and colleagues (Girdler et al., 2004) examined a pathophysiologic impact of 
history of sexual abuse. These researchers examined the hypothalamic-pituitary-thyroid 
axis hormone concentrations in a group of women (N= 50) during different phases of 
their ovulatory cycles. Increased total T3 concentrations were noted in women with 
histories of major depression; these increased concentrations also predicted their 
premenstrual symptoms. The results indicated that women with histories of sexual abuse 
had higher levels of conversion of T4 to T3 and increased binding of thyroid hormones in 
women with both premenstrual dysphoric disorder and history of sexual abuse. These 
results indicate that further pathophysiologic testing may be needed in women with mood 
disorders.  
 
 
SUMMARY OF THE REVIEW OF LITERATURE 
Despite advances in research, mood disorders are often undiagnosed and 
untreated in HIV-positive populations (Bing et al., 2001; M. Conway et al., 2004; Evans 
et al., 1996). Although many health care providers assume that depression is a natural, 
inevitable reaction to the diagnosis of HIV, patients who are HIV-positive are often under 
screened for mood disorders. Diagnosis of mood disorders within the HIV-positive 
population is complex, due to the overlapping somatic symptoms associated with 
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 HAART and signs and symptoms of specific HIV-related disorders (Norman et al., 1992; 
Perkins et al., 1994). The prevalence of mood disorders in the HIV population is higher 
than that of the general population. HIV has become a treatable chronic condition. 
Longitudinal studies are needed to identify varying levels of depressive and anxiety symptoms 
over time, examine underlying vulnerabilities to mood disorders in this population, as well as 
to examine optimal treatment therapies over time.  
 
HIV-positive women are part of a unique population with additional risks for 
mood disorders. The majority of the responsibility of family caregiving falls on women, 
adding additional stressors (Hooyman & Gonyea, 1999). HIV-positive women with 
children are more likely than men to suffer from chronic sorrow related to their illness, 
fear of death, poverty, and social isolation (Morrison et al., 2002). Although it is 
impossible to accurately predict with certainty those that will develop depressive or 
anxiety symptoms, the assessment of underlying vulnerabilities may aid the screening 
process. Many cross-sectional studies have investigated levels of depressive and anxiety 
symptoms at specific points of time, yet these studies do not account for the variety of 
symptoms that may occur at different points in time in the trajectory of HIV-infection. 
Most of the cross-sectional and longitudinal studies in the HIV literature support the 
positive association between HIV and anxiety and depressive symptoms. Although 
published studies examined predictors of depressive and anxiety symptoms among HIV-
positive persons, demographic characteristics of the samples including race, gender, and 
sexual preference vary greatly, making generalizability to populations of African 
American HIV-positive women difficult.  
 
HIV-positive women experience increased levels of depressive and anxiety 
symptoms. Therefore, the present study will address the relationships between underlying 
vulnerabilities; both inherited (family history of mood disorders, family history of alcohol 
and/or drug use) and acquired (educational level, income level, alcohol and/or drug use, 
HIV disclosure status, sleep quality, and history of sexual abuse and/or assault) to 
depressive and anxiety symptoms. Because these relationships have not been previously 
described using multiple risks as predictors in this population, findings will provide 
significant insights regarding the experiences of this understudied population of African 
American women who are HIV-positive. Specific aspects of the current study’s 
methodology are presented in the next chapter.  
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 CHAPTER 3. METHODOLOGY 
The incidence of HIV infection continues to increase, especially among the 
heterosexual population (Centers for Disease Control and Prevention, 2007c).  HIV is a 
virus that is commonly spread through the exposure to infected blood and bodily fluids 
during sexual activity (Centers for Disease Control and Prevention, 2000, 2003).  Studies 
demonstrate that there is a high prevalence of depression among HIV-positive persons 
(Bing et al., 2001; Ferrando et al., 1998; Rabkin, Wagner, & Rabkin, 1999) as well as co-
morbid anxiety (Ciesla & Roberts, 2001). Additionally, HIV-positive women are at an 
even greater risk for depression and anxiety (Bing et al., 2001; Ciesla & Roberts, 2001; 
Moore et al., 1999). It is important that risk factors for depression and anxiety, both 
inherited and acquired, be identified. Early identification and treatment of depression and 
anxiety can have a direct impact on quality of life and treatment adherence in HIV-
positive persons (Moore et al., 1999; Valente, 2003). The purposes of the study are 
fourfold: (1) to describe the level of depressive and anxiety symptoms in African 
American women who were HIV-positive; (2) to describe the underlying vulnerabilities, 
both inherited and acquired, for depressive and anxiety symptoms in African American 
women who were HIV-positive; (3) to identify which vulnerabilities serve as predictors 
of depressive and anxiety symptoms among African American HIV-positive women; and 
(4) to describe the differences in levels of depressive and anxiety symptoms among 
African American HIV-positive pregnant and African American women.  This chapter 
explains the processes utilized to answer the research questions of this study. This chapter 
explicates the research design, setting and sample, recruitment, inclusion and exclusion 
criteria, sample size, instruments, procedures, consideration of human subjects, and data 
analysis.  
 
 
RESEARCH DESIGN 
 A non-experimental, descriptive, correlation design was employed to obtain 
information on potential predictors of depressive and anxiety symptoms among African 
American HIV-positive women.  This descriptive correlation design was used to 
accomplish the following objectives: 1) to describe the levels of anxiety and depressive 
symptoms among African American women who were HIV-positive, 2) to identify the 
inherited and acquired vulnerabilities that predict depressive and anxiety symptoms 
among African American women who were HIV-positive, 3) to quantify the inherited 
and acquired vulnerabilities that predict depressive and anxiety symptoms among African 
American women who were HIV-positive, 4) to determine the predictors of anxiety and 
depression symptoms among African American women who were HIV-positive, 5) to 
determine the differences in levels of depressive and anxiety symptoms among African 
American HIV-positive pregnant and African American HIV-positive non-pregnant 
women, 6) to determine the relationship between predictors of depressive and anxiety 
symptoms among African American HIV-positive pregnant and African American HIV-
positive non-pregnant women, and 7) to determine the differences in levels of depressive 
and anxiety symptoms among African American HIV-positive pregnant and African 
American HIV-positive non-pregnant women.   
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 The study was cross-sectional as the variables were measured at a single point in 
time. All instruments that measured depressive and anxiety symptoms have established 
reliability and validity. According to Polit and Hungler (Polit & Hungler, 1995), 
descriptive research is used to observe, describe, and document specific phenomena 
rather than explaining the phenomena. Correlation research examines relationships 
between variables (Polit & Hungler, 1995).  
 
In a review of pertinent literature, the incidence of depression among HIV-
positive persons has been well documented, however, information regarding the triggers, 
or predictors of depression have not been fully explored. There was also a lack of 
information regarding anxiety among HIV-positive persons, although anxiety is often 
accompanied by a concomitant diagnosis of depression (Hirschfeld, 2001; J. M. Murphy 
et al., 2004). Therefore, the underlying predictors of both depressive and anxiety 
symptoms were addressed in this study. 
 
 
SETTING AND SAMPLE 
 The setting was an outpatient university obstetrical and gynecological clinic and 
an outpatient adult infectious disease clinic that specializes in HIV. Both ambulatory 
clinics were located in the mid-south.  Outpatient infectious disease clinics, the local 
county health department, and other obstetrical and gynecological clinics in the mid-
south area often refer their HIV-positive, female clients to the outpatient university clinic 
for obstetrical and gynecological health care.  Likewise, primary care providers, the local 
county health department, and other obstetrical and gynecological clinics in the mid-
south area also refer their HIV-positive, female clients to the outpatient adult infectious 
disease clinic.  
 
In the obstetrical clinic, a designated physician and nurse practitioner who had 
extensive infectious disease and HIV treatment and management experience, provided 
health care for this population of HIV-positive women.  Although the clinic was open 
each weekday, HIV-positive women were seen on two designated days each week.  
Transportation and childcare were available to all HIV-positive women attending the 
study obstetrics and gynecology clinic through community support agencies.  
 
The adult infectious disease clinic employed seven physicians and two nurse 
practitioners who had extensive infectious disease and HIV treatment and management 
experience and who provided health care for this population of HIV-positive patients.  
The clinic was open each weekday; HIV-positive men and women were seen Tuesday 
through Friday. Mondays were reserved for new HIV-positive patients.  Transportation 
and childcare were available to all HIV-positive women attending the study clinics 
through community support agencies. 
 
The study employed a non-probability convenience sample drawn from African 
American women, who were HIV positive, and were patients either in the outpatient 
obstetrics and gynecology or the university outpatient infectious disease clinic in an 
urban southeastern city.  All women who met the inclusion criteria were potential 
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 participants. The target population was African American HIV-positive women in the 
mid-south, which was reflective of the HIV-infected population in the area, as well as in 
the university’s clinic populations. This population was chosen because African 
American women are underrepresented in published studies examining depressive and 
anxiety symptoms in the HIV-positive population.  
 
The obstetrics and gynecology clinic saw approximately 5000 women per month. 
HIV-positive women represented approximately 3% of the clinic population.  
Approximately 60% of the HIV-positive pregnant women seen in the practice were newly 
diagnosed, while approximately 40% were women who knew of their HIV status and had 
become pregnant. HIV-positive non-pregnant women receiving gynecological 
consultation accounted for 10% of the HIV-positive women receiving care at the 
university obstetrics and gynecology clinic. The infectious disease clinic exclusively saw 
patients who were HIV-positive.  The infectious disease clinic saw approximately 350 
patients per month.  Forty percent of the clinic population was women; 75% of the 
population was African American. All African American HIV-positive women who 
received medical care at the designated clinics between September 1, 2006 and February 
28, 2007 were approached for study participation. Of the 90 who were approached, 80 
gave consent and completed the study.   
 
RECRUITMENT 
The clinic nurse, nurse practitioner, social worker, or physician informed the 
women who met study inclusion criteria about the study during their routine obstetrical or 
infectious disease medical appointments. The researcher developed an implementation 
plan that she discussed with clinic staff, and ensured that standardized recruitment 
techniques were maintained throughout enrollment. The researcher periodically verified 
that all interviewers appropriately implemented the recruitment plan, which provided 
consistency to the data collection process. Training regarding potential questions and 
answers, as well as an interview script was provided to the interviewers by the researcher. 
All interviewers participated in role play activities that simulated the interview and data 
collection process to ensure that plan was implemented appropriately and consistently. 
Providers gave interested women’s contact information to the researcher. Women who 
expressed interest were contacted by the researcher. These contacts with potential 
participants by the investigator were either via telephone or through a personal visit 
during their routine clinic appointment. African American women who were HIV-
positive and who agreed to participate and met the study criteria completed the informed 
consent process, signed the informed consent and completed the designated paper and 
pencil instruments. 
 
Inclusion Criteria 
 The sample population was African American women who were HIV-positive, 
and were current patients in the university outpatient obstetrics and gynecology or 
infectious disease clinic. The sample was recruited from HIV-positive women who were 
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 being treated in the special care clinic of the university obstetric and gynecologic clinic or 
the university infectious disease clinic. Criteria for inclusion into this study were as 
follows: 1) female gender, 2) self-identified as African American and non-Hispanic, 3) 
HIV-positive as documented by HIV-ELISA and HIV Western Blot test results 
abstracted from participant health records, 4) aged 18 years or greater on last birthday, 5) 
possessing ability to read and write in the English language as verified by highest 
educational level completed being at least the ninth grade, and 6) receiving medical care 
at the university obstetrics and gynecology or infectious disease clinic. 
 
Exclusion Criteria 
Women were excluded if they had existing co-morbid diseases that contributed to the 
potential inability of participants to answer questionnaires. Therefore participants were 
excluded from participating in the study if they had the following diagnoses: 1) HIV 
dementia, active Cytomegalovirus, or Toxoplasmosis; 2) mental retardation; and 3) latest 
CD4 cell count < 200. Presence of compromised immune status, as measured by CD4 
cell count less than 200 was collected from the medical record, and was used to 
determine if the participant was at risk for developing AIDS dementia, CMV, or 
toxoplasmosis, which could impact mental abilities, and possibly interfere with accurate 
completion of instrumentation. Exclusion criteria were determined through medical 
record review. 
 
Sample Size 
 The sample size necessary to adequately conduct this study was determined by a 
power analysis calculated on the basis of multiple regression analysis. A sample of 80 
participants was interviewed. To ensure an adequate sample size, a minimum of 80 
African American HIV-positive women were recruited for this study. Due to the volume 
of patients available in each clinic, a three-to-one ratio was established by the researcher 
in order to obtain an adequate sample size (three non-pregnant women to every pregnant 
woman). A power analysis was performed to determine the number of subjects needed to 
ensure an alpha of .05 using the statistical package Power Precision. The effect size was 
chosen according to Cohen's criteria (Cohen, 1987) for a moderate effect size (r = .30). 
This analysis ensured adequate numbers of subjects needed to detect clinically significant 
results. Using an alpha set at .05, the proposed study had power of 0.80 with eight 
independent variables included in the prediction model. 
 
INSTRUMENTS 
The investigator used multiple paper and pencil instruments to address the 
variables of interest contained in the research questions. All instruments were placed in 
packets and were numbered for tracking purposes. A copy of each instrument is provided 
in Appendices A1-A4. Instruments that were included in each packet were the following: 
a researcher-developed demographic data questionnaire, Pittsburgh Sleep Quality Index 
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 (PSQI), Center for Epidemiological Studies Depression Scale (CES-D), Edinburgh 
Postnatal Depression Scale (EPDS), and the Beck Anxiety Inventory (BAI). Since the 
demographic data questionnaire was developed by the researcher and had not been used 
in the clinical setting, the instrument was administered to five randomly selected African 
American women who were HIV-positive. These women were then excluded from 
participating in the final study, as they had prior exposure to the instrumentation. This 
pilot test of the researcher-developed demographic data questionnaire was performed in 
order to determine the effectiveness of instructions, clarity of questionnaire items, and 
time required to complete the questionnaire. The pilot test of the researcher-developed 
questionnaire allowed the researcher to revise the instrument based on results of the pilot 
test. 
 
The study instruments were selected based on a review of literature and 
professional experience, and their purpose was to gather specific information needed to 
investigate the variables included in the research questions.  The PSQI (Buysse et al., 
1989), CES-D (Radloff, 1977), EDPS (Cox et al., 1987) and the BAI (A. T. Beck et al., 
1988) have been used in African American, female, and HIV-positive populations, and 
were conceptually congruent with the study. A blank at the top of each questionnaire was 
used for a code number to track respondents. Coding allowed the researcher to quantify 
the numbers of participants, as well as maintain confidentiality of the participants’ 
identities.   
 
Demographic Data Instrument 
The researcher-developed demographic instrument (Appendix A) is a self-report 
and self-administered questionnaire that was designed to collect information regarding 
participant characteristics, and included: age, marital status, employment status, 
socioeconomic status (evaluated by reported annual income), educational level, religion, 
HIV disclosure status, reproductive history, mental health history, sexual abuse and/or 
assault history, alcohol and/or drug use, length of time since HIV diagnosis, and partner 
information. Family characteristics collected in the demographic data instrument included 
family history of mood disorders and family history of alcohol and/or drug use. Thus, 
both inherited and acquired vulnerabilities were assessed with this scale. Each item 
constructed for this instrument was subjected to testing with Question Understanding 
AID or QUAID (Graesser, Cai, Louwerse, & Daniel, 2006). QUAID is a software 
program that assists survey designers to improve the wording, syntax, and semantics of 
survey questions. The tool identifies potential problems that survey respondents might 
have with understanding the meaning of survey items. Thus the software allows the 
survey item developer to review problems and improve the clarity of items and enhance 
reliability and validity of answers. The QUAID program picks up problems such as 
unfamiliar technical terms, vague or imprecise relative terms, vague or ambiguous noun 
phrases, complex syntax, and working memory overload. The demographic data 
instrument was pre-tested with five African American women who were HIV-positive in 
order to identify confusing questions and ensure clarification. The 40-item instrument had 
an estimated completion time of five minutes. 
49 
 Sleep Quality Instrument 
 The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate multiple 
dimensions of sleep quality (See Appendix B). The PSQI (Buysse et al., 1989) is a 19-
item, self-report, retrospective instrument designed to collect information regarding sleep 
quality and sleep disturbances over a one month period. The 19-items are grouped into 
seven equally weighted component scores including: 1) Subjective Sleep Quality (one 
item); 2) Sleep Latency (two items); 3) Sleep Duration (one item); 4) Habitual Sleep 
Efficiency (three items); 5) Sleep Disturbances (nine items); 6) Use of Sleeping 
Medication (one item); and 7) Daytime Dysfunction (two items). The PSQI has been 
widely used in a variety of populations, including populations of persons with chronic 
pain (Currie, Wilson, & Curran, 2002; M. T. Smith, Perlis, Smith, Giles, & Carmody, 
2000), renal disease/transplant (Carpenter & Andrykowski, 1998), cancer (Carpenter & 
Andrykowski, 1998), and HIV (Currie et al., 2002; Mock et al., 2002; Nokes & Kendrew, 
1996; Nokes & Kendrew, 2001; Phillips et al., 2005). The PSQI has also been used in 
populations of African American HIV-positive women (Mock et al., 2002). 
 
Items one through four are participant entry of usual bed time, usual awake time, 
total minutes of sleep, and total minutes of sleep latency. Items five through 18 are four-
point Likert-type scale responses related to frequency of problems, with zero indicating 
not during the past month; one indicating less than once a week; two indicating once or 
twice a week; and three indicating three or more times per week. Item 19 is a four-point 
Likert-type scale rating of overall sleep quality. A score of zero is very good, one is fairly 
good, two is fairly bad, and three is very bad. 
 
 The cumulative score range of the PQSI is zero to 21. Scoring the PSQI takes an 
estimated five minutes as scores from each item are added for a summed Global Score. 
Higher Global Scores are indicative of poorer sleep quality. A cut-off score of five or 
greater is indicative of poor sleep quality.  
 
The PSQI has demonstrated reliability and validity. High internal consistency was 
demonstrated by Buyesse (Buysse et al., 1989), with a Cronbach’s alpha coefficient of 
0.83 for the seven component scores. Criterion validity was established in order to 
differentiate “good sleepers” from “poor sleepers”. When compared to more costly and 
time consuming methods of sleep quality measurement (structured clinical interviews and 
polysomnographic testing), the PSQI Global score of five or greater correctly identified 
88.5% of patients and controls in the original report (Buysse et al., 1989). Cronbach’s 
alpha coefficient of the PQSI in the current study was 0.80. The estimated time of 
completion is five to ten minutes.  
 
Depressive Symptom Instruments 
 Two instruments were used to screen for depressive symptoms in the sample. This 
allowed the researcher to compare the participants’ scores on two different instruments 
that were designed to capture similar information. This process also added to the body of 
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 knowledge regarding screening instruments in the African American population. This is 
imperative, as much of the published literature focuses on white populations.  
 
The Center for Epidemiological Studies-Depression Scale (CES-D) was used in 
this study to measure the levels of depressive symptoms in the participants (see Appendix 
C). The CES-D (Radloff, 1977) was developed by the Center for Epidemiological Studies 
to measure the level of depressive symptoms in the general population. The CES-D has 
the ability to identify persons that experience depressive symptoms, but would not 
necessarily meet criteria to be diagnosed as clinically depressed (Moore et al., 1999). The 
CES-D is a screening instrument, and its use is not intended for the diagnosis of 
depression. The scale has been used extensively in the general and chronically ill 
populations (Radloff, 1977), including HIV-infected populations (Currie et al., 2002; 
Hudson et al., 2004; Lyketsos et al., 1996; Moore et al., 1999; Phillips et al., 2005), 
specifically HIV-positive women (Hudson et al., 2004; Ickovics et al., 2001; Mock et al., 
2002).The CES-D has been used in populations of HIV-positive African Americans 
(Low-Beer et al., 2000; Mock et al., 2002; Robbins, Phillips, Dudgeon, & Hand, 2004). 
 
The CES-D contains 20 items, and assesses sleep disturbances, energy levels, 
feelings of guilt and depressed mood, and appetite loss in the respondents. The CES-D 
asks the individual to recall the presence of these issues in the prior week. Each item has 
a range of zero to three, with rarely or none of the time equaling zero points, and most or 
all of the time equaling three points.  Scoring for positive items is reversed. Adding the 
sum of answers completes scoring. Possible total scores range from zero to 60, with the 
higher scores indicating the higher levels of depressive symptomatology.  The total score 
on the CES-D can be divided into four distinct categories, with zero to 15 indicating no 
depressive symptoms, 16-20 mild distress, 21-30 moderate distress, and 31-60 severe 
distress (Radloff, 1977).  
 
The CES-D is an accurate instrument, with high internal consistency and test-
retest reliability and can be completed in five to 10 minutes. Items for the CES-D were 
selected from several instruments, including: Beck’s Depression Inventory (A. T. Beck, 
Rial, & Rickels, 1974) the Minnesota Multi-phasic Personality Inventory, Raskin’s 
Depression Scale (Raskin, Schulterbrandt, Reatig, & McKeon, 1969), and Zung’s Self-
rating Depression Scale (Zung, 1965). Therefore, the CES-D has both construct and 
content validity.  
 
The CES-D has been found to be reliable and valid in the general population, as 
well as populations of women (Fogel & Martin, 1992; Hasin, Stinson, Ogburn, & Grant, 
2007; Hudson et al., 2004; Low-Beer et al., 2000; Phillips et al., 2005; Sullivan et al., 
1996), including pregnant women (Hannah et al., 1992); and populations of both chronic 
and terminal diseases, including HIV (Currie et al., 2002; Hudson et al., 2004; Lyketsos 
et al., 1996; Moore et al., 1999; Phillips et al., 2005). The CES-D has demonstrated 
reliability and validity in African American women (Hudson et al., 2004; Ickovics et al., 
2001; R. Lester & Petrie, 1998; Liebschutz et al., 2003; Mock et al., 2002). Therefore, the 
CES-D is an appropriate instrument to use in a population of African American women 
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 who are HIV-positive. Cronbach’s alpha coefficient of the CES-D in the current study 
was 0.90.  
 
The Edinburgh Postnatal Depression Scale (EPDS) was used in this study to 
measure the levels of depressive symptoms in the participants (see Appendix D). The 
EPDS (Cox et al., 1987) was developed for screening postpartum women for depressive 
symptoms. The EPDS has also been used as a screening tool in pregnancy (Murray, 
Cooper, & Stein, 1991), and terminal illness (Lloyd-Williams, Friedman, & Rudd, 2000).  
The EPDS has been well validated in both populations of women in the post-partum 
period (Chabrol & Teissedre, 2004; Cox et al., 1987; Dennis, Janssen, & Singer, 2004; 
Evins et al., 2000; Hannah et al., 1992) and populations of women with older children 
(Cox, Chapman, Murray, & Jones, 1996).  
 
Like the CES-D, the EPDS is a screening instrument and was not designed as an 
instrument to diagnose depression. The EPDS is an accurate instrument, with high 
sensitivity and specificity and test-retest reliability, and can be completed in less than five 
minutes. The EPDS was specifically developed for assessing postpartum depression, as 
other depression symptom instruments, specifically the Beck Depression Inventory (BDI) 
and the CES-D, illustrated elevated depressive symptom scores in symptomatic pregnant 
women due to the inclusion of somatic symptom assessments in the BDI and CES-D 
(Holcomb, Stone, Lustman, Gavard, & Mostello, 1996; J. K.   Myers & Weissman, 
1980).  
 
The EPDS (Cox et al., 1987) is a 10-item questionnaire that asks subjects to report 
the severity of symptoms experienced in the last seven days. Each item on the EPDS has 
a range of zero to three, with rarely or none of the time equaling zero points, and most or 
all of the time equaling three points.  Scoring for positive items is reversed. The sum of 
the scores is used as a total score. A score of ten or higher is indicative of the need for 
further screening. Total scores of 10-13 are indicative of mild depressive symptoms; 
scores greater than 13 are indicative of moderate depressive symptoms (Cox et al., 1987).  
Literature supports the use of the minimum score (threshold) of 10 as predictive 
of postnatal depression (Chabrol & Teissedre, 2004; Hannah et al., 1992). EPDS scores at 
five days postpartum have been highly correlated (Spearman rank correlation, r = 0.60; p 
< .0001) with EPDS scores at six weeks postpartum (Hannah et al., 1992).  EPDS scores 
obtained at postpartum day two or three have been highly correlated (Spearman rank 
correlation, r = 0.59; p < .0001) with EPDS scores obtained four to six weeks postpartum 
(Chabrol & Teissedre, 2004).  
There is a minimum score of zero and a maximum score of 30. Questions 3, 5-10 
are reverse scored, discouraging the subject from answering the same way for each 
question. Question 10 addresses suicidal thoughts, and must be carefully assessed. If a 
subject has a total score less than ten, but notes suicidal tendencies, a referral should be 
made immediately. Prompt referral for those participants with EPDS scores less than ten, 
but with positive indications of suicidal thoughts, was ensured through immediate 
assessment after questionnaire completion. Cronbach’s alpha coefficient of the EPDS in 
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 the current study was 0.91. The EPDS values were positively correlated with the CES-D 
values in the present study, thereby illustrating convergent validity of the instruments. 
 
Anxiety Symptom Instrument 
The Beck Anxiety Inventory (BAI) [available at Pearson Education, Inc. (A. T. 
Beck et al., 1988)] was used in this study to measure the levels of anxiety symptoms in 
the participants. The BAI is a 21-item instrument that asks subjects to report the degree of 
symptoms in the past week. Each item is scored on a four-point scale from zero to three. 
The items are summed to obtain a total score from zero to 63.  A total score of zero to 21 
is indicative of little or no anxiety symptoms. A total score of 22-35 is indicative of 
moderate anxiety symptoms, and a sum of 36 or greater is cause for concern (A. T. Beck 
et al., 1988). Each item is descriptive of subjective, somatic, or panic-related symptoms 
of anxiety. The BAI was developed to discriminate anxiety from depression by 
measuring anxiety symptoms that infrequently occur with depression. The BAI is self-
administered, but can also be administered verbally by a trained administrator. 
Approximately five to 10 minutes are required for completion of the BAI, and the 
instrument has been recommended in populations that are 17 years or greater or fifth 
grade reading level (American Psychiatric Association Task Force, 2000). 
 
Reliability and both convergent and discriminate validity of the BAI have been 
established. The BAI has high internal consistency and item-total correlations that range 
from .30 to .71 (median= .60) (American Psychiatric Association Task Force, 2000). 
One-week test-retest reliability is .75.  Positive correlation between the BAI and clinical 
evaluations has been illustrated. The BAI has been used in populations of women (Bauer, 
Costa, & Hesselbrock, 2001). Internal consistency reliability for the study sample was 
calculated using Cronbach’s alpha coefficient, and was 0.93. 
 
 
PROCEDURE 
 The researcher requested permission to conduct the study from the University of 
Tennessee Health Science Center Institutional Review Board.  Upon obtaining approval 
(Appendix E), the researcher secured use of the clinics for research purposes through the 
clinic manager and medical directors.  A formal letter documenting this agreement is 
provided (Appendices F and G). The purpose of the study was explained to the women by 
the clinic social worker (SW) during clinic visits.  The clinic social worker was a vital 
part of the research team and was included in the IRB application process.  The principle 
investigator (PI) was available to study participants for additional questions or concerns.  
 
Women who expressed the desire to participate in the research study and met 
inclusion criteria were enrolled in the study. After obtaining verbal and written consent 
(Appendix H) the completed informed consents were placed in an envelope marked 
INFORMED CONSENTS. The questionnaires were assembled into research packets that 
were marked with a code number prior to their distribution.  The SW maintained a list of 
participants and their corresponding code numbers. This process allowed a method of 
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 tracking the participants that needed additional assessments based on their scores on the 
CES-D (Radloff, 1977), EPDS (Cox et al., 1987), and BAI (A. T. Beck et al., 1988).  The 
tracking process ensured that those subjects needing further assessment or immediate 
referral (suicidal tendencies as noted on the EPDS) were addressed promptly. 
 
Participants completed the packets in the privacy of the examination room. The 
SW distributed the questionnaires, and the PI was available for questions during the 
questionnaire completion process.  Instructions for questionnaire completion were 
verbally delivered by the SW, following a written script prepared by the PI. The 
participants were given instructions to complete the research packets, which included the 
Demographic Data Questionnaire, PSQI (Buysse et al., 1989), CES-D (Radloff, 1977), 
EPDS (Cox et al., 1987), and BAI (A. T. Beck et al., 1988). Participants were asked to 
not write their names or any other identifier on any of the instruments, as they were 
marked with code numbers. Completed questionnaires were reviewed by the SW for 
missing data. The SW was trained to assist participants with unanswered questions in a 
manner that allowed the participant to independently answer questions following 
instruction. Any missing data were obtained and then the packets were placed in a 
separate envelope marked, QUESTIONNAIRES. This procedure discouraged the 
identification of the subjects by the PI. The researcher was aware that although physical 
harm was not a danger in this study, much care was taken to prevent psychological harm 
to the participants.  The PI provided time after the completion of the questionnaires for 
the participants to express thoughts and feelings.   
 
Instrumentation was scored within a four hour period. This limited time frame 
allowed those participants needing further evaluation to be identified and referred to a 
health care provider for additional assessment. The signed informed consents and 
completed questionnaires were kept in a secure locked file cabinet within the PI’s locked 
office. The SW maintained a list of all research participants and their corresponding code 
numbers. This allowed the PI to alert the SW of participants needing further evaluation 
without identifying the participant.  The signed informed consents and the completed 
research questionnaires were secured and stored per IRB requirements. 
 
 
CONSIDERATION OF HUMAN SUBJECTS 
The rights of human subjects as study participants require protection and 
consideration.  All requirements of the Health Information Privacy and Protection Act 
(HIPPA) were met and followed throughout the research process. The subjects’ protected 
health information (PHI) collected in the study from medical records was used for 
research purposes only. The ethical principles of (1) respect for people, (2) beneficence, 
and (3) justice (National Institutes of Health, 1979) were observed during the conduct of 
this study. 
 
The ethical principle of respect for persons requires researchers to obtain 
informed consent from research participants, maintain confidentiality, and protect 
participants with impaired decision-making capacity (Hulley, 2001). The Belmont Report 
(National Institutes of Health, 1979) describes the respect for persons as the recognition 
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 that individuals are autonomous agents. Respect for participants was illustrated when the 
subjects completed the informed consent process, as pertinent issues regarding risks, 
benefits, and alternatives to participation were covered in the informed consent 
(Appendix H).  
 
The participants were guaranteed additional privacy with the anonymity that was 
built into the participant identification system. Each research packet was numbered, with 
the informed consent and questionnaires assigned a numerical code. Participants were 
asked to not include their names, initials, or any other identifying marks on the research 
materials. Confidentiality was ensured as the participants were informed that the 
researcher would not be able to identify them based on questionnaire responses. 
Participants were informed that their responses would be kept confidential, stored in a 
secure area, and destroyed in compliance with University of Tennessee Health Science 
Center Institutional Review Board procedures.  
 
 The ethical principle of beneficence in research requires that participants be 
protected from harm. Participants were protected from harm. The research study was 
designed to maximize benefits and minimize risks to the participants. This study involved 
minimal risk to the subjects. Psychological risks involved with being rejected as a subject 
were minimized through the consistent use of clearly defined inclusion and exclusion 
criteria. The benefits of the study were identification of women that needed additional 
assessment through collaboration with the clinic SW. Processes were in place to ensure 
that women needing additional screening were quickly referred. Follow-up was ensured 
by the SW. 
 
 The ethical principle of justice was ensured as the participants were informed that 
study participation was completely voluntary and refusing to participate in the study 
would not affect their access to medical care. Fair treatment of study participants was 
guaranteed through consistent instruction for questionnaire completion, as defined by the 
prepared script. These procedures helped ensure that all participants were treated in the 
same fashion throughout the screening, informed consent, and data collection process. No 
participant received a monetary incentive for participation. 
  
 
DATA ANALYSIS  
The SW examined all completed questionnaires; missing data were gathered by 
the SW prior to the subject’s departure. Data were transferred entered onto an Excel 
spreadsheet with assigned code numbers in order to protect participants’ confidentiality 
and anonymity. All data analysis was completed using the JMP™ statistical software 
program. The specific statistical analyses used to answer the research questions are 
explained in detail in the paragraphs that follow. 
 
Nominal measurement was used to assign numbers to responses on the 
demographic data form, classifying characteristics into categories. Descriptive statistics 
including: measures of central tendency (i.e., mean and median), frequency distributions, 
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 and variability (i.e., standard deviation) were used to summarize and describe the 
demographic data.    
 
Research Question 1 
a. What are the levels of depressive symptoms in pregnant African-American 
women who are HIV-positive? 
b. What are the levels of anxiety symptoms in pregnant African-American women 
who are HIV-positive? 
c. What are the levels of depressive symptoms in non-pregnant African-American 
women who are HIV-positive? 
d. What are the levels of anxiety symptoms in non-pregnant African-American 
women who are HIV-positive? 
 
 Research questions a through d were answered through the results of the CES-D, 
EPDS and BAI. Levels of depressive and anxiety symptoms in the sample were 
illustrated by their scores on the CES-D, EPDS, and BAI. These scores were continuous 
in nature, and results reported as descriptive statistics (i.e., mean, median, interquartile 
range, and standard deviation).  
 
Research Question 2 
a. What is the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to depressive symptoms 
among pregnant African American women who are HIV positive? 
b. What is the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to depressive symptoms among pregnant African 
American women who are HIV positive? 
c. What is the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to depressive symptoms 
among non-pregnant African American women who are HIV positive? 
d. What is the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to depressive symptoms among non-pregnant African 
American women who are HIV positive? 
 
 Research questions 2a-2d were answered using correlation statistical procedures. 
Independent variables for inherited vulnerabilities (family history of mood disorders, 
family history of alcohol and/or drug use) and acquired (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) vulnerabilities were categorical in nature.  Correlation analysis using Pearson 
correlation coefficient was used to describe the relationship between variables.  The 
presence or absence of independent variables was addressed using dummy coding, with 
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 educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep 
quality, history of sexual abuse or assault) presence being 1, and absence being 0.  
 
Research Question 3 
a. What is the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to anxiety symptoms among 
pregnant African American women who are HIV positive? 
b. What is the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to anxiety symptoms among pregnant African American 
women who are HIV positive? 
c. What is the relationship of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) to anxiety symptoms among 
non-pregnant African American women who are HIV positive? 
d. What is the relationship of acquired vulnerabilities (educational level, income 
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of 
sexual abuse or assault) to anxiety symptoms among non-pregnant African 
American women who are HIV positive? 
 
 Research questions 3a-3d were answered using correlation statistical procedures. 
Independent variables for inherited vulnerabilities (family history of mood disorders, 
family history of alcohol and/or drug use) and acquired (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) vulnerabilities were categorical in nature.  Correlation analyses were used to 
describe the relationship between variables. Correlation analysis using Pearson’s 
correlation coefficient was used to describe the relationship between variables.  
Categorical variables were dummy coded as present (1) versus not present (0) to facilitate 
interpretation of study results. 
 
Research Question 4 
a. What is the influence of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) on the level of depressive 
symptoms reported by non-pregnant African-American women who are HIV 
positive?  
b. What is the influence of acquired vulnerabilities (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual 
abuse or assault) on the level of depressive symptoms reported by non-pregnant 
African-American women who are HIV positive? 
 
 Research questions 4a and 4b were answered using multiple regression analysis. 
The influence of the independent variables (inherited and acquired vulnerabilities) on the 
dependent variables (CES-D, EPDS scores) was established. Stepwise multiple 
regression analysis was performed in order to determine which independent variables 
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 best predicted the dependent variables. Dummy coding was used to identify the presence 
(1) or absence (0) of independent variables. In order to systematically test each variable, 
stepwise multiple regression with backward elimination was performed. Independent 
variables that illustrated statistically significant correlations were entered into the 
equation, and then one by one eliminated to test the influence of each independent 
variables (inherited and acquired vulnerabilities) on the dependent variables (CES-D, 
EPDS scores).   
 
Research Question 5 
a. What is the influence of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) on the level of anxiety 
symptoms reported by non-pregnant African-American women who are HIV 
positive? 
b. What is the influence of acquired vulnerabilities (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual 
abuse or assault) on the level of anxiety symptoms reported by non-pregnant 
African-American women who are HIV positive? 
 
 Preliminary results revealed that the non-pregnant African American women who 
were HIV-positive had low levels of anxiety symptoms, as evidenced by BAI scores. 
Dummy coding was used to identify the presence (1) or absence (0) of independent 
variables. In order to systematically test each variable, stepwise multiple regression with 
backward elimination was performed. Independent variables that illustrated statistically 
significant correlations were entered into the equation, and then one by one eliminated to 
test the influence of each independent variables (inherited and acquired vulnerabilities) 
on the dependent variables (BAI scores).  
 
 
SUMMARY 
 In this chapter, the design of the current study has been discussed.  The 
limitations, setting, population, sample, instrumentation, and procedure were reviewed.  
The methods of protection of human subjects and data analysis were also identified.   
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 CHAPTER 4. RESULTS 
The purposes of this study of HIV-positive women are fourfold: (1) to  determine 
the levels of depressive and anxiety symptoms in pregnant and non-pregnant African 
American women who were HIV-positive; (2) to describe the association between 
underlying vulnerabilities, both inherited and acquired and depressive symptoms in 
pregnant and non-pregnant African American women who were HIV-positive; (3) to 
estimate the association between underlying vulnerabilities, both inherited and acquired, 
and anxiety symptoms in pregnant and non-pregnant African American women who were 
HIV-positive; and (4) to identify the predictors of depressive and anxiety symptoms 
among African American HIV-positive non-pregnant women.   
 
Prior to conducting data analyses, subjects’ responses to study questionnaires 
were entered into a Microsoft™ Excel spreadsheets then uploaded into the JMP™ 
statistical analysis software program. Descriptive statistics were estimated for each 
variable as were skewness and kurtosis scores to determine normality. Stem and leaf plots 
were also generated to assess normality. Many of the study variables were not normally 
distributed, resulting in the need to use nonparametric statistics for some analyses. For 
both independent and dependent variables that were normally distributed, mean scores 
with corresponding standard deviations were used to describe the data; for variables that 
were not normally distributed, the median (Mdn) and interquartile range (IQR) were 
reported. Finally, the results of each research question were addressed. Dummy coding 
was used to identify the presence (recoded as a score of 1) or absence (recoded as a score 
of 0) of specific categorical variables that were originally coded with more than two 
levels. This approach permitted the inclusion of these variables within regression 
analyses (Penhazur & Schmelkin, 1991).  
 
 
DEMOGRAPHIC FINDINGS  
 The mean age for the sample was 33±10.7 years. The pregnant group was 
significantly younger than the non-pregnant group (24.4±4.58 versus 36±10.57 years; 
t = -6.847, p <.0001) and had fewer children (1.8±1.23 vs. 2.49±1.82; t = -1.755, p = 
.043). However, the groups did not differ significantly with regard to their education (X2 
= .207, df = 1, p = .768) and income (X2 = .192, df = 1, p = .194) categories. The majority 
of the women in the present study were poor and unmarried. Most participants reported 
their marital status as single (n = 14, 70% of the pregnant women vs. n = 32, 53.3% of the 
non-pregnant women). A few of the non-pregnant group (n = 6, 10%) were widowed. 
One woman reported AIDS as the cause of her spouse’s death; another woman reported 
that her husband committed suicide after she was hospitalized and diagnosed with AIDS. 
This participant also reported that after the suicide, she learned that her husband knew 
about his HIV diagnosis for many years prior to her diagnosis.  
 
Almost half (49%) of the total sample of pregnant and non-pregnant women 
reported annual household incomes of less than $5000, (63% of the pregnant women; 
44% of the non-pregnant women). Employment was varied, with 47.5% of the total 
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 sample being unemployed, and 45% of the total sample being employed part time. Over 
half of the total sample (n = 47, 58.75%) had educational levels greater than high school 
graduate. Table 4.1 provides a sociodemographic summary of attributes of African 
American women who were HIV positive. 
 
 
INHERITED AND ACQUIRED VULNERABILITIES 
The investigator assessed inherited and acquired vulnerabilities using items 
included on the researcher’s Demographic Questionnaire. Inherited vulnerabilities 
assessed included family history of mood disorders and family history of alcohol and/or 
drug use. Acquired vulnerabilities measured were educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, and history of sexual abuse 
or assault. Table 4.2 provides a summary of measures of inherited and acquired 
vulnerabilities for the total sample as well as for pregnant and non-pregnant women. In 
general, less than half of the total sample (N = 80) reported a positive family history of 
mood disorders (35%) and family history of alcohol and/or drug use (32.5%). One third 
of the participants (n = 25; 31%) reported alcohol and/or drug use, with the majority of 
those women being in the non-pregnant group. The majority of the total sample (N = 80) 
had educational levels of high school graduate or higher (n = 71; 88.75%). Low income 
levels (less than $5000/year) were seen in both groups of women, affecting over half 
(63%) of the pregnant women and slightly less than half (44%) of the non-pregnant 
women. The majority of the sample had disclosed their HIV status to at least one person 
(n = 74; 92.5%), with sexual partners being the most commonly identified person.  Poor 
sleep quality was prevalent in both groups of women, with 65% of the pregnant women 
and 62% of the non-pregnant women having PSQI scores indicative of poor sleep. 
History of sexual assault was illustrated in both groups, with 35% of the pregnant and 
44% of the non-pregnant group reporting a positive history of sexual assault.   Current 
alcohol and/or drug use was higher in the non-pregnant group (40%) than the pregnant 
group (5%). Over one third of the total sample reported a history of mood disorder 
(38%), with similar results noted in the two groups (30% of pregnant women vs. 41% of 
non-pregnant women).  
 
 
AIM ONE 
 Examine the levels of depressive and anxiety symptoms in African American 
women (pregnant and non-pregnant) who are HIV-positive in a southeastern urban 
university obstetrics and gynecology and infectious disease practice.  
 
All Women: Total Scale Scores for Outcome Variables 
Outcome variables were assessed based upon total scores from the CES-D, EPDS, 
and BAI for the entire sample (N = 80) of both pregnant (n=20) and non-pregnant (n=60) 
women. Average scores of depressive and anxiety symptoms are summarized in Table 
4.3. The total score of the CES-D, a measure of depressive symptoms, is the sum of all 
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Table 4.1  Sociodemographic Attributes of African American Women Who Were HIV-
positive. 
 
 Total 
(N=80) 
 Pregnant 
(n=20) 
 Non-Pregnant 
(n=60) 
 n (%)  n (%)  n (%) 
Income (annual)         
<5000  38 (48.72%)  12 (63.16%)  26 (44.07%) 
5000-10,000 17 (21.8%)  1 (5.26%)  16 (27.12%) 
10,000-15,000 11 (14.1%)  4 (21.05%)  7 (11.86%) 
15,000-25,000 8 (10.26%)  1 (5.26%)  7 (11.86%) 
25,000 or higher 4 (5.13%)  1 (5.26%)  3 (5.09%) 
       
Educational  
  (highest completed) 
      
9th-11th grade 9 (11.25%)  2 (10%)  7 (11.86%) 
HS/GED 24 (30%)  6 (30%)  18 (30%) 
Some College 28 (35%)  8 (40%)  20 (33.33%) 
Bachelor’s Degree 18 (22.5%)  4 (20%)  14 (23.33%) 
Master’s Degree 1 (1.25%)  0   1 (1.67%) 
       
Employment Status       
Unemployed 21 (26.25%)  6 (30%)  15 (25%) 
Employed FT 5 (6.25%)  2 (10%)  3 (5%) 
Employed PT 36 (45%)  10 (50%)  26 (43.33%) 
Unemployed But looking 17 (21.25%)  2 (10%)  15 (25%) 
       
Marital Status       
Single 46 (57.5%)  14 (70%)  32 (53.33%) 
Married 14 (17.5%)  2 (10%)  12 (20%) 
Divorced 3 (3.75%)  1 (5%)  2 (3.33%) 
Widowed 4 (7.5%)  0   6 (10%) 
Cohabitating 11 13.75%)  3 (15%)  8 (13.33%) 
 
Note: HS=High School; GED= General Education Equivalent; PT= Part Time; FT= Full 
Time. Between group differences were not significant. 
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Table 4.2  Inherited and Acquired Vulnerabilities Reported by the Total Sample and 
Pregnant and Non-Pregnant HIV-positive African American Women. 
 
Vulnerability 
Total 
N = 80 
n (%) 
Pregnant 
n=20 
n (%) 
Non-
Pregnant 
n= 60  
n (%) 
Significance 
Between 
Pregnant and 
Non-Pregnant 
p-value 
Inherited Vulnerabilities     
Family history of mood 
disorder 
28(35.0) 6 (30.0) 22 (37.0) 0.59 
Family history of alcohol 
and/or drug use 
26(32.5) 4 (20.0) 22(37.0) 0.16 
     
Acquired Vulnerabilities     
Current alcohol and/or 
drug use 
25 (31%) 1(5%) 24 (40%) 0.0011 
     
Educational  level     
(High School graduate or 
higher) 
71 (88.75%) 18 (90%) 53 (88.33%) 0.88 
     
Income level     
(< $5000.00/year) 38 (49%) 12(63%) 26 (44%) 0.26 
     
Disclosed HIV status 74 (92.5%) 19 (95%) 55 (92%) 0.59 
     
Poor sleep quality     
(PSQI >5) 50 (62.5%) 13 (65%) 37 (62%) 0.40 
     
History of sexual abuse or 
assault 
33 (42%) 7 (35%) 26 (44%)  
 
Note. *PSQI = Pittsburgh Sleep Quality Instrument 
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Table 4.3  Descriptive Statistics for Depressive and Anxiety Symptoms in African 
American HIV-positive Women. 
 
Outcome variable N M±SD Mdn IQR 
CES-D 80 18.35 ± 13.19 17 23.75 
EPDS 80 9.04 ± 7.3 6.5 12.75 
BAI 80 11.2 ± 11.54 7 16 
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale; BAI=Beck Anxiety Inventory 
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 item responses. Results ranged from 0 to 60 with a cut-off score of 16 reflecting clinically 
relevant depressive symptoms in the general population (Radloff, 1977). Total CES-D 
scores for the study sample ranged from 3 (fewest depressive symptoms) to 53 (most 
depressive symptoms). Less than half of the sample (n = 38, 47.5%) had CES-D scores 
less than 16, which indicated the absence of significant depressive symptoms (Radloff, 
1977). Twelve (15%) women had CES-D scores of 16-20 indicating clinically mild 
depressive symptoms, 12 (15%) women had scores of 21-30 indicating moderate 
depressive symptoms, and 18 (22.5%) women had scores greater than 31 indicating 
severe distress (Radloff, 1977).  A total of 42 (52.5%) women in the sample (N=80) had 
CES-D scores of 16 or greater requiring referral to their case manager for follow-up.  
 
The total score of the EPDS is the sum of all item responses and can range from 0 
to 30 with a cut-off score of 10 indicating a need for further screening for depression 
(Cox et al., 1987). Total scores for depressive symptoms with the EPDS for the study 
sample ranged from 0 (fewest depressive symptoms) to 26 (most depressive symptoms).  
The majority of the sample (n = 44, 55%) had EPDS scores of less than nine, which 
indicated the absence of significant depressive symptoms (Cox et al., 1987). Thirteen 
women (16.25%) had EPDS scores between 10 and 13, indicating clinically mild 
depressive symptoms; and 23 (28.75%) had EPDS scores higher than 13, indicating 
moderate to severe depressive symptoms (Cox et al., 1987). All participants with elevated 
scores were reported to their case manager for follow-up.  Table 4.4 illustrates levels of 
specific categories of depressive symptoms. 
 
Anxiety scores for the sample, which reflected the sum of all items, were lower 
than expected. Most of the sample had BAI scores below the level suggestive of the need 
for additional screening (Table 4.2). BAI scores for the total sample of both pregnant and 
non-pregnant women ranged from zero to 45, with the majority (n = 69,  86.25%) of the 
women exhibiting BAI scores of less than 21, illustrating little or no anxiety (A. T. Beck 
et al., 1988). BAI scores in the 22-35 range are indicative of moderate levels of anxiety 
(A. T. Beck et al., 1988). A small proportion of the total sample (n = 6; 7.5%) had BAI 
scores in the moderate range (A. T. Beck et al., 1988). BAI scores that were 36 and 
greater were indicative a high levels of anxiety and cause for concern (A. T. Beck et al., 
1988). Five (6.25%) women in the total sample exhibited high levels of anxiety based on 
their BAI scores.  Table 4.5 illustrates the specific levels of anxiety symptoms in the total 
group of African American women who were HIV-positive. 
 
 
Pregnant Women: Total Scale Scores for Outcome Variables 
Levels of depressive symptoms in pregnant African-American women who were 
HIV-positive were also examined. Data were assessed for symmetry, or skewness, using 
Pearson’s skewness coefficient. Perfectly symmetrical distributions have equal means 
and medians, with a Pearson skewness coefficient of 0 (Penhazur & Schmelkin, 1991). 
Pearson skewness coefficient results that fall between -1 and +1 are acceptable, 
indicating data that are normally distributed. Values above or below -1 and +1 are 
substantially skewed distribution (Penhazur & Schmelkin, 1991). Depressive symptoms, 
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Table 4.4  Descriptive Statistics for Specific Levels of Depressive Symptoms in Total 
Sample of African American HIV-positive Women (N = 80). 
 
CES-D Scores N % EPDS Scores N % 
None (0-15)    38 47.5% None  (0-9) 44 55% 
Mild (16-20) 12 15% Mild (10-13) 13 16.25% 
Moderate (21-30) 12 15% Moderate to Severe (≥14) 23 28.75% 
Severe (≥ 31) 18 22.5%    
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale 
 
65 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.5  Descriptive Statistics for Specific Levels of Anxiety 
Symptoms in Total Sample of African American HIV-positive Women 
(N = 80).   
 
BAI Scores n % 
None to mild (0-21) 69 86.25 
Moderate (22-35) 6 7.5 
Severe (≥ 36) 5 6.25% 
Note: BAI= Beck Anxiety Inventory 
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 as measured using the CES-D, were positively skewed (Pearson’s skewness coefficient 
0.78). Data were treated for the purposes of statistically analysis as normally distributed. 
As seen with the CES-D, depressive symptom scores measured using the EPDS (mean 
8.7; median 5.5) were dissimilar, although the Pearson’s skewness coefficient was 0.34, 
which is less than +1, indicating data that are normally distributed. Results indicated that 
as a group, almost half of the sample (45%) of pregnant African-American women who 
were HIV-positive had CES-D scores indicative of the need for referral and additional 
assessment of depressive symptoms. Consequently, over half of the pregnant women in 
the sample (55%) reported depressive symptoms below the recommended cut-off for the 
CES-D (total score < 16) (Radloff, 1977). The median score of the CES-D in this group 
of pregnant women was 9 (interquartile range of 27.5). Results were similar for the 
EPDS. A score of 0-9 is indicative of the absence of clinically relevant depressive 
symptoms (Cox et al., 1987).  EPDS scores for this group of pregnant women were below 
the recommended cut-off needed for further evaluation (median 5.5; interquartile range 
14). On average, for both measures pregnant women did not have clinically relevant 
levels of depressive symptoms. Table 4.6 illustrates levels of depressive symptoms in this 
sample of pregnant African American women who were HIV-positive. 
 
 Levels of anxiety symptoms in pregnant African-American women who were 
HIV-positive were positively skewed (Pearson’s skewness coefficient 1.29), and greater 
than +1, indicating data that were not normally distributed. Results indicated that 
pregnant African-American women in the sample who were HIV-positive did not report 
anxiety symptoms that needed further evaluation. The majority of the sample of pregnant 
women exhibited anxiety symptoms below the recommended cut-off of 21 for the BAI 
(A. T. Beck et al., 1988). The median for BAI scores in this group was 5.5 and the 
interquartile range 19.5. Pregnant women in this sample did not have clinically relevant 
anxiety symptom levels. Table 4.7 illustrates levels of anxiety symptoms in this group of 
pregnant African American women who were HIV-positive. 
 
All Non-Pregnant Women: Total Scale Scores for Outcome Variables 
Levels of depressive symptoms in non-pregnant African-American women who 
were HIV-positive were examined using descriptive statistics. Results indicated that the 
levels of depressive symptoms in non-pregnant African-American women who were 
HIV-positive were positively skewed for both the CES-D (Pearson’s skewness coefficient  
(0.56) and EPDS (Pearson’s skewness coefficient 0.6). These Pearson’s skewness 
coefficient values reflected data that were approximately normally distributed. 
 
Results for aim one indicated that the typical non-pregnant African-American 
women in the study sample who were HIV-positive had mild depressive symptoms when 
measured by the CES-D (mean 18.6; standard deviation 12.53) and the EPDS (mean 
9.15; standard deviation 7.29).  CES-D scores for the typical non-pregnant women in this  
sample ranged from 3 to 46. EPDS scores for the typical non-pregnant women in this 
sample ranged from 0 to 26. In this group of non-pregnant African American HIV- 
positive women, CES-D and EPDS scores suggest that depressive symptoms were 
typically mild. Current treatment with antidepressants was not an exclusion criterion for 
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Table 4.6  Descriptive Statistics for Specific Levels of Depressive Symptoms in Sample 
of Pregnant African American HIV-positive Women (n = 20). 
 
CES-D Scores n % EPDS Scores N % 
None (0-15)    11 55% None (0-9) 11 55% 
Mild (16-20) 1 5% Mild (10-13) 3 15% 
Moderate  (21-30)   1 5% Moderate to Severe (≥14) 6 30% 
Severe (≥ 31) 7 35%    
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale 
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Table 4.7  Descriptive Statistics for Specific Levels of Anxiety 
Symptoms in Sample of Pregnant African American HIV-positive 
Women (n = 20) 
 
BAI Scores n % 
None to mild (0-21)    17 85 
Moderate (22-35)   3 15 
Severe (≥ 36) 0 0 
 
Note: BAI= Beck Anxiety Inventory 
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 the current study. Nine (15%) of the non-pregnant women (n = 60) were on 
antidepressants at the time of their participation in the study, although eight of these 
women had elevated depressive symptom scores. Table 4.8 illustrates levels of depressive 
symptoms in this sample of non-pregnant African American women who were HIV-
positive. 
 
 Levels of anxiety symptoms in the typical non-pregnant African-American 
women who were HIV-positive were examined. Results were positively skewed 
(Pearson’s skewness coefficient 1.29), and greater than +1, indicating data that were not 
normally distributed. Results indicated that most of the non-pregnant African-American 
women in the study who were HIV-positive had little or no anxiety (median 7, 
interquartile range 16). Anxiety scores in this group of non-pregnant women ranged from 
zero to 45. Table 4.9 illustrates levels of anxiety symptoms in this group of non-pregnant 
African American women who were HIV-positive. 
 
 The Wilcoxon Signed Rank Sums test was performed to assess the significance of 
between group differences (pregnant versus non-pregnant) for each outcome. Depression 
scores as measured by the CES-D were similar (p =.486) in both groups as was EPDS 
scores (p=.743). Anxiety scores were also similar for the groups (p=.558).  Table 4.10 
depicts a summary of the results of depressive and anxiety symptom scores in pregnant 
and non-pregnant women. As a group neither pregnant nor non pregnant women in the 
study sample had clinically relevant levels of depressive or anxiety symptoms. 
 
 
AIM TWO 
Examine the associations among inherited (family history of mood disorders, 
family history of alcohol and/or drug use) and acquired (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) vulnerabilities and depressive symptoms in pregnant and non-pregnant African 
American women who were HIV-positive.  
 
Correlation statistics were used to analyze the relationship of inherited 
vulnerabilities (e.g. family history of mood disorders, family history of alcohol and/or 
drug use) to depressive symptoms among pregnant African American women who were 
HIV positive. Table 4.11 summarizes the correlation analyses in this group of pregnant 
women, illustrating the statistical significance of the correlation between family history 
of mood disorders and depressive symptoms.  
 
 Family history of mood disorders was captured on the Demographic 
Questionnaire. Results were dummy coded, with no family history of mood disorder 
coded as 0 and positive family history of mood disorders coded as 1. There was a 
moderate but significant association between family history of mood disorders and 
depressive symptoms on the CES-D (r= 0.58; p = 0.0073). Results for the EPDS were 
similar (r = 0.59; p = .058), however the level of significance was slightly above the A 
priory alpha of p ≤ 0.05.  Thus, family history of mood disorders was associated with  
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Table 4.8  Descriptive Statistics for Specific Levels of Depressive Symptoms in Sample 
of Non-Pregnant African American HIV-positive Women (n = 60).  
 
CES-D Scores n % EPDS Scores N % 
None (0-15)    27 45% None  (0-9) 33 55% 
Mild (16-20) 11 18.3% Mild (10-13) 10 16.7% 
Moderate (21-30) 11 18.3% Moderate to Severe (≥14) 17 28.3% 
Severe (≥ 31) 11 18.3%    
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale 
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Table 4.9  Descriptive Statistics for Specific Levels of Anxiety Symptoms 
in Sample of Non-Pregnant African American HIV-positive Women (n = 
60).  
 
BAI Scores n % 
None to mild (0-21)  52 86.7 
Moderate  (22-35)  3 5 
Severe (≥ 36) 5 8.3 
 
Note: BAI= Beck Anxiety Inventory 
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Table 4.10  Depressive and Anxiety Symptom Scores in Pregnant (n = 20) and Non-
Pregnant (n = 60) African American HIV-positive Women. 
 
Outcome 
Pregnant (n=20) 
Mdn (IQR) 
Non-pregnant (n=60) 
Mdn (IQR) 
CES-D 9 (27.5) 17 (21) 
EPDS 5.5 (14) 8 (11.75) 
BAI 5.5(19)  7 (16) 
 
Note: Median (Mdn) and interquartile ranges (IQR) were reported for data that were not 
normally distributed. CES-D=Center for Epidemiologic Studies Depression Scale; 
EPDS=Edinburgh Postnatal Depression Scale; BAI=Beck Anxiety Inventory. Between 
group differences were non-significant. The study a priori alpha was p≤.05. 
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Table 4.11  Pearson Correlation (r) Analysis between Inherited Vulnerabilities and 
Depressive Symptoms for Pregnant African American Women Who Were HIV-positive 
(n = 20). 
 
Inherited Vulnerability 
Depressive Symptoms 
(CES-D Scores) 
r (p value) 
Depressive Symptoms 
(EPDS Scores) 
r (p value) 
Family History of Mood Disorders .58 (.0073) .59 (.058) 
Family History of Alcohol/Drug Use .30 (.20) .19 (.42) 
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale. A priori alpha for the study was p≤ 0.05. 
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 depressive symptoms in this group of pregnant African American women who were HIV-
positive. Women with a positive family history of mood disorders had higher depression 
scores than women with a negative family history on both measures of depressive 
symptoms. 
 
Family history of alcohol and/or drug use was captured on the Demographic 
Questionnaire. Results were dummy coded with no family history of alcohol and/or drug 
use coded as 0 and positive family history of alcohol and/or drug use coded as 1. There 
was a non-significant association between family history of alcohol and/or drug use with 
depressive symptoms on both the CES-D (r = 0.30; p = 0.20) and the EPDS (r = 0.19; p = 
.42).  Thus, family history of alcohol and/or drug use was not significantly associated 
with depressive symptoms as measured by the CES-D, or the EPDS in this group of 
pregnant African American women who were HIV-positive.  
 
Correlation statistics were used to analyze the relationship of acquired 
vulnerabilities (educational level, income level, alcohol and/or drug use, HIV disclosure 
status, sleep quality, history of sexual abuse or assault) to depressive symptoms among 
pregnant African American women who were HIV positive. Table 4.12 provides the 
complete results of these correlation analyses 
 
Two categories of educational level were used for analysis, HS/GED (coded as 0) 
and HS/GED or higher (coded as 1). Educational level was not significantly associated 
with depressive symptoms when measured with the CES-D (r = -0.12; p = 0.62) or EPDS 
( r = -0.09; p = 0.72). Thus, educational level was not significantly associated with 
depressive symptoms in this group of pregnant African American women who were 
HIV-positive.  
 
Income level was captured on the Demographic Questionnaire as annual 
household income in a categorical fashion. Five categories of income were collapsed into 
two categories, which was a reflection of the sample income distribution. Income level 
was coded 0 if income was less than $5000/year and 1 if participants income was 
$5000/year or greater. Income level was not significantly correlated with depressive 
symptoms when measured be the CES-D (r =- 0.06; p = 0.80) or the EPDS (r = 0.09; 8; p 
= 0.69). Thus, socioeconomic level was not significantly associated with depressive 
symptoms in this group of pregnant African American women who were HIV-positive.  
 
The association between substance use and depressive symptom scores on the 
CES-D were non-significant (r = 0.22; p = 0.35). Likewise, the correlation between 
alcohol and/or drug use and depressive symptoms using the EPDS was also non-
significant (r = 0.42, p = 0.07). Thus, substance use was not significantly associated with 
depressive symptoms in this group of pregnant African American women who were 
HIV-positive. 
 
Disclosure of HIV status was measured on the Demographic Questionnaire by the 
number of persons to whom the subject had disclosed her HIV status. Pregnant women 
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Table 4.12  Pearson Correlation (r) Analysis between Acquired Vulnerabilities and 
Depressive Symptoms for Pregnant African American Women Who Were HIV-positive 
(n = 20). 
 
Acquired Vulnerability 
CES-D Depressive 
Symptoms Scores 
r (p value) 
EPDS Depressive 
Symptoms Scores 
r (p value) 
Income -.01 (.80) .010(.69) 
Educational Level -.12(.62) -.09(.72) 
Alcohol and/or Drug Use .22(.35) .42(.07) 
HIV Disclosure Status .54(.01)* .37(.11) 
History of Sexual Assault .28(.23) .27(.24) 
Sleep Quality .61(.0004)* .67(.0001)* 
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale. *The study a priori alpha was p≤.05. 
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 Prior to conducting zero-order correlation analysis, nominal level variables that 
reflected was implemented to signify no disclosure to others (coded 0) or disclosure to 
others (coded 1). HIV disclosure status was significantly correlated with depressive 
symptoms when measured by the CES-D (r = 0.54; p = 0.01), but not with the EPDS (r = 
0.37; p = 0.11) in this pregnant subgroup. Therefore, the pregnant women that had 
disclosed their HIV status displayed higher levels of depressive symptoms on the CES-D.  
Mixed results were illustrated in regard to HIV disclosure status, with HIV disclosure 
status being associated with higher scores on the CES-d but not on the EPDS. 
Application of Pearson (r) correlation analyses allowed the researcher to determine the 
direction and strength of the relationship between variables (Penhazur & Schmelkin, 
1991). This statistical approach allowed the researcher to determine whether or not 
inherited vulnerabilities were significantly related to depressive symptoms (See Table 
4.13). Pregnant women who disclosed their HIV status had significantly higher 
depression scores (more depressive symptoms) on the CES-D (mean 18.16) but not the 
EPDS (mean 8.95) compared to women who had not disclosed their status (mean CES-D 
score 5; mean EPDS score 4).  
 
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater 
indicating poor sleep quality. In this group of pregnant women, there was a significant 
strong, positive correlation between sleep quality and depressive symptoms on the CES-
D (r = 0.61; p = 0.0004) and EPDS (r = 0.67; p = 0.0001). As sleep quality scores 
increased (worsened), depression scores increased (worsened). Sleep quality was the 
acquired vulnerability with the strongest association with depressive symptoms in 
pregnant participants.  
 
History of sexual abuse or assault was measured on the Demographic 
Questionnaire. Results indicated a low positive, but non-significant correlation between 
depressive symptoms and sexual abuse or assault when measured with the CES-D (r= 
0.30; p = 0.23). Similarly, correlation was non-significant when the EPDS was used to 
assess depressive symptoms (r = 0.27; p = 0.24). Thus, results of these analyses indicated 
that there was not a significant association between history of sexual assault or abuse and 
depressive symptoms when measured using both the CES-D and EPDS in this group of 
pregnant African American women who were HIV-positive. 
 
The relationship of inherited vulnerabilities (e.g., family history of mood 
disorders and family history of alcohol and/or drug use) to depressive symptoms among 
non-pregnant African American women who were HIV positive was examined using 
correlation analyses. Pearson’s correlations were estimated to answer this research 
question as most variables were normally distributed. The presence or absence of each of 
the inherited vulnerabilities was obtained in the Demographic Questionnaire.  
 
The associations between inherited vulnerabilities and depressive symptoms were 
not significant in this group of non-pregnant women. Family history of mood disorders 
was dummy coded as 0 if there was no family history of mood disorders and 1 if there 
was a positive family history of mood disorders. The correlation between family history 
of mood disorders and depressive symptoms with the CES-D was not statistically 
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Table 4.13  Pearson Correlation (r ) Analyses between Inherited Vulnerabilities and 
Depressive Symptoms for Non-Pregnant African American Women Who Were HIV-
positive (n = 60). 
 
Inherited Vulnerability 
CES-D Depressive 
Symptoms Scores 
r (p value) 
EPDS Depressive 
Symptoms Scores 
r (p value) 
Family history of mood 
disorders 
.23 (0.08) .23 (0.08) 
Family history of 
alcohol/drug use 
.10 (0.46) .25 (0.06) 
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale. A priori alpha for the study was p≤ 0.05. 
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 significant (r = 0.23, p = 0.08).  Similarly, there was a non-significant association (r 
=0.23, p =.08) between family history of mood disorders and depressive symptoms when 
measured by the EPDS.  Thus, family history of mood disorders was not significantly 
associated with depressive symptoms in this group of non-pregnant African American 
women who were HIV-positive. 
 
Family history of alcohol and/or drug use was not significantly correlated with 
depressive symptoms when measured by the CES-D (r = 0.10; p = 0.46), or the EPDS (r 
= 0.25; p = 0.06). Thus, family history of alcohol and/or drug use was not associated with 
depressive symptoms in this group of non-pregnant African American women who were 
HIV-positive when measured by the CES-D and EPDS. Participants who had a positive 
family history of alcohol and/or drug use reported greater depressive symptoms on the 
CES-D (mean CES-D score 20.18) and the EPDS (mean EPDS score 11.5) compared to 
women who did not have a positive family history (mean CES-D score 17.68; mean 
EPDS score 7.79). 
 
The relationship of acquired vulnerabilities (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) to depressive symptoms among non-pregnant African American women who 
were HIV positive was examined.  
 
Educational level was captured on the Demographic Questionnaire in a 
categorical fashion. Although four categories were present on the questionnaire, the 
majority of the sample clustered in two categories, less than high school graduate or 
equivalent diploma (HS/GED) and high school graduate or equivalent diploma 
(HS/GED) or higher, therefore these two categories were used for correlation analysis. 
Dummy coding was used with a score of zero assigned for women with less than 
HS/GED and one for women who had HS/GED or higher educational levels. Educational 
level was not significantly correlated with depressive symptoms when measured with the 
CES-D (r  = 0.17; p = 0.19). or EPDS (r = 0.17; p = 0.18) in non-pregnant study 
participants. 
 
Income level was also captured on the Demographic Questionnaire as annual 
household income in a categorical fashion. Although there were five categories present, 
the sample responses primarily clustered in two categories, less than $5000 per year and 
$5000 per year or greater, thus these two categories were used for analysis. Dummy 
codes of 0 and 1 were assigned to signify income less than $5000 per year and $5000 per 
year or greater, respectively. Income level was not significantly correlated with 
depressive symptoms when measured with the CES-D (r = 0.14; p = 0.29) or the EPDS (r 
= -0.04; p = 0.76). Thus, income level was not significantly associated with depressive 
symptoms in this group of non-pregnant African American women who were HIV-
positive. 
 
Current alcohol and/or drug use was captured on the Demographic Questionnaire.  
Prior to conducting the zero-order correlation analysis, substance use was dummy coded 
as zero if there was no history and one if there was a positive history of this 
79 
 characteristic. Athough substance use was an acquired vulnerability that was positively 
correlated with depressive symptoms, the strength of the association was weak but 
significant using the CES-D (r  = 0.28; p = 0.03), but not on the EPDS (r = 0.24; p = 
0.06). Thus, substance use garnered mixed results; significantly associated with 
depressive symptoms on one of the two depressive symptom measurements in this group 
of non-pregnant African American women who were HIV-positive. Depression 
symptoms were significantly higher in non-pregnant women who had a positive history 
of substance use compared to women who did not report alcohol and/or drug use. 
 
The number of persons the subject had disclosed her HIV status to on the 
Demographic Questionnaire reflected their HIV disclosure status. Dummy coding was 
implemented to signify two categories: no disclosure to others, coded as 0, or disclosure 
to others, coded as 1. HIV disclosure status was not significantly correlated with 
depressive symptoms when measured by the CES-D (r =  -0.15; p = 0.24) or the EPDS (r  
= -0.16; p = 0.38) in this group of non-pregnant African American women who were 
HIV-positive. 
 
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater 
suggestive of poor sleep quality. In this group of non-pregnant women, there was a 
significant positive correlation between sleep quality and depressive symptoms on the 
CES-D (r = 0.69; p < 0.001) and EPDS (r = 0.63; p <0.001).  The strength of both of 
these correlations was moderate. As sleep quality scores increased (e.g. poorer sleep 
quality), depressive symptoms scores significantly increased (more depressive symptoms 
occurred). Thus, sleep quality was significantly associated with depressive symptoms in 
this group of non-pregnant African American women who were HIV-positive. 
 
History of sexual abuse or assault was measured on the Demographic 
Questionnaire. Responses were dummy coded as no history of sexual abuse or assault 
(coded as 0) or history of sexual abuse or assault (coded as 1). This acquired vulnerability 
was not significantly correlated with depressive symptoms on the CES-D (r = 0.24; p = 
0.06) or the EPDS (r = 0.18; p = 0.16). Thus, history of sexual assault was not 
significantly related to depressive symptoms in this group of non-pregnant African 
American women who were HIV-positive. Table 4.14 provides a summary of findings  
related to acquired vulnerabilities and depressive symptoms in this group of non-pregnant 
women. 
 
 
AIM THREE 
Examine the associations among inherited (family history of mood disorders, 
family history of alcohol and/or use) and acquired (educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) vulnerabilities and anxiety symptoms in pregnant and non-pregnant African 
American women who were HIV-positive. 
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Table 4.14  Pearson Correlation (r) Analysis between Acquired Vulnerabilities and 
Depressive Symptoms for Non-Pregnant African American Women Who Were HIV-
positive (n = 60). 
 
Acquired Vulnerability 
CES-D Depressive 
Symptoms Scores 
r (p value) 
EPDS Depressive 
Symptoms Scores 
r (p value) 
Income .14(.29) -.04(.76) 
Educational Level .17(.19) .17(.18) 
Alcohol and/or Drug Use .28(.03)* .24(.06) 
HIV Disclosure Status -.15(.24) -.12(.38) 
History of Sexual Assault .24(.06) .18(.16) 
Sleep Quality .69(<.0001)* .63(<.0001)* 
 
Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh 
Postnatal Depression Scale. The symbol r refers to Pearson Correlation. A priori alpha 
for the study was p≤ 0.05. 
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 Pregnant African American women who were HIV-positive were assessed. The 
influence of inherited vulnerabilities (e.g. family history of mood disorders, family 
history of alcohol and/or drug use) on anxiety symptoms among pregnant African 
American women who were HIV positive was examined using correlation statistics.  
 
Family history of mood disorders was dummy coded, with no family history of 
mood disorders coded as 0 and positive family history of mood disorders coded as 1.  
Family history of mood disorders was significantly correlated with anxiety symptoms on 
the BAI (r = 0.64; p = 0.003).  Thus, a positive family history of mood disorders was 
associated with greater anxiety scores in this group of pregnant African American 
women who were HIV-positive. 
 
Family history of alcohol and/or drug use was captured on the Demographic 
Questionnaire. Results were dummy coded for categorization, with no family history of 
alcohol and/or drug use (coded as 0) and positive family history of alcohol and/or drug 
use (coded as 1).  Family history of alcohol and/or drug use was not significantly 
correlated with anxiety symptoms in this group of pregnant women (r = 0.35; p = 0.13). 
Table 4.15 provides an illustration of these results.  
 
Correlation statistics were used to examine the association of acquired 
vulnerabilities (educational level, income level, alcohol and/or drug use, HIV disclosure 
status, sleep quality, history of sexual abuse or assault) to anxiety symptoms among 
pregnant African American women who are HIV positive.  
 
Educational level was captured on the demographic questionnaire in a categorical 
fashion. As with the previous analyses, four categories were collapsed into two 
categories, less than HS/GED (coded as 0) and HS/GED or greater (coded as 1). Most of 
the participants reported educational levels in these categories.  Educational level was 
negatively correlated with elevated anxiety symptoms when measured with the BAI 
however, the association was non-significant (r = -0.6; p = 0.81) in this group of 
pregnant African American women who were HIV-positive.  
 
Income level was captured on the Demographic Questionnaire as annual 
household income in a categorical fashion. As with earlier analyses, five categories were 
collapsed into two, illustrating less than $5000 per year (coded as 0) and $5000 per year 
or greater (coded as 1). Income level was not significantly correlated with anxiety 
symptoms when measured be the BAI (r = 0.12; p = 0.66) in this group of pregnant 
African American women who were HIV-positive. 
 
Alcohol and/or drug use was captured on the Demographic Questionnaire. 
Dummy coding was implemented to signify no substance use (coded as 0) or positive 
substance use (coded as 1). Substance use had a positive but statistically non-significant 
correlation with anxiety scores on BAI (r = 0.25; p = 0.3). 
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Table 4.15  Pearson  Correlation (r) Analysis between Inherited Vulnerabilities and 
Anxiety Symptoms for Pregnant African American Women Who Were HIV-positive  
(n = 20). 
 
Inherited Vulnerability Anxiety Symptom (BAI) Scores 
r (p value) 
Family History of Mood Disorders .64 (.0003)* 
Family History of Alcohol/Drug Use .35 (.13) 
 
Note: BAI= Beck Anxiety Inventory. Study a priori alpha was *p≤.05. 
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 Disclosure of HIV status was measured on the Demographic Questionnaire. 
Dummy coding was implemented to signify no disclosure to others (coded as 0) or 
disclosure to others (coded as 1). HIV disclosure status was positively and significantly 
correlated with anxiety symptoms when measured by the BAI (r = 0.52; p = 0.02). Thus, 
pregnant HIV-positive African American women in the sample who disclosed their HIV 
status had significantly higher anxiety scores (more severe anxiety symptoms) than 
women who had not disclosed their status. 
 
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater 
indicating poor sleep quality. In this group of pregnant women, there was a significant 
positive correlation between sleep quality and anxiety symptoms on the BAI (r =  0.68; p 
= 0.001). Thus, women with greater sleep quality scores (poorer sleep quality) also had 
greater anxiety scores (more severe anxiety) in this group of pregnant African American 
women who were HIV-positive. 
 
History of sexual abuse or assault was measured and responses were dummy 
coded as no history of sexual abuse or assault (coded as 0) or history of sexual abuse or 
assault (coded as 1). History of sexual abuse or assault was positively correlated with 
anxiety scores on the BAI (r = 0.33; p = 0.16), but this finding was not statistically 
significant at the p < 0.05 level.  Thus, history of sexual abuse or assault was not 
significantly related to anxiety symptoms in this group of pregnant African American 
women who were HIV-positive.  Table 4.16 illustrates a summary of the correlation 
results for this group of pregnant women who were HIV-positive. 
 
Non-pregnant African American women who were HIV-positive women were 
assessed and associations between inherited vulnerabilities (e.g. family history of mood 
disorders, family history of alcohol and/or drug use) and anxiety symptoms examined 
using correlation analyses. Anxiety symptoms were measured using the BAI.  Family 
history of mood disorders was dummy coded 1 or 0, respectively if the characteristic was 
present or absent. Family history of mood disorders was positively correlated with 
anxiety symptoms (r = 0.33; p = 0.0093). Non-pregnant women with a positive family 
history of mood disorders had significantly higher anxiety scores (mean BAI score 16.77) 
than women who did not have a family history of these disorders (mean BAI score 8.6).  
 
Family history of alcohol and/or drug use was not correlated with anxiety 
symptoms (r = 0.19; p = 0.14). Women who had a positive family history of alcohol 
and/or drug use reported more anxiety symptoms (mean BAI score 14.59) than women 
who had no family history (mean BAI score 9.86). Table 4.17 shows correlation results 
of inherited vulnerabilities with anxiety symptoms in the non-pregnant study participants, 
with family history of mood disorders being associated with higher BAI scores. 
 
The influence of acquired vulnerabilities (e.g. educational level, income level, 
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or 
assault) on anxiety symptoms among non-pregnant African American women who were 
HIV positive was examined using correlation analyses. 
84 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.16  Pearson Correlation (r) Analysis between Acquired Vulnerabilities and 
Anxiety Symptoms for Pregnant African American Women Who Were HIV-positive  
(n = 20). 
 
Acquired Vulnerability 
Anxiety Symptoms  
(BAI Scores) 
r (p value) 
Alcohol and/or Drug Use .25 (.30) 
Educational Level .6 (.81) 
Income .12(.66) 
HIV Disclosure Status .52 (.002)* 
Sleep Quality .68(.0010)* 
History of Sexual Assault .33(.16) 
 
Note: BAI=Beck Anxiety Inventory. Study a priori alpha was *p≤.05. 
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Table 4.17  Pearson  Correlation (r) Analysis between Inherited Vulnerabilities and 
Anxiety Symptoms for Non-Pregnant African American Women Who Were HIV-
positive (n = 60). 
 
Inherited Vulnerability 
Anxiety Symptom  
(BAI) Scores 
r (p value) 
Family History of Mood Disorders .33(.0093)* 
Family History of Alcohol/Drug Use .19 (.14) 
 
Note: BAI= Beck Anxiety Inventory. A priori alpha was *p≤.05. 
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 Educational level was captured in a categorical fashion. Most of the sample fell 
into two main categories: less than HS/GED or HS/GED or greater, the four categories 
were collapsed into these two categories for statistical analysis. Educational level was not 
significantly correlated with anxiety symptoms when measured with the BAI in this 
group of non-pregnant women who were HIV positive (r = 0.1; p = 0.44).   
 
Income level was captured in a categorical fashion on the Demographic 
Questionnaire as annual household income. Two main categories of income were present 
in the sample. Dummy coding was implemented to signify income less than $5000 per 
year (coded as 0) and $5000 per year or greater (coded as 1). Income level was not 
significantly correlated with anxiety symptoms when measured with the BAI (r = 0.21; p 
= 0.12) in this group of non-pregnant African American women who were HIV-positive. 
 
Substance use was coded 0 if the characteristic was absent and 1 if present. 
Substance use had a positive correlation with anxiety scores on BAI (r = 0.24). The 
strength of this correlation was weak, and was not statistically significant (p = 
0.06).Thus, a history of substance use was not significantly associated with higher 
anxiety scores for this group of non-pregnant women. 
 
Disclosure of HIV status was reported on the Demographic Questionnaire as the 
number of persons to whom the participant had disclosed her HIV status. Dummy coding 
was implemented to signify no disclosure to others as a score of 0 or disclosure to others 
as a score of 1. HIV disclosure status was not significantly correlated with anxiety 
symptoms when measured by the BAI (r = -0.0072; p = 0.96) in this group of non-
pregnant African American women who were HIV-positive. 
 
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater 
indicating poor sleep quality. In this group of non-pregnant women, there was a 
significant positive correlation between sleep quality and anxiety symptoms on the BAI 
(r = 0.69; p <.0001). Thus poorer sleep quality was significantly associated with more 
anxiety symptoms in this group of non-pregnant women.  
 
History of sexual abuse or assault was measured on the Demographic 
Questionnaire. Responses were dummy coded as no history of sexual abuse or assault 
(coded as 0) or history of sexual abuse or assault (coded as1). A history of sexual abuse 
or assault was not significantly correlated with anxiety scores on the BAI (r= 0.15; p = 
0.26) in this group of non-pregnant African American women who were HIV-positive. 
Table 4.18 provides a summary of these correlation analyses. 
 
 
AIM FOUR 
Examine the influence of inherited vulnerabilities (family history of mood 
disorders, family history of alcohol and/or drug use) and acquired vulnerabilities 
(educational level, income status, alcohol and/or drug use, HIV disclosure status, sleep 
quality,  
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Table 4.18  Pearson Correlation (r) Analysis between Acquired Vulnerabilities and 
Anxiety Symptoms for Non-Pregnant African American Women Who Were HIV-
positive (n = 60). 
 
Acquired Vulnerability 
Anxiety Symptoms (BAI Scores) 
r (p value) 
Alcohol and/or Drug Use .24 (.06) 
Educational Level .10 (.44) 
Income .21 (.12) 
HIV Disclosure Status -.01 (.96) 
Sleep Quality .69 (<.0001)* 
History of Sexual Assault .15 (.26) 
 
Note: BAI=Beck Anxiety Inventory. Study a priori alpha was *p≤.05. 
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 history of sexual abuse or assault) on depressive symptoms in non-pregnant African 
American women who were HIV-positive. 
 
In the current study, variables were identified as appropriate for entry as 
predictors into the multiple regression model through the use of Pearson correlation 
coefficients. Pearson correlation coefficients were estimated between dependent variables 
(depressive symptoms as measured by total CES-D scores) and independent variables 
(inherited and acquired vulnerabilities). Statistically significant correlations were 
identified as those with a p value ≤ 0.2. Only one independent inherited variable, family 
history of mood disorder met this criterion and was entered into the stepwise equation. 
Stepwise multiple regression analyses with backward elimination were performed and 
variables were eliminated if the variable was ≥ .20 p-value. In stepwise multiple 
regression analyses, all independent variables were entered one by one into the regression 
model, and then one by one, each variable is deleted in order to identify a significant drop 
in R2 (Penhazur & Schmelkin, 1991). The stepwise approach with backward elimination 
was selected in order to illustrate the power of a single independent variable on the 
dependent variables (depressive and anxiety symptoms).   
 
For regression analysis, family history of mood disorders was the only inherited 
variable that remained in the model. However, neither the model, nor the predictor, 
family history of mood disorders, was statistically significant. Only 4% of the adjusted 
variance in depressive symptom scores was explained by a positive family history of 
mood disorder. Table 4.19 illustrates simple regression analysis for depressive symptoms 
as measured by CES-D scores in this sample of non-pregnant women.  
 
The same statistical analyses were conducted to examine the influence of 
inherited vulnerabilities on depressive symptoms as measured by total EPDS scores. Two 
variables were entered into the stepwise equation (family history of mood disorders and 
family history of alcohol and/or drug use) because Pearson correlation coefficients were 
significant at the ≤ .20 level. Backward elimination was performed and independent 
variables were eliminated if the individual variable was ≥ .20 p-value. The only variable 
eliminated from the model was family history of mood disorder. The final model retained 
family history of substance use; however, neither the predictor nor the model was 
statistically significant. Only 5% of the variance in depressive symptom scores was 
explained by a positive family history of substance use. Table 4.20 illustrates the 
complete simple regression results for the influence of inherited vulnerabilities on 
depressive symptoms as measured by the EPDS. 
 
Based on the zero-order correlations, the acquired vulnerabilities (educational 
level, income level, alcohol and/or drug use, HIV disclosure status, sleep quality, history 
of sexual abuse or assault) were entered into the first regression model conducted to 
predict depressive symptoms using the CES-D.  
 
Four variables were entered into the stepwise equation (educational level, alcohol 
and/or drug use, sleep quality, and history of sexual abuse or assault) as they met the 
previously described selection criteria. Two variables were eliminated from the model, 
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Table 4.19  Summary of Stepwise Simple Regression Analysis by Backward 
Elimination for Depressive Symptom Scores Using the CES-D* among Non-
Pregnant African American HIV-positive Women (n = 60). 
 
 
Predictor 
Parameter 
Estimate SE p 
Intercept 16.421053 1.995271 8.23 <.0001 
Family History of Mood 
Disorders 
5.9425837 3.295081 1.80 0.0765 
 
Note. R2 =0.0531; adjusted R2 =0.036774, df =59; CES-D = Center for 
Epidemiologic Studies Depression Scale. Predictor variable classified as an inherited 
vulnerability 
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Table 4.20  Summary of Stepwise Simple Regression Analysis by Backward 
Elimination for Depressive Symptoms Measured by EPDS* among Non-Pregnant 
African American HIV-positive Women (n = 60). 
 
Predictor 
Parameter 
Estimate SE t p 
Intercept 7.78947 1.155712 6.74 <.0001 
Family History of 
Alcohol/Drug Use 
3.7105263 1.908595 1.94 0.0567 
 
Note. R2 = 0.0612, adjusted R2 = 0.045, df =58;  
*EPDS= Edinburgh Postnatal Depression Scale. Predictor variable is classified as an 
inherited vulnerability 
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 educational level and history of sexual abuse or assault. The final model retained 
substance use and sleep quality and both predictors as well as the model were statistically 
significant. Substance use was significant at the p = .0020 level, indicating that a positive 
history of substance abuse was significantly associated with higher depressive symptom 
levels on the CES-D. Sleep quality was significant at the p < .0001 level, indicating that 
poorer sleep quality was significantly associated with higher depressive symptom levels 
on the CES-D. Thus, both predictors and the model were significant (Model statistics R2 
= .5451, df = 57, p < .0001). Greater depressive symptoms were associated with a history 
of substance use and poorer sleep quality. Table 4.21 provides a summary of multiple 
regression analysis results. 
 
Based on the zero-order correlations, the acquired vulnerabilities (educational 
level, income level, alcohol and/or drug use, HIV disclosure status, sleep quality, history 
of sexual abuse or assault) were entered into the second regression model. Stepwise 
multiple regression with backward elimination was conducted to predict depressive 
symptoms using the EPDS. Three variables were entered into the stepwise equation 
(substance use, educational level, and sleep quality). The only variable eliminated from 
the model was educational level. The final model retained substance use and sleep quality 
and both predictors and the model were statistically significant. Substance abuse was 
significant at the p = .0145 level, indicating that a positive history of substance abuse was 
significantly associated with higher depressive levels on the EPDS total score. Sleep 
quality was significant at the p < .0001 level, indicating that poorer sleep quality was 
significantly associated with higher depressive symptom levels on the EPDS total score. 
Acquired vulnerabilities accounted for 46% of the variance in EPDS total score. The 
regression model for depressive symptoms indicated that substance use and sleep quality 
were the significant acquired vulnerabilities that influenced the EPDS total score. In 
contrast, education level was not a significant predictor of depression. See Table 4.22 for 
complete model results. 
 
 
AIM FIVE 
Examine the influence of inherited vulnerabilities (family history of mood 
disorders, and family history of alcohol and/or drug use) and acquired vulnerabilities 
(educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep 
quality, and history of sexual abuse or assault) on anxiety symptoms in non-pregnant 
African American women who are HIV-positive. Although anxiety symptom levels were 
relatively low, regression analyses were completed for prediction purposes. 
 
Stepwise multiple regression analysis with backward elimination was used to 
answer this question. In order to identify the most appropriate variables for entry as 
predictors into the regression model, Pearson correlation coefficients were estimated 
between outcome variables and predictor variables. Using the bivariate results obtained in 
correlation analyses, separate multiple regression analyses with backward elimination 
were conducted for inherited and acquired vulnerabilities with the outcome variable (BAI  
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Table 4.21  Summary of Stepwise Multiple Regression Analysis by Backward 
Elimination for Depressive Symptoms Measured by CES-D among Non-Pregnant 
African American HIV-positive Women (n = 60). 
 
Predictor 
Parameter 
Estimate SE t p 
Intercept 2.3882439 2.201078 1.09 0.2825 
Alcohol and/or Drug Use 7.199529 2.227402 3.23 0.0020 
Sleep Quality 1.7276818 0.218227 7.92 <0.0001 
 
Note. R 2 = .5731, Adjusted R 2 = .5420, df=55. Predictor variables are classified as 
acquired vulnerabilities.  
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Table 4.22  Summary of Stepwise Multiple Regression Analysis by Backward 
Elimination for Depressive Symptoms Measured by EPDS among Non-Pregnant African 
American HIV-positive Women (n = 60). 
 
Predictor 
Parameter 
Estimate SE t p 
Intercept 0.6813078 1.428049 0.48 0.6351 
Alcohol and/or Drug Use 3.6451532 1.445128 2.52 0.0145 
Sleep Quality 0.9085051 0.141584 6.42 <0.0001 
 
Note. R2 = .46, Adjusted R2 = .4344, df=56. Predictor variables classified as acquired 
vulnerabilities. EPDS = Edinburgh Postnatal Depression Scale.   
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 scores to assess anxiety).  
 
Two inherited vulnerabilities were entered into the stepwise equation, family 
history of mood disorders and family history of substance use, because Pearson 
correlation coefficients were significant at the ≤ .20 level. Backward elimination was 
performed and variables were eliminated if the individual variable was ≥ .20 p-value. The 
only variable eliminated from the model was family history of substance use. The final 
model retained family history of substance use, which was non-significant (p = .1402). 
Table 4.23 depicts complete multiple regression results for this model. 
 
The influence of acquired vulnerabilities on anxiety symptoms among non-
pregnant African American women who were HIV-positive was examined using 
stepwise multiple regression analysis with backward elimination. In order to identify 
which predictors could be used for regression analyses, Pearson correlation coefficients 
were estimated between outcome variables and acquired vulnerabilities. Statistically 
significant correlations were identified, and these items were used in the multiple 
regression analysis. Although there were six hypothesized predictor variables identified 
as potential acquired vulnerabilities, only alcohol and/or drug use and sleep quality were 
significantly correlated with anxiety and included in the regression analyses.  
 
Backward elimination was performed and variables were eliminated if the 
individual variable was ≥ .20 p-value. Neither variable was eliminated from the model. 
Substance use was significant at the p = .0073 level, indicating that a positive history of 
alcohol and/or drug use was significantly associated with higher anxiety symptom levels 
on the BAI. Sleep quality was significant at the p ≤ 0.05 level, indicating that poorer 
sleep quality was significantly associated with higher anxiety symptom levels as 
measured by the BAI. Thus, both predictors and the model were significant (Model 
statistics R2 = .5259, F = .33.72, df = 2, p < .0001).Thus, greater anxiety symptoms were 
associated with alcohol and/or drug use and poorer sleep quality. Table 4.24 provides a 
summary of the model statistics. 
 
Regression diagnostic analyses were performed to evaluate bivariate relationships 
between predictor variables included in the multiple regression analyses. The use of 
highly intercorrelated variables should be avoided, as their influence on one another 
limits individual predictor strength. Schroeder (Schroeder, 1990) and Fox (Fox, 1997) 
provide suggestions regarding identification of multicollinearity. For each predictor 
variable in the regression model, correlation coefficients should be identified. Potential 
problems may exist if there is a high correlation coefficient that exists between variables. 
Schroeder (Schroeder, 1990) and Fox (Fox, 1997) also suggest using methods such as 
estimating tolerance to test the validity of regression models. Variance inflation factor 
analysis is also useful to detect multicollinearity. A tolerance close to zero is indicative of 
collinearity; a variance inflation factor < 10 is indicative of no significant collinearity. 
For the current study a tolerance level less than .20 and variance inflation factor greater 
than 4.0 were indicative of significant collinearity.
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Table 4.23  Summary of Stepwise Multiple Regression Analysis by Backward 
Elimination for Anxiety Symptoms Measured by BAI among Non-Pregnant African 
American HIV-positive Women (n = 60). 
 
Predictor 
Parameter 
Estimate SS F p 
Intercept 8.10954 0 0.00000 1.0000 
Family History of Mood 
Disorders 
7.42638 672.1055 5.187 0.0265* 
Family History of 
Alcohol/Drug Use 
2.09305 53.38781 0.412 0.5235 
 
Note. R2 = 0.1174, adjusted R2 = 0.0865, df =57, p =.1402. Predictor variables are 
classified as inherited vulnerabilities. BAI = Beck Anxiety Inventory 
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Table 4.24  Summary of Stepwise Multiple Regression Analysis by Backward 
Elimination for Anxiety Symptoms Measured by BAI among Non-Pregnant African 
American HIV-positive Women (n = 60). 
 
Predictor 
Parameter 
Estimate SS F p 
Intercept -3.46575 0.000 1.000  
Alcohol and/or Drug Use 6.01172 520.394 7.739 0.0073 
Sleep Quality 1.64074 4038.277 60.051 0.0000 
 
Note. R 2 = .5420, Adjusted R 2 = .5259, df=57, p < .0001 Predictor variables are 
classified as acquired vulnerabilities. BAI = Beck Anxiety Inventory 
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 For each predictor variable used in this study, tolerance and variance inflation 
factor was examined. Tables 4.25 through 4.28 illustrate regression diagnostic analyses 
suggesting that multicollinearity was present at acceptable levels in the study models. 
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Table 4.25  Collinearity Diagnostics for the Model of Inherited Vulnerabilities and 
Anxiety Symptoms (n=60). 
 
Variable df Tolerance 
Variance Inflation 
Factor 
Intercept 1  0.0000 
Family History of Mood Disorders 1 .8898 1.2385 
Family History of Alcohol/Drug Use 1 .8898 1.2385 
 
Note. Tolerance levels less than .20 and variance inflation factor levels greater than 
4.0 indicative of significant collinearity. 
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Table 4.26  Collinearity Diagnostics for the Model of Acquired Vulnerabilities and 
Anxiety Symptoms  (n=60). 
 
Variable df Tolerance 
Variance Inflation 
Factor 
Intercept 1 . 0.0000 
Alcohol and or Drug Use  1 .9999 1.0001 
Sleep Quality  1 .9999 1.0001 
 
Note. Tolerance levels less than .20 and variance inflation factor levels greater than 
4.0 indicative of significant collinearity.  
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Table 4.27  Collinearity Diagnostics for the Model of Depression as Measured with 
the Center for Epidemiologic Depression Scale and Acquired Vulnerabilities (n=60). 
 
Variable df Tolerance 
Variance Inflation 
Factor 
Intercept 1  .0000 
Alcohol and or Drug Use 1 .9360 1.068444 
Education Level 1 .9689 1.0321 
Sleep Quality 1 .94503 1.0582 
History of Sexual Assault 1 .9001 1.1109 
 
Note. Tolerance levels less than .20 and variance inflation factor levels greater than 
4.0 indicative of significant collinearity. 
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Table 4.28  Collinearity Diagnostics for the Model of Caregiver Depression as 
Measured with the Edinburg Postnatal Depression Scale and Acquired Vulnerabilities 
(n=60). 
 
Variable df Tolerance 
Variance Inflation 
Factor 
Intercept 1 . .0000 
Alcohol and or Drug Use 1 .9979 1.0021 
Education Level 1 .9786 1.0219 
Sleep Quality 1 .9806 1.0198 
 
Note. Tolerance levels less than .20 and variance inflation factor levels greater than 
4.0 indicative of significant collinearity. 
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 CHAPTER 5. DISCUSSION AND IMPLICATIONS 
DISCUSSION 
 The systematic investigation of predictors of depressive and anxiety symptoms 
among African American HIV-positive women has been understudied. Thus, the aims of 
this study were to identify the levels of depressive and anxiety symptoms and the 
predictors of depressive and anxiety symptoms in African American women who were 
HIV-positive and receiving health care in a mid-southern city in the United States. While 
preliminary, these findings provide direction that can help health care providers recognize 
HIV-positive women who are at increased risk for the development of mood disorders.  
 
 
DEMOGRAPHIC FINDINGS  
 The majority of the women in the present study were poor and unmarried. Most 
participants reported their marital status as single (n=14, 70% pregnant vs. n=32, 53.3% 
non-pregnant). A few of the non-pregnant group (n=6, 10%) were widowed. One woman 
reported AIDS as the cause of her spouse’s death; another woman reported that her 
husband committed suicide after she was hospitalized and diagnosed with AIDS. This 
participant also reported that after the suicide, she learned that her husband knew about 
his HIV diagnosis for many years prior to her diagnosis.  
 
Almost half (49%) of the total sample of pregnant and non-pregnant women 
reported annual household incomes of less than $5000, (63% of the pregnant women; 
44% of the non-pregnant women). Almost one-half (47.3%) of the total sample was 
unemployed, whereas 45% of the total sample reported part-time employment. Levels of 
disability were not assessed for this sample of women; however disability could explain 
the high prevalence of unemployment reported by study participants. These results are 
similar to findings of regional HIV demographic results, indicating that HIV is a disease 
that significantly affects southern, minority women who are poor (Centers for Control 
and Prevention, 2007; Centers for Disease Control and Prevention, 2007b, 2007c; Reif, 
Whetten, Ostermann, & Raper, 2006).  
 
Levels of disability were not assessed for this sample of women; however 
disability could explain the high prevalence of unemployment reported by study 
participants. These results are similar to findings of regional HIV demographic results, 
indicating that HIV is a disease that significantly affects southern, minority women who 
are poor (Centers for Disease Control and Prevention, 2005, 2007b, 2007c; Reif et al., 
2006; U. S. Census Bureau, 2006). Participants in the current study were recruited from 
ambulatory clinics located within a public safety net hospital, adding to the likelihood 
that the sample would consist of predominately poor women. 
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 AIM ONE. LEVELS OF DEPRESSIVE AND ANXIETY SYMPTOMS  
Depressive Symptoms 
Scores on the CES-D and EPDS defined depressive symptoms in the current 
study. Although most participants denied feeling depressed in the two weeks prior to 
completion of the questionnaires, approximately 50% of participants in the sample had 
both CES-D and EPDS scores requiring referral to the social worker (e.g. case manager). 
Denial of depressive symptoms could be related to the fear and stigma of mental illness 
that is pervasive within many African American communities. Sussman and colleagues 
(Sussman, Robins, & Earls, 1987) found that the proportion of African Americans who 
feared mental health treatment was 2.5 times greater than the proportion of whites. 
Research indicates that African Americans are more likely to be diagnosed with severe 
mental illnesses like paranoid schizophrenia and less likely to be diagnosed with affective 
disorders than their white counterparts (Adebimpe, 1981; Bolden & Wicks, 2005; 
Neighbors et al., 1989). Stigma contributes to delays in seeking mental health care and 
treatment. Moreover, African Americans are more likely to use non-psychiatric services 
such as prayer, primary care, and emergency services, rather than seek specific mental 
health treatment (United States Department of Health and Human Services, 1999; K. 
Wells et al., 2001)  
 
The clinically relevant depressive symptom scores found in this sample could 
reflect the overlap seen between symptoms of depression and symptoms of chronic 
illness. Overlapping symptoms for depression and HIV include poor appetite, weight 
loss, fatigue, and poor sleep (Kalichman, Rompa, & Cage, 2000). The CES-D captures 
depressed affect, positive affect, and somatic complaints, however, researchers have 
illustrated similar factors in HIV-symptomatic persons (Cochran & Mays, 1994) , which 
may have resulted in inflated depressive symptoms scores on  the CES-D in symptomatic 
HIV-positive persons (Kalichman et al., 2000). The mean CD4 count in this sample was 
over 500, reflecting a clinically stable population, although HIV specific symptoms were 
not assessed in this study.  Some of the women who had elevated depressive symptom 
scores may have been clinically depressed and were referred for further evaluation. Two 
of the women were immediately assessed by their provider and started on antidepressants 
the day of their participation. Researchers have found similar rates of depressive 
symptoms in HIV positive women (Ickovics et al., 2001; McDaniel, Fowlie, 
Summerville, Farber, & Cohen-Cole, 1995) . 
 
The non-pregnant group of women in the present study had a higher level of 
depressive symptoms than the pregnant group of women. These results may be attributed 
to the fact that the non-pregnant group had a longer duration of HIV diagnoses. While 
this longer duration could provide time to accept the diagnosis, many of these women 
experienced multiple illness-related life events that potentially contributed to higher 
depressive symptom levels. Specifically, this group of non-pregnant women more often 
reported losing partners to AIDS, which may account for higher levels of depressive 
symptom scores. Pregnant women in the study might have felt greater hope and optimism 
than the non-pregnant group. In a meta-analysis of qualitative research (Sandelowski & 
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 Barroso, 2003), HIV-positive women reported that motherhood gave them a sense of 
identity, reason to improve their lives, strength, hope, and joy. However these qualitative 
results do not account for the greater depressive symptoms reported by non-pregnant 
participants who were also mothers. HIV-positive mothers have reported negative 
impacts of their disease, specifically the stigma associated with the disease, negative 
impact of HIV on their children, and guilt associated with possible transmission of HIV 
to their children (Sandelowski et al., 2003). HIV-positive women have also reported a 
fear of disapproval from others when they decide to have children (Sandelowski et al., 
2003). In the current study, pregnant participants’ depressive symptoms scores could 
have been influenced by the hope that their unborn babies would not be HIV-infected; 
however this information was not elicited from the study sample. 
 
Anxiety Symptoms 
 Although depressive and anxiety symptoms often occur  simultaneously in the 
general population, the present study did not confirm the coexistence of clinically 
relevant levels of both symptom types. The levels of depressive symptoms were clinically 
relevant in both groups of women, while anxiety symptoms were in general uncommon in 
both groups. Most (83%) of the sample had BAI scores of less than 22, which is 
indicative of little or no anxiety (A. T. Beck et al., 1988). Only three women (15%) in the 
group of 20 pregnant women had BAI scores at or above a clinically relevant level 
compared to eight non-pregnant women (13%). Conversely, almost half of the total 
sample of 80 women had CES-D scores (52.46%) and EPDS scores (48.75%) indicating 
the need for referral and additional assessment of depressive symptoms.  
 
National data related to the co-morbidity of depressive and anxiety symptoms in 
the general population (Hirschfeld, 2001; R. C. Kessler, McGonagle, Nelson et al., 1994) 
indicate higher incidence rates than reported in the current sample of women. Kessler and 
colleagues (R. C. Kessler, McGonagle, Nelson et al., 1994) reported a 10.3% prevalence 
rate for depression, while the prevalence rate for generalized anxiety disorder was 3.1%. 
In a second larger study (N=9282), Kessler and colleagues (R. C. Kessler et al., 2005) 
reported anxiety as the most prevalent DSM-IV disorder in the general population 
(18.1%), with over half of the participants having more than one disorder. In another 
study, 75% of patients diagnosed with major depressive disorder in the primary care 
setting also had an anxiety disorder (Olfson et al., 2000). Thus, the prevalence rate of 
anxiety symptoms in the current study was lower than that of the general population. A 
possible explanation for this finding is the underreporting of symptoms of anxiety. 
Evidence suggests that persons are likely to underreport symptoms that they perceive as 
embarrassing (R. C. Kessler et al., 2002; Merikangas et al., 1998). While these findings 
were unexpected, it is unclear if the low levels of anxiety symptoms occurred because 
women with significant depressive symptoms did not have clinical depression. Anxiety 
typically precedes depression (Zimmerman & Chelminski, 2003). This point is 
particularly important as the depressive symptom instruments used in this study are 
screening tests rather than diagnostic tests. Clinically significant depressive symptom 
scores on screening tests may reflect a false positive score which is especially common in 
populations in which chronic illness symptoms overlap with symptoms of depression 
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 (Cavanaugh, Clark, & Gibbons, 1983). Although the current study revealed low levels of 
anxiety symptoms in the presence of clinically important depressive symptoms, the 
continued assessment of both anxiety and depression is warranted due to national trends 
documenting their coexistence (R. C. Kessler et al., 2005).   
 
 
AIM TWO. ASSOCIATIONS AMONG INHERITED AND ACQUIRED 
VULNERABILITIES AND DEPRESSIVE SYMPTOMS 
Inherited Vulnerabilities and Depressive Symptoms 
Non-pregnant women in the study sample with a positive family history of mood 
disorders, an inherited vulnerability, did not report associated increases in depressive 
symptom scores as measured by the CES-D or the EPDS. Similarly, non-pregnant women 
in the study sample with a positive family history of alcohol and/or drug use, an inherited 
vulnerability, did not report associated increases in depressive symptom scores as 
measured by the CES-D or the EPDS.  Of the 80 women participating in this study only 
26 reported a positive family history of alcohol and/or drug use. Additionally, the use of 
dummy-coding that was implemented for the categorization of family history results 
(presence or absence of the variable) limited the variability needed to show significant 
correlations, as the value for the score was either 0 or 1.  
Inherited vulnerabilities revealed similar mixed associations with depressive 
symptom scores in the group of pregnant women. Family history of mood disorders was 
significantly and positively associated with higher levels of depressive symptoms on both 
the CES-D and EPDS scores, however, no association was found between family history 
of alcohol and drug use and depressive symptom scores in this group of 20 pregnant 
women.  These findings were surprising given that research in the general population has 
consistently indicated a link between depressive symptoms and a positive family history 
of both mood disorders and alcohol/drug use (Gutman & Nemeroff, 2003; King et al., 
2006; Kosten et al., 1992; Weissman et al., 2005). Alternative explanations for these 
findings may be denial of family history of alcohol and/or drug use or embarrassment, 
which could have lead to underreporting of family histories of alcohol and/or drug use. 
Of the 80 women participating in this study only 26 reported a positive family history of 
alcohol and/or drug use; a similar number (n= 28) reported a family history of mood 
disorder. For a correlation to be found between variables that are scored as 0 or 1 (the 
presence or absence of the variable of interest) there must be sufficient numbers of 
persons with and without the variable of interest to detect this association. 
 
Acquired Vulnerabilities and Depressive Symptoms 
 Women who reported a positive history of personal alcohol and/or drug use and 
poor sleep quality as indicators of acquired vulnerabilities had higher levels of depressive 
symptoms on both the CES-D and EPDS, in both groups of women (pregnant and non-
pregnant). These findings are consistent with the literature, with correlations between 
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 alcohol and drug use and depressive symptoms reported in women (Darko, McCutchan, 
Kripke, Gillin, & Golshan, 1992; Darko, Mitler, & Miller, 1998; Dixit & Crum, 2000; 
Mock et al., 2002; Norman et al., 1992; Penzak, Reddy, & Grimsley, 2000; Reardon & 
Buka, 2002; Schutte et al., 1995; Tam, Weisner, & Mertens, 2000; K. Wells et al., 2001), 
and African American populations (Reardon & Buka, 2002; Tam et al., 2000; K. Wells et 
al., 2001). 
 
Poor sleep quality and depressive symptoms have also been well-documented in 
the literature (Neubauer, 2004). Clinically relevant depressive symptom scores were 
found on the CES-D and EPDS in both groups (non-pregnant and pregnant) of women 
that had PSQI scores above the cut-off (≥5). Most all of the women with clinically 
relevant PSQI scores had scores above the study mandated cutoffs for both the CES-D 
and EPDS. Results of the current study largely parallel published research with regard to 
poor sleep quality and depressive symptoms in HIV-positive women (Lee et al., 2001) 
and HIV-positive men (Perkins et al., 1994). Only seven women in the sample had 
clinically relevant PSQI scores without clinically relevant CES-D or EPDS scores. This 
strong association between sleep quality and depressive symptoms however could reflect 
sleep difficulties related to HIV, side effect of medications, or poor sleep environment 
(Darko et al., 1992; Darko et al., 1998; Mock et al., 2002; Norman et al., 1992; Penzak et 
al., 2000; Reardon & Buka, 2002; Tam et al., 2000; K. Wells et al., 2001). Although 
causal relationships are difficult to infer, poor sleep quality and depressive symptoms are 
often concomitant problems, with one contributing to the other. 
 
HIV disclosure status was significantly correlated with higher depressive 
symptom scores on the CES-D, but not the EPDS, in the group of pregnant women. The 
CES-D has a much wider scoring range than the EPDS, which may make it easier to find 
a significant association between depressive symptom levels and HIV disclosure status.  
When diagnostic criteria for depression according the DSM-IV are compared to the 
screening content of the CES-D and EPDS, both instruments target the same symptoms.  
 
The clinically relevant depressive symptom scores on the EPDS in the population 
of pregnant women that had disclosed their HIV status was surprising. This finding was 
unexpected as the act of disclosure was hypothesized to decrease depressive symptoms, 
increase support services and networks, thereby decreasing depressive symptoms 
(Schmidt & Goggin, 2002; D. K. Smith et al., 1996). However, Schmidt and Goggin 
(Schmidt & Goggin, 2002) reported that the HIV-positive single mothers in their study 
reported less satisfaction from the disclosure process, lower levels of perceived social 
support, and higher levels of depressive symptoms, findings that were different than the 
majority of positive results associated with disclosure. Moreover, the majority of the 
sample in the current study was single and mothers, offering support to Schmidt and 
Goggin’s (Schmidt & Goggin, 2002) results, as well as a plausible explanation for these 
findings.  
 
Additional alternative reasons for inconsistent results include the small sample 
size (which may not adequately reflect the experiences of the population) and the feelings 
of shame and abandonment that could have been felt by those women that had exposed 
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 their HIV to others. HIV is a disease that is not viewed by others with sympathy and 
support unlike other diseases such as cancer. When a disease, such as HIV, is frequently 
acquired through behavioral choices, the resulting perception may be that the person 
“deserves” the disease. If this is the perception, psychological and social support may be 
withheld. These confounding findings are noteworthy. Sensitivity of instrumentation 
should be evaluated when instruments designed to measure the same variable reveal 
different results. Mosack and Shore (Mosack & Shore, 2003) reported that the CES-D 
identified higher numbers of women with depressive symptoms than the EPDS when 
administered to the same group of women. Although the family history of the sample in 
Mosack and Shore’s study (Mosack & Shore, 2003) was not discussed, the affect of 
family history cannot be ignored, and could have impacted their study results.  
 
AIM THREE. ASSOCIATIONS AMONG INHERITED AND ACQUIRED 
VULNERABILITIES AND ANXIETY SYMPTOMS 
Inherited Vulnerabilities and Anxiety Symptoms 
Women in the present study (N = 80) who reported inherited vulnerabilities of 
family history of mood disorders had higher BAI scores than women who did not report 
family history of mood disorders. Similar findings were noted for women who reported a 
positive history of family history of alcohol and/or drug use, with their BAI scores higher 
than the women who did not report a family history of alcohol and/or drug use. Similar 
findings are reported in the literature. McLeod and colleagues (McLeod, Foster, Hoehn-
Saric, Svikis, & Hipsley, 1994) investigated the relationship between family history of 
alcoholism and increased levels of anxiety symptoms in a group of women that were 
being treated for generalized anxiety disorder (n = 54). The majority of the sample (76%) 
reported an alcohol use disorder in a first degree relative. Investigators specified that 
within the group of women that reported a family history of alcohol use disorder, the 
majority of them (74%) reported paternal family history. The current study did not 
specify which relative had a history of alcohol and/or drug use. Determining maternal or 
paternal history, as well as multi-generational information would have added depth to the 
family history aspect of the current study. 
 
Similarly, anxiety disorders were prevalent among subjects (N = 454) with a 
family history of alcohol dependence in a longitudinal study of college students 
(Kushner, Sher, & Erickson, 1999). Additional literature reflects that children born to 
parents with a history of substance use disorders have been shown to be at greater risk for 
developing drug and alcohol abuse problems of their own, as well as problems with 
anxiety and depression (Barnard & McKeganey, 2004; Clark, Cornelius, Wood, & 
Vanyukov, 2004; S. L. Harter, 2000). Family history of alcohol and/or drug use revealed 
inconsistent associations, with elevated BAI scores noted in the group of non-pregnant 
women but not the pregnant group.  Alternative explanations for the confounding results 
could be a result of participants’ inability to accurately recall family histories or possible 
reluctance to report potentially embarrassing family histories. 
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 Acquired Vulnerabilities and Anxiety Symptoms 
 The findings indicated that the women, both pregnant and non-pregnant, who 
reported active substance use and poor sleep quality, had elevated BAI scores. Similar 
results are noted in published studies, with elevated anxiety symptoms found in 
populations of alcohol and drug using women (Dixit & Crum, 2000; Holahan et al., 2003; 
Schutte et al., 1995). As noted with depressive symptoms, HIV disclosure status was 
unexpectedly associated with increased anxiety symptoms in the group of pregnant 
women, indicating that women who had disclosed their HIV status demonstrated elevated 
anxiety symptom scores on the BAI.  Negative consequences of HIV disclosure, such as 
rejection and isolation, have been reported (Lovejoy, 1990). However, suppressing 
communication about difficult experiences increases the likelihood of stress-related 
problems (Greenberg & Stone, 1992; Holahan et al., 2003; Pennebaker, Colder, & Sharp, 
1990). Therefore, the concept that disclosing one’s HIV status would be the first step in 
communicating about HIV and thereby gaining social support, which in turn could 
decrease stress and anxiety. The unexpected findings in the current study could be 
attributed to the shame and stigma that is often associated with HIV, and possibly 
experienced by this group of pregnant women after they disclosed their HIV status.  
 
The study findings indicated that poor sleep quality was significantly and 
positively associated with anxiety symptoms in both groups (pregnant and non-pregnant) 
of women, although conflicting reports are noted in the literature. Published literature 
reveals sleep disturbances in persons with anxiety symptoms in studies involving both 
objective (e. g. sleep somnography) assessments (Fuller, Waters, Binks, & Anderson, 
1997; Kripke et al., 2004) and subjective (e. g. self reported) sleep assessments (Kripke et 
al., 2004; Neubauer, 2004; Nokes & Kendrew, 2001).  Other studies report the absence of 
significant associations between sleep disturbances and anxiety (Darko, Mitler, & White, 
1995; Norman et al., 1992).  
 
 
AIM FOUR. PREDICTORS OF DEPRESSIVE SYMPTOMS 
Inherited Vulnerabilities and Depressive Symptoms  
Although both inherited and acquired vulnerabilities were explored, acquired 
vulnerabilities were the only significant predictors of depressive symptoms in this sample 
of non-pregnant women. Neither family history of mood disorders nor family history of 
alcohol and/or drug use was a significant predictor of depressive symptoms in the current 
study. These findings were in contrast to much of the published literature, which reports 
these inherited vulnerabilities as predictors for depressive symptoms. Family history of 
mood disorders has been a strong predictor of mood disorders (Gershon et al., 1982; 
Klein et al., 2001; Weissman et al., 1987; Weissman et al., 1997; Weissman et al., 2005). 
Many studies of families of adults have shown that children born to parents with major 
depressive disorder have a three-fold risk of experiencing major depressive disorder 
themselves (Downey & Coyne, 1990; Lieb et al., 2002; Williamson et al., 2004).  Results 
of multiple studies have also found a significant positive association between family 
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 history of substance use and mood disorders (Clark et al., 2004; Kendler, Davis, & 
Kessler, 1997; Maier et al., 1994). Differences noted in the current study and previously 
published literature could be related to the small number of women who reported positive 
family histories. Only 22 of the 60 non-pregnant women in the sample (36.67%) reported 
a family history of alcohol and/or drug use. Thus, the study may have not been 
sufficiently powered to detect the influence of this variable on depressive symptoms.  
 
Acquired Vulnerabilities and Depressive Symptoms 
The findings indicated that the acquired vulnerabilities of current alcohol and/or 
drug use and poor sleep quality were predictive of higher depressive symptom scores in 
this population of non-pregnant African American women. Substance use has been 
consistently identified in the literature as a predictor of depressive symptoms. The results 
of the current study are consistent with previous literature (Clark et al., 2004; Holahan et 
al., 2003; Kendler et al., 1997; Olfson et al., 2000). Alcohol and/or drug use has been 
associated with depressive symptoms in the general population and many studies have 
described the relationship between alcohol use and mood disorders (Clark et al., 2004; 
Dixit & Crum, 2000; Holahan et al., 2003; Schutte et al., 1995).  
 
Poor sleep quality was a significant predictor of depressive symptoms in this 
population of non-pregnant African American women. The findings in the current study 
are consistent with much of the previous literature. Norman and colleagues (Norman et 
al., 1992) report similar findings in their sample of asymptomatic HIV-infected men and 
Lee and Miramontes (Lee et al., 2001) report similar findings in their sample of HIV-
positive women.  The latter study examined the relationship between sleep, depression, 
and fatigue in a group of HIV-positive women (N=100). While the Lee and Miramontes 
(Lee et al., 2001) study examined subjective measurements of depressive symptoms and 
fatigue and objective measurements of sleep efficiency, and the current study examined 
subjectively reported sleep quality and depressive symptoms, results are comparable.  
 
 
AIM FIVE. PREDICTORS OF ANXIETY SYMPTOMS 
Inherited Vulnerabilities and Anxiety Symptoms 
The findings indicated that acquired vulnerabilities served as predictors of anxiety 
symptoms in this group of non-pregnant women. Again, the acquired vulnerabilities of 
current alcohol and/or drug use and poor sleep quality were the only predictors of anxiety 
symptoms in this group of non-pregnant women.  Inherited vulnerabilities, family history 
of mood disorders and family history of alcohol and/or drug use, were not predictors of 
anxiety symptoms in this sample. Although important historical markers, the presence of 
these inherited vulnerabilities were not significant predictors of anxiety symptoms. In 
addition, family history of mood disorders was present in 22 of the non-pregnant women 
in the sample (36.67%), while 22 women (36.67%) in the group of non-pregnant women 
110 
 reported a family history of alcohol and/or drug use.  Low numbers of participating 
pregnant women could have hindered the ability to detect significant associations.  
 
Acquired Vulnerabilities and Anxiety Symptoms 
The acquired vulnerabilities that were predictors of depressive and anxiety 
symptoms in this group of non-pregnant African American women who are HIV-positive 
were alcohol and/or drug use and sleep quality. The findings indicated that the acquired 
vulnerability of alcohol and/or drug use significantly predicted anxiety symptoms in this 
group of non-pregnant African American women. Consistent with previous studies, 
higher levels of anxiety symptoms have been associated with alcohol and/or drug use in 
populations of adults (Burke, Burke, & Rae, 1994; Christie et al., 1988; Kushner et al., 
1999) women (K. P. Conway, Compton, Stinson, & Grant, 2006), African Americans 
(Ginsburg & Drake, 2002), and HIV-positive persons (Bing et al., 2001). Alcohol use 
disorders have been associated with higher rates of major depressive disorders (Goodwin, 
Kroenke, Hoven, & Spitzer, 2003).  
 
Although substance use has been well documented as a correlate of mood 
disorders (R. C. Kessler, McGonagle, Zhao et al., 1994; Regier et al., 1990), the evidence 
related to sleep assessment, including sleep quality and sleep hygiene is limited. Sleep 
quality and dysfunction have been studied in HIV-positive women as predictors of 
fatigue (Mock et al., 2002). Overlapping characteristics may have been present within the 
current study, as poor sleep quality is a common complaint among patients with HIV 
infection (Darko et al., 1998; Darko et al., 1995; Mock et al., 2002; Penzak et al., 2000), 
alcohol use disorders (Dahl et al., 2003), depression (Darko et al., 1992; Mock et al., 
2002; Norman et al., 1992),  and anxiety (Neubauer, 2004). 
 
Poor sleep quality was noted in the majority of the sample. Although poor sleep 
quality has been associated with mood disorders (Darko et al., 1992; Mock et al., 2002; 
Neubauer, 2004; Norman et al., 1992) sleep assessments are not routinely obtained or 
documented in the medical record (Rubinstein & Selwyn, 1998). Although the PSQI has 
been widely used as an instrument for measuring sleep quality, it does not address the 
physical or environmental characteristics that directly affect sleep quality. The synergistic 
and circular nature of insomnia and mood disorders has been discussed and bidirectional 
relationships revealed (Neubauer, 2004). Therefore, comprehensive sleep quality 
assessments, which include environmental aspects, should be incorporated into routine 
HIV care.  
 
 
LIMITATIONS AND STRENGTHS 
 This study had four limitations. First, this study implemented a cross-sectional, 
descriptive correlation design. This research design identifies associations present 
between and among variables during a specific point in time. Cross-sectional designs do 
not permit the exploration of changes over time, nor do they permit exploration of cause 
and effect. Neither the chronicity of symptoms, nor the recurrences of symptoms are 
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 captured in cross-sectional studies. Thus, these results concerning levels of anxiety and 
depressive symptoms, support associations with inherited and acquired vulnerabilities, 
but do not address causality, changes over time,  or disease progression.  
 
The second limitation was convenience sampling; the fact that the entire sample 
was recruited from health care clinics indicated that these women were receiving health 
care. Consequently, women who did not receive routine health care were excluded from 
the sample. This subgroup women, who were not available to participate in this study 
could have experienced higher or lower rates of depressive and anxiety symptoms than 
the participants in the current study. Therefore, the results of the current study may be 
biased, limiting the external validity of the study findings to other populations. Randomly 
selected study participants would have strengthened the design of the study however this 
is seldom possible in health-related research.  
 
The majority of the sample in the current study was poor, reporting an annual 
household income below 5000.00. Higher rates of depressive illness have been reported 
in poor populations (Everson et al., 2002; Gazmararian et al., 1995; Huurre, Eerola, 
Rahkonen, & Aro, 2007). Low levels of education (less than high school degree or 
equivalent) were noted in only nine (11.25%) of the participants. A third of the sample 
[28 (35%)] had some college experience, and 19 (23.75%) reported a Bachelor’s degree 
or higher. Study results show that educated women expose themselves to the risk of HIV 
infection. The inclusion of a wider range of socioeconomic levels would have enhanced 
the external validity of the study, although the sample in the current study reflects current 
HIV demographic trends (Centers for Disease Control and Prevention, 2007c). 
 
  Lastly, self-rated and self-reported measures of anxiety and depressive 
symptoms, as well as alcohol and/or drug use may not accurately capture precise 
information.  Self-reporting of anxiety and depressive symptoms may be limited due to 
embarrassment and may not address the actual presence of symptoms. The ability of self-
report measurements for depressive and anxiety symptoms to discriminate between 
persons with true depressive and anxiety symptoms and persons with false positive 
results is never 100% accurate (Sharp & Lipsky, 2002). The CES-D, EPDS, and BAI are 
all recommended as screening instruments. Self-rated evaluations of depressive and 
anxiety symptoms have demonstrated both harms and benefits. According to the United 
States Preventive Services Task Force (United States Preventive Services Task Force, 
2002), the potential benefits of screening for depressive disorders include identifying 
those who need treatment, reducing morbidity and mortality, and improving quality of 
life, while potential harms of screening include false-positive screening results, adverse 
effects related to labeling persons with false positive results, as well as treating persons 
with false-positive results.  Since all symptom information was self-reported, a complete 
accurate account of symptomatology may not have been portrayed, due to factors such as 
denial or hurried completion of instrumentation.  
 
Conflicting accounts have been published regarding the reporting of 
psychological symptoms by African Americans. Plant and Sachs-Ericsson (Plant & 
Sachs-Ericsson, 2004) and colleagues report that ethnic minority women report more 
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 depressive symptoms than Caucasian women, while Wallsten (Wallsten, 2000) reports 
that African Americans also are less likely to report psychological symptoms. George and 
Lynch (George & Lynch, 2003) report that African Americans experience greater stress 
than White Americans, therefore experience greater depressive symptoms than White 
Americans. However, African Americans are less likely to seek outpatient mental health 
care (Alegria et al., 2004; K. Wells et al., 2001) than their white counterparts and are 
underrepresented in published research studies, further limiting comparisons across 
studies. 
 
Self-reporting of current alcohol and/or drug use was used in the current study. 
This created another bias; participants may have chosen to not report illegal drug use. 
Literature illustrates several reasons person may be untruthful regarding alcohol and/or 
drug use. Fear of being reported to the authorities, fear of legal implications, 
embarrassment, or distrust of the healthcare system (S. M. Smith et al., 2006). 
Participants may have engaged in alcohol and/or drug use, but did not want their medical 
care provider to know, therefore reported no use or lower levels of use. The under 
reporting of alcohol and/or drug use may have occurred in the pregnant group, as society 
does not view substance use as acceptable behavior in pregnant women. Despite these 
factors related to accuracy of self-reported alcohol and /or drug use assessments, 
literature suggests the majority of self-reports are valid (Alegria et al., 2004; Latkin, 
1997; Sobell & Sobell, 1978). Literature reports the accuracy of self-reported 
measurements of substance use can be enhanced if the participant is not under the 
influence of alcohol and/or drugs, completes the assessment or interview in a clinical 
research setting, and is ensured confidentiality (Sobell & Sobell, 1978). Although 
assessments were performed at clinical locations and participants were informed of 
confidentiality and questionnaire coding, the possibility of inaccurate reports of substance 
use remains.  
 
Concomitant psychological assessment by a psychologist or psychiatrists would 
have strengthened the results and possibly given a more accurate portrayal of the mental 
health of the participants. Additional interviews with the researcher and health care 
providers could have added to a complete assessment of symptomatology. Follow-up data 
could have provided additional information regarding results of psychiatric evaluations 
that were conducted as a result of reported depressive and anxiety symptomatology. 
Furthermore, the comparison of clinical assessments with questionnaire scores would 
have provided additional validity to the study.  The present study results are reflective of 
self-reported assessments of depressive and anxiety symptoms in this population of 
African American women.  
 
 Despite these methodological limitations, the present study has several strengths. 
This was the first study to examine specific inherited and acquired vulnerabilities in 
African American women who were HIV-positive. Most studies have examined the 
effects of family history of mood disorders or family history of alcohol and drug use in 
mentally ill or clinically depressed populations. The present study examined actual 
predictors of symptoms, which may aid health care providers in the comprehensive care 
of patients, increasing their ability to anticipate complications based on patients’ specific 
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 family and personal histories. Educational level, income level, alcohol and/or drug use, 
history of sexual assault or abuse, HIV disclosure status, and sleep quality were acquired 
vulnerabilities that was explored in the current study. Although educational level, income 
level, and alcohol and/or drug use are aspects that have previously been identified and 
studied as predictors of mood disorders, the relationships of these variables as they apply 
to HIV-positive women have not fully been explored. Women and minorities continue to 
be underrepresented populations in research studies, particularly research pertaining to 
HIV/AIDS. As women of color are significantly affected by HIV, and AIDS is the 
number one killer of African American women between the ages of 25 and 34 in the 
United States, their inclusion in research becomes important and necessary.  
 
The assessment of history of sexual abuse or assault, HIV disclosure status, and 
sleep quality were vulnerabilities that have not fully been explored in this population of 
HIV-positive African American women.  Although history of sexual abuse and assault 
and HIV disclosure status were not predictors of depressive or anxiety symptoms in this 
population of African American women, these vulnerabilities should be assessed in 
clinical settings, as they have been shown to be relevant to mood disorders in other 
studies pertaining to women (Barbe et al., 2004). In this group of HIV-positive women, 
33 (41.25%) reported a history of sexual assault. However, 40 women (50%) reported 
first sexual experience that occurred when they were younger than age 18 and their 
partner was at least 3 years older, which legally constitutes statutory rape in the state of 
Tennessee. Seventeen of these women reported histories of sexual assault; therefore, if 
the additional 23 women were added to the total number of sexual assault histories, the 
total would be 53 (66.25%) of the sample.  
 
Additionally, the exclusively African American sample of women in the current 
study’s sample provides an important contribution. Women and minorities continue to be 
underrepresented in research studies; therefore this study adds information to the body of 
literature. Although much of the earlier HIV literature reflected White, male, homosexual 
populations, the demographic characteristics of more recent studies reflect the changing 
face of AIDS. As HIV continues to disproportionately affect minorities in the United 
States, additional studies comprised of African American samples becomes imperative.  
 
An additional strength of the study was that subjects were recruited from 
outpatient clinics that employed specialists in the field of HIV. The reputation of the 
clinics for their expertise in HIV care and management resulted in population of patients 
that encompassed a variety of socio-economic levels. Although most of the sample that 
participated in the current study was poor and unemployed, the expertise of the clinical 
sites increased the likelihood that patients from a wider range of socioeconomic levels 
was available in the population from which the sample was recruited. Wider ranges of 
socioeconomic levels and inclusion of both rural and urban populations would have 
enhanced the external validity of the study.  
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 IMPLICATIONS 
The results of this study have important implications for health care practice. 
Increased awareness of potential vulnerabilities to depressive and anxiety symptoms by 
healthcare providers may lead to increased screening for mood disorders. Research has 
shown that primary care physicians fail to recognize and treat 30% to 50% of adult 
depressed patients (Simon, Goldberg, Von Korff, & Ustun, 2002; Von Korff & Simon, 
1996).  Moreover, failure to detect depression may be greater for African American or 
Hispanic patients and for patients under 35 years (Borowsky et al., 2000).  Therefore, the 
need for accurate, comprehensive screening and assessment of depressive and anxiety 
symptoms in the health care setting remains crucial. Comprehensive screening as a 
holistic approach may assist in the integration of mental health services into primary care 
(Dodds et al., 2000).  
 
The current study revealed the presence of sub-clinical levels of anxiety and 
depressive symptoms in some participants and potentially clinical levels in others, 
establishing the need for individual, ongoing assessment of vulnerabilities. Identification 
of patients needing further evaluation and treatment may decrease adverse events and 
psychological related hospitalizations. About 50% of women in the sample had scores 
requiring referral to the social worker. Although no participant in the current study 
required immediate hospitalization, two of the participants were started on anti-
depressants the day of study participation. These two women were referred to their 
provider based on their elevated study questionnaire scores and additional clinical 
assessment prior to initiating treatment antidepressant drugs. Current treatment with 
antidepressants was not an exclusion criterion for the current study.  Nine (15%) of the 
non-pregnant women (n=60) were on antidepressants at the time of their participation in 
the study; nevertheless eight of these women had elevated depressive symptom scores. 
Therefore, the assessment of adequacy and efficacy of psychiatric medications is 
indicated as an ongoing aspect of comprehensive health care. In this sample of women, 
medication treatment was not consistently associated with sub-clinical symptom levels. 
No assessment was made, however regarding the duration of antidepressant therapy. 
 
The overwhelming presence of poor sleep quality in the sample, combined with 
the association of poor sleep quality with anxiety and depressive symptoms, demonstrates 
the need for routine assessment and documentation of sleep practices. Although sleep 
disturbances were common in the HIV-positive women in this study and other studies, 
assessment of sleep is not routinely documented in patients’ medical records (Rubinstein 
& Selwyn, 1998). The adverse effects of poor sleep quality are multifaceted. Sleep and 
health are impacted by the immune system. Sleep disturbances have been shown to 
worsen as the course of HIV worsens (Darko et al., 1998; Mock et al., 2002; Nokes & 
Kendrew, 2001; Sobell & Sobell, 1978). Poor sleep quality has been associated with 
increased morbidity and mortality in HIV-positive persons (Darko et al., 1998). 
Immunological molecules, including cytokines, impact sleep regulation (Motivala, 
Sarfatti, Olmos, & Irwin, 2005).   Impaired sleep is often a symptom of psychiatric 
disorders, including anxiety and depression (Neubauer, 2004), while chronic insomnia is 
a risk factor for the development and recurrence of psychiatric disorders (Lustberg & 
Reynolds, 2000). Women with poor sleep quality were not being treated for insomnia, 
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 indicating either a lack of appropriate screening or insufficient communication with their 
provider. Therefore, assessment of sleep quality and sleep disturbances should be part of 
comprehensive medical care, and documented as such particularly in patients who are 
HIV positive.  
 
Increased adherence to antiretroviral medications may prolong the duration of the 
regimen as well as decrease transmission of medication resistant virus (A. Ammassari et 
al., 2004). The relationship of decreased antiretroviral adherence and mood disorders has 
been well established. Depression in persons who are HIV-positive often results in 
decreased adherence to antiretroviral medications (Chander, Lau, & Moore, 2006; 
Starace et al., 2002) and increased risk-taking behaviors (Croughan, Miller, Wagelin, & 
Whitman, 1982; Hutton, Lyketsos, Zenilman, Thompson, & Erbelding, 2004; Valente, 
2003). A significant percentage of the participants in this study had CES-D, EPDS, and 
BAI scores requiring immediate referral to the social worker, suggesting that patients 
were not routinely assessed for signs and symptoms of depression or anxiety, despite the 
fact that they were routinely receiving health care. As adherence to HAART can be 
reduced by comorbid psychiatric disorders (Starace et al., 2002) it is imperative that 
comprehensive psychosocial assessments, including routine screening for depressive and 
anxiety symptoms, be a routine aspect of HIV care, similar to the practice of obtaining 
laboratory evaluations.   
 
Adherence to antiretroviral medications has been inversely related to substance 
use in HIV-positive persons (Chander et al., 2006; Welch, 2000). The most common 
substance used by women in the current study was alcohol, with 19 of the 24 women that 
reported substance use reporting recent alcohol use. Routine assessment of substance use 
is crucial to comprehensive HIV care. Collectively, these study results indicate the 
importance of comprehensive assessments of potential vulnerabilities.  Inquiry regarding 
substance use and sleep quality, along with interval antiretroviral adherence assessments, 
may increase the early identification of adherence problems. Noncompliance is one of the 
main causes of antiretroviral resistance. Identification of barriers to adherence may 
lengthen the time the person is able to use a specific antiretroviral regimen. In addition to 
comprehensive assessment, thorough documentation is vital to patient care.  
 
The vast majority (92.5%) of the sample had disclosed their HIV status to others. 
Thus, it was not possible to show an association between disclosure and depressive and 
anxiety symptoms as there was limited variability in HIV disclosure status. Despite this 
finding, disclosure remains an important aspect of HIV. Increased disclosure of HIV 
status to sex partners has the potential to decrease HIV transmission. Failure to disclose 
HIV status can have devastating effects on public health. The most effective means of 
HIV prevention among sexually active persons is consistent condom use (Centers for 
Disease Control and Prevention, 2005).  Lack of consistent condom use has been shown 
to be prevalent in persons that did not disclose their HIV status to their partner (Chander 
et al., 2006; Niccolai et al., 1999; Stein et al., 1998; Stein & Samet, 1999). Disclosure of 
HIV status to family members and/or friends may help decrease stigma related to HIV, 
while increasing support systems for patients. Stigma has been shown to “thrive in an 
environment of ignorance and half-truths” (Valdiserri, 2002) p. 342). Therefore, HIV 
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 education and awareness would be the first step utilized to decrease stigma. Although 
HIV disclosure was not a predictor of anxiety or depressive symptoms in the present 
study because virtually all participants reported disclosing their status, the assessment of 
HIV disclosure remains an important aspect of HIV care, and should be addressed 
regularly as part of an ongoing psychosocial assessment.  
 
Although cross-sectional data do not describe incidences that are present over 
time, they do describe a snapshot assessment of individual characteristics. In the present 
study, the participants expressed a multitude of psychological and social burdens that 
would not have been assessed in a regular clinical appointment. The completion of the 
study instruments led many patients to expound upon their experiences, thereby opening 
communication with the clinical researcher. This type of revelation was often 
accompanied by tears and expressions of relief that they were able to share their 
experiences, concerns, and secrets with someone. Some participants reported being 
victims of incest; while others disclosed a spouse’s suicide after a participant was 
diagnosed with HIV; another reported weekly childhood rape by the man that transported 
the participant to church every Sunday; and another reported displacement from her New 
Orleans home and trauma related to hurricane Katrina. These unplanned discoveries 
suggest that including psychosocial assessments in the care of persons who are HIV 
positive would add additional support for the patient, as well as enhance providers’ 
insights into the lives of patients. Ongoing assessments, such as social work or case 
management assessments at every visit, not only when a patient expresses a concern or 
crisis, could provide an opportunity for patients to share some of these challenging 
aspects of their lives. The inability to share traumatizing experiences may increase 
depressive symptoms in this population. Depressive symptoms have been shown to 
negatively affect HIV/AIDS treatment outcomes (A. Ammassari et al., 2004; Ickovics et 
al., 2001; Lyketsos et al., 1996; Starace et al., 2002; Vyavaharkar et al., 2007), often 
impacting adherence with HAART (A. Ammassari et al., 2004; A. A. M. Ammassari et 
al., 2003; Starace et al., 2002; Vyavaharkar et al., 2007).   
 
 
THEORETICAL IMPLICATIONS 
Study findings provide partial support for the stress diathesis model as two of the 
acquired vulnerabilities were significant predictors of anxiety and depressive symptoms. 
The identification of vulnerabilities, both inherited and acquired, is an important tool in 
comprehensive psychosocial assessments. The occurrence of stressful life events has 
been found to increase the probability of a depressive episode in elderly populations 
(Emmerson, Burvill, Finlay-Jones, & Hall, 1989), as well as populations of HIV-positive 
women (Moore et al., 1999). Two acquired vulnerabilities, alcohol and/or drug use and 
poor sleep quality, were significant predictors of anxiety and depressive symptoms. 
Comorbid alcohol and/or drug use and psychiatric disorders have been well-documented 
in the general population (Helzer & Pryzbeck, 1988; R. C. Kessler et al., 1997; Regier et 
al., 1990; Starace et al., 2002; Vyavaharkar et al., 2007). The relationship between sleep 
quality and depression in the HIV-positive population is also well documented (Darko et 
al., 1992; Mock et al., 2002; Norman et al., 1992). The inherited vulnerability of family 
history of mood disorders was associated with higher CES-D, EPDS, and BAI scores in 
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 the study sample. Findings were similar to previously published literature (Gutman & 
Nemeroff, 2003) suggesting that the assessment of pertinent inherited and acquired 
vulnerabilities should be a part of the routine assessment of African American women 
who are HIV-positive to identify women that may be at an increased risk for mood 
disorders.  
 
 
FUTURE RESEARCH 
Study findings provide guidance for future research in this population of women. 
Future directions might include a longitudinal study that would follow participants over 
time, thereby assessing the presence of vulnerabilities, depressive and anxiety symptoms 
and other long-term outcomes related to the HIV-diagnosis. This type of research would 
add to the understanding of the effects of stress over time, which may be especially 
important in immunocompromised populations, such as those persons with HIV.  Poor 
sleep quality was a predictor of anxiety and depressive symptoms in the current study and 
insomnia has been associated with psychiatric disorders, including depression (Lustberg 
& Reynolds, 2000). Future studies should include assessment of sleep quality and sleep 
hygiene, as well as test of established interventions that could improve sleep quality in 
the study population.  
 
Conflicting evidence regarding the impact of sleep quality and HIV disease 
progression is noted in the literature. The impact of sleep quality on immunity (decrease 
in CD4 count) has been illustrated in several studies (Darko et al., 1992; Mock et al., 
2002; Norman et al., 1992). Confounding results were noted in other studies involving 
HIV-infected populations (Nokes, Chidekel, & Kendrew, 1999; Perkins et al., 1994; 
Rubinstein & Selwyn, 1998), showing no effect of insomnia on immunologic markers 
(CD4 count). The relationship between sleep and CD4 counts was not assessed in the 
current study, although on average participants had counts of 505. The effect of poor 
sleep quality in HIV-positive women has been well documented (Lee et al., 2001; Mock 
et al., 2002). Sleep quality has the ability to affect many facets of well-being. Quality of 
life in HIV-positive women has been associated with increased sleep quality and other 
health-promoting behaviors such as exercise, stress management, and healthy eating 
habits (Gielen, McDonnell, Wu, O'Campo, & Faden, 2001). Therefore, future studies 
should include not only sleep assessments, but also interventions that can improve sleep 
quality. 
 
Stigma, shame, and fear continue to be additional stressors related to HIV, which 
often delay or prevent treatment (Valdiserri, 2002). In the current study, six of the 
participants (7.5%) had not disclosed their HIV-positive status. The CDC (Branson et al., 
2006) estimates that of the approximately 1 to 1.2 million persons living with HIV in the 
United States about 25% (252,000-312,000 persons) were unaware of their infection. It is 
thought that many of these persons have unknowingly transmitted HIV. The lack of 
awareness of current HIV infection leads to two main issues: 1) increased numbers of 
HIV transmission and 2) lack of medical care, thereby increasing morbidity and mortality 
related to HIV/AIDS (Branson et al., 2006). Therefore, future research should 
concentrate on the factors that are related to these difficulties.   
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Future research studies should include structured clinical interviews as well as 
self-report measurements of depressive and anxiety symptoms. This comprehensive 
approach would provide a more thorough and accurate mental health assessment, as self-
report measures are often confounded by denial and under reporting of symptoms. This 
comprehensive approach would identify persons in need of additional screening, referral, 
and treatment. Self-esteem measurement might provide insights regarding the mental 
health status of African American women who are HIV-positive. Research has shown 
that self esteem decreases as a result of severe mental illness (Shahar & Davidson, 2003). 
Additionally, poor self-esteem commonly occurs in the context of depressive symptoms, 
particularly in women.  
 
Future research should also include a comprehensive housing assessment, as 
housing situations in this population are often unstable, unsafe, and nonpermanent. 
Almost half (45%) of the HIV-positive persons served by the Ryan White Care Act in 
2002 (N=844,687) reported non-permanent housing (USDHHS Health Resources and 
Services Administration, 2002). Although housing is transient, and often temporary for 
persons with HIV, this issue was not systematically explored in the study sample. 
However, several study participants (9, 11.25%) shared concerns related to this issue. 
Concerns such as these, if persistent, likely serve as an acquired vulnerability that 
contributes to the risk for depression and anxiety. 
 
Early postnatal screening measures should be studied further, especially in 
minority populations, as they have been grossly underrepresented in previous research. 
Literature suggests that EPDS scores within the first few days of delivery are highly 
correlated with EPDS obtained at four to six weeks postpartum (Chabrol & Teissedre, 
2004; Hannah et al., 1992). Implementing routine screening of postpartum women before 
hospital discharge may identify those women at risk for postpartum depression earlier, 
thereby decreasing risks associated with postpartum depression for both mother and baby.  
 
Finally, additional research should include qualitative or mixed methods studies 
to explore the specific factors that contribute to mood disorders, HIV disclosure, and 
decision making processes related to family planning in the HIV-positive population. 
Qualitative research can aid the progress of nursing research by guiding research that has 
a direct impact on nursing practice (Barroso & Powell-Cope, 2000). There are existing 
qualitative research studies in the HIV literature regarding adherence to antiretroviral 
medication and barriers to care (Bunting et al., 1999; Bunting & Seaton, 1999), and a 
qualitative meta-analysis, or metasynthesis, explored the experience of living with HIV 
(Barroso & Powell-Cope, 2000). Future research could use focus groups in different 
types of populations to explore sleep quality and sleep hygiene practices, as poor sleep 
quality had an impact on depressive and anxiety symptoms in this study. Sleep is affected 
by many factors which should be explored in other populations as well. Environmental 
factors such as temperature, noise levels, numbers of children in the home, numbers of 
people in the bed, and insect infestation in the home were some of the points the 
participants reported at the end of questionnaire completion. Findings from the current 
study reveal that women present with a multitude of histories and vulnerabilities that are 
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 often complex.  Qualitative research may lead to a greater understanding of the meaning 
of being HIV-positive, which may help researchers and healthcare providers gain 
understanding, rather than relying on preconceived ideas of what the experience of living 
with HIV is truly like.  
 
 
CONCLUSIONS 
This study provided insights regarding the impact of vulnerabilities, both 
inherited and acquired, on depressive and anxiety symptoms. Study findings emphasize 
the importance of comprehensive assessments and ongoing communication with patients. 
Participants were willing to disclose additional challenges they faced on a daily basis and 
often valued the opportunity to share their personal stories. Disclosing their concerns, for 
many participant,  was therapeutic. This study highlighted alcohol and/or drug use and 
poor sleep quality as predictors of depressive and anxiety symptoms in a sample of non-
pregnant African American women who were HIV-positive. Key findings in both groups 
of women included significant associations between both inherited and acquired 
vulnerabilities and elevated depressive and anxiety symptom scores. Alcohol and/or drug 
use and poor sleep quality were the acquired vulnerabilities that were significantly and 
positively associated with increased depressive and anxiety scores in both groups of 
women. Family history of  mood disorders was significantly and positively correlated 
with depressive and anxiety symptoms in the group of pregnant women; while family 
history of mood disorders was significantly and positively associated with elevated 
anxiety symptom scores in the group of non-pregnant women. Additional findings in the 
non-pregnant group revealed an unexpected significant positive association between HIV 
disclosure status and elevated CES-D scores, indicating that women that had disclosed 
their HIV status reported more depressive symptoms. However, this association did not 
occur for EPDS scores.  
 
Developing specific evidence-based interventions remains an important aspect of 
clinical research and practice, particularly with regard to the poor sleep quality that 
occurred in an important proportion of study participants. While the participants in this 
study were exclusively African American women who were HIV-positive, findings could 
be relevant for other populations who share similar experiences and vulnerabilities. 
Underserved populations, including racial and ethnic minorities, continue to receive 
inadequate mental health treatment, often because of stigma and poor access to care. 
Decreasing the stigma related to both HIV and mental illness, may increase access to 
healthcare services and improve health outcomes in this population. Addressing unmet 
needs of traditionally underserved populations in the United States is a social imperative 
for all Americans as the experiences and unmet needs of these populations have 
important implications for the future health of this nation. 
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